UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 10-Q

 

(Mark One)

☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal period ended: December 31, 2020

 

☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _____ to _____

 

Commission File Number: 000-31810

 

 

 

Cinedigm Corp.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   22-3720962
(State or Other Jurisdiction of
Incorporation or Organization)
  (I.R.S. Employer
Identification No.)
     
237 West 35th Street, Suite 605, New York, NY   10001
(Address of principal executive offices)   (Zip Code)

 

(212) 206-8600

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol   Name of each exchange on which registered
CLASS A COMMON STOCK, PAR VALUE $0.001 PER SHARE   CIDM   NASDAQ GLOBAL MARKET

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

  

Large accelerated filer    Accelerated filer    Non-accelerated filer    Smaller reporting company    Emerging Growth Company 

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes No ☒    

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

As of February 19, 2021, 165,953,762 shares of Class A Common Stock, $0.001 par value, were outstanding.

 

 

 

 

   

CINEDIGM CORP.

TABLE OF CONTENTS

 

    Page
  PART I - FINANCIAL INFORMATION  
     
Item 1. Condensed Consolidated Financial Statements (Unaudited) 1
  Condensed Consolidated Balance Sheets at December 31, 2020 (Unaudited) and March 31, 2020 1
  Unaudited Condensed Consolidated Statements of Operations for the Three Months and Nine Months ended December 31, 2020 and 2019 2
  Unaudited Condensed Consolidated Statements of Comprehensive Loss for the Three Months and Nine months ended December 31, 2020 and 2019 3
  Unaudited Condensed Consolidated Statement of Equity (Deficit) for the Three Months and Nine Months December 31, 2020 and 2019 4
  Unaudited Condensed Consolidated Statements of Cash Flows for the Nine Months ended December 31, 2020 and 2019 6
  Notes to the Condensed Consolidated Financial Statements (Unaudited) 7
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 35
Item 4. Controls and Procedures 46
     
  PART II - OTHER INFORMATION  
     
Item 1. Legal Proceedings 47
Item 1A. Risk Factors 47
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 47
Item 3. Defaults Upon Senior Securities 47
Item 4. Mine Safety Disclosures 47
Item 5. Other Information 47
Item 6. Exhibits 47
Exhibit Index 48
Signatures 49

 

i

 

    

PART I - FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)

 

CINEDIGM CORP.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except for share and per share data)

 

    December 31,
2020
    March 31,
2020
 
    (Unaudited)        
ASSETS            
Current assets            
Cash and cash equivalents   $ 26,207     $ 14,294  
Accounts receivable, net     25,088       34,785  
Inventory, net     223       582  
Unbilled revenue     3,077       1,992  
Prepaid and other current assets     7,390       9,409  
Total current assets     61,985       61,062  
Restricted cash     1,000       1,000  
Equity investment in Starrise, a related party, at fair value     7,584       23,433  
Property and equipment, net     4,241       7,967  
Right-of-use assets    
-
      1,210  
Intangible assets, net     8,039       6,924  
Goodwill     8,701       8,701  
Other long-term assets     139       143  
Total assets   $ 91,689     $ 110,440  
LIABILITIES AND EQUITY (DEFICIT)                
Current liabilities                
Accounts payable and accrued expenses   $ 54,137     $ 77,085  
Current portion of notes payable, including unamortized debt discount of $146 and $460 respectively
(see Note 6)
    11,890       37,249  
Current portion of notes payable, non-recourse including unamortized debt discount of $— and $763, respectively (see Note 6)     11,153       11,442  
Operating lease liabilities     117       593  
Current portion of deferred revenue     1,336       1,645  
Total current liabilities     78,633       128,014  
                 
Notes payable     2,153      
 
Operating lease liabilities, noncurrent     17       684  
Deferred revenue, net of current portion     4       919  
Other long-term liabilities    
-
      110  
Total liabilities     80,807       129,727  
Commitments and contingencies (see Note 8)    
 
     
 
 
Stockholders’ equity (deficit)                
Preferred stock, 15,000,000 shares authorized; Series A 10% - $0.001 par value per share; 20 shares authorized; and 7 shares issued and outstanding at December 31, 2020 and March 31, 2020. Liquidation preference of $3,648     3,559       3,559  
Common stock, $0.001 par value; Class A stock 200,000,000 and 150,000,000 shares authorized at December 31, 2020 and March 31, 2020, respectively; 155,487,934 and 63,251,429 shares issued and 154,174,098 and 61,937,593 shares outstanding at December 31, 2020 and March 31, 2020, respectively     153       62  
Additional paid-in capital     487,418       400,784  
Treasury stock, at cost; 1,313,836 Class A common shares at December 31, 2020 and March 31, 2020     (11,603 )     (11,603 )
Accumulated deficit     (467,214 )     (410,904 )
Accumulated other comprehensive (loss) income     (94 )     92  
Total stockholders’ equity (deficit) of Cinedigm Corp.     12,219       (18,010 )
Deficit attributable to noncontrolling interest     (1,337 )     (1,277 )
Total equity (deficit)     10,882       (19,287 )
Total liabilities and equity   $ 91,689     $ 110,440  

 

See accompanying Notes to Condensed Consolidated Financial Statements

 

1

 

      

CINEDIGM CORP.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

(In thousands, except for share and per share data)

 

    Three Months Ended
December 31,
    Nine Months Ended
December 31,
 
    2020     2019     2020     2019  
Revenues   $ 9,954     $ 11,512     $ 23,154     $ 31,556  
Costs and expenses:                                
Direct operating (excludes depreciation and amortization shown below)     4,385       5,726       11,394       13,425  
Selling, general and administrative     5,361       2,997       15,369       13,834  
(Recovery) provision for doubtful accounts     70       (5 )     (123 )     321  
                                 
Depreciation and amortization of property and equipment     822       1,594       3,691       4,977  
Amortization of intangible assets     597       589       1,778       2,178  
Total operating expenses     11,235       10,901       32,109       34,735  
(Loss) income operations     (1,281 )     611       (8,955 )     (3,179 )
Interest expense, net     (948 )     (1,618 )     (3,432 )     (5,713 )
Loss on extinguishment of notes payable     (540 )    
      (852 )    
 
Change in fair value of equity investment in Starrise, a related party     (6,751 )    
      (42,377 )    
 
Other expense, net     (147 )     (1,019 )     (668 )     (1,187 )
Loss from operations before income taxes     (9,667 )     (2,026 )     (56,284 )     (10,079 )
Income tax benefit (expense)    
      (136 )     181       (210 )
Net loss     (9,667 )     (2,162 )     (56,103 )     (10,289 )
Net income (loss) attributable to noncontrolling interest     23       (7 )     60       (8 )
Net loss attributable to controlling interests     (9,644 )     (2,169 )     (56,043 )     (10,297 )
Preferred stock dividends     (89 )     (89 )     (267 )     (267 )
Net loss attributable to common stockholders   $ (9,733 )   $ (2,258 )   $ (56,310 )   $ (10,564 )
Net loss per Class A common stock attributable to common stockholders - basic and diluted:   $ (0.07 )   $ (0.05 )   $ (0.49 )   $ (0.26 )
Weighted average number of Class A common stock outstanding: basic and diluted     136,866,072       42,418,641       115,347,494       40,745,114  

   

See accompanying Notes to Condensed Consolidated Financial Statements

 

2

 

  

CINEDIGM CORP.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

(Unaudited)

(In thousands)

 

    Three Months Ended
December 31,
    Nine Months Ended
December 31,
 
    2020     2019     2020     2019  
Net loss   $ (9,667 )   $ (2,162 )   $ (56,103 )   $ (10,289 )
Other comprehensive (loss) income: foreign exchange translation     (76 )     (3 )     (186 )     25  
Comprehensive loss     (9,743 )     (2,165 )     (56,289 )     (10,264 )
Less: comprehensive income (loss) attributable to noncontrolling interest     23       (7 )     60       (8 )
Comprehensive loss attributable to controlling interests   $ (9,720 )   $ (2,172 )   $ (56,229 )   $ (10,272 )

 

See accompanying Notes to Condensed Consolidated Financial Statements

 

3

 

   

CINEDIGM CORP.

CONSOLIDATED STATEMENTS OF EQUITY (DEFICIT)

(Unaudited)

(In thousands, except share data)

 

    Series A Preferred Stock     Class A
Common Stock
    Treasury     Additional Paid-In     Accumulated     Accumulated Other Comprehensive     Total Stockholders’     Non-Controlling     Total  
    Shares     Amount     Shares     Amount     Shares     Amount     Capital     Deficit     Income     Deficit     Interest     Deficit  
Balances as of March 31, 2019           7     $ 3,559       35,678,597     $ 36       1,313,836     $ (11,603 )   $ 368,531     $ (395,814 )   $       10     $ (35,281 )   $ (1,287 )   $ (36,568 )
Foreign exchange translation          
           
      —
           
     
     
      6       6      
      6  
Stock-based compensation          
           
           
      11      
     
      11      
      11  
Preferred stock dividends paid with common stock    
     
      45,390      
     
     
      89       (89 )    
     
     
     
 
Net loss          
           
           
     
      (5,033 )    
      (5,033 )     (6 )     (5,039 )
Balances as of June 30, 2019     7       3,559       35,723,987       36       1,313,836       (11,603 )     368,631       (400,936 )     16       (40,297 )     (1,293 )     (41,590 )
Foreign exchange translation          
           
           
     
     
      22       22      
      22  
Stock-based compensation          
           
           
      178      
     
      178      
      178  
Issuance of Class A common stock    
     
      3,900,000       4      
     
      5,846      
     
      5,850      
      5,850  
Preferred stock dividends paid with common stock    
     
      65,749      
     
     
      89       (89 )    
     
     
     
 
Fair value of conversion feature in connection with convertible note          
           
           
      478      
     
      478      
      478  
Net (loss) income          
           
           
     
      (3,095 )    
      (3,095 )     7       (3,088 )
Balances as of September 30, 2019     7     $ 3,559       39,689,736     $ 40       1,313,836     $ (11,603 )   $ 375,222     $ (404,120 )   $ 38     $ (36,864 )   $ (1,286 )   $ (38,150 )
Foreign exchange translation          
           
           
     
     
      (3 )     (3 )    
      (3 )
Stock-based compensation          
           
           
      178      
     
      178      
      178  
Preferred stock dividends paid with common stock    
     
      102,345      
     
     
      89       (89 )    
     
     
     
 
Net (loss) income          
           
           
     
      (2,169 )    
      (2,169 )     7       (2,162 )
Balances as of December 31, 2019     7     $ 3,559       39,792,081     $ 40       1,313,836     $ (11,603 )   $ 375,489     $ (406,378 )   $ 35     $ (38,858 )   $ (1,279 )   $ (40,137 )

 

See accompanying Notes to Condensed Consolidated Financial Statements

  

4

 

   

CINEDIGM CORP.

CONSOLIDATED STATEMENTS OF EQUITY (DEFICIT)

(Unaudited)

(In thousands, except share data)

 

    Series A Preferred Stock     Class A
Common Stock
    Treasury     Additional Paid-In     Accumulated     Accumulated Other Comprehensive     Total Stockholders’
Equity
    Non-Controlling     Total
Equity
 
    Shares     Amount     Shares     Amount     Shares     Amount     Capital     Deficit     Loss     (Deficit)     Interest     (Deficit)  
Balances as of March 31, 2020          7     $ 3,559       61,937,593     $      62       1,313,836     $ (11,603 )   $ 400,784     $ (410,904 )   $      92     $ (18,010 )   $ (1,277 )   $ (19,287 )
Foreign exchange translation          
           
           
           
      (80 )     (80 )    
      (80 )
Stock issued in connection with the SPA with certain investors, net    
     
      10,666,666       11      
     
      7,139      
     
      7,150      
      7,150  
Issuance of Class A common stock in connection with the Starrise transaction, a related party    
     
      29,855,081       30      
     
      11,016      
     
      11,046      
      11,046  
Contributed capital under the Starrise transaction, a related party          
           
           
      17,187      
     
      17,187      
      17,187  
Issuance of stock in connection with settlement of second lien loan    
     
      329,501      
     
     
      757      
     
      757      
      757  
Exercise of warrants for Class A common stock    
     
      236,899      
     
     
      301      
     
      301      
      301  
Stock-based compensation          
           
           
      177      
     
      177      
      177  
Preferred stock dividends paid with common stock    
     
      267,079      
     
     
      89       (89 )    
     
     
     
 
Net loss          
           
           
     
      (19,856 )    
      (19,856 )     (14 )     (19,870 )
Balances as of June 30, 2020     7       3,559       103,292,819       103       1,313,836       (11,603 )     437,450       (430,849 )     12       (1,328 )     (1,291 )     (2,619 )
Foreign exchange translation          
           
           
           
      (30 )     (30 )    
      (30 )
July 2020 issuance of Class A common stock, net of $695 in issuance costs    
     
      7,213,334       7      
     
      10,118      
              10,125      
      10,125  
Common stock issued in connection with conversion of Convertible Notes    
     
      10,000,000       10      
     
      14,990      
     
      15,000      
      15,000  
Issuance of common stock for third party professional service    
     
      80,000      
     
     
      71      
     
      71      
      71  
Issuance of Class A common stock to management and employees    
     
      689,364       1      
     
      785      
     
      786      
      786  
Issuance of common stock in connection with performance stock units    
     
      373,647      
     
     
     
     
     
     
     
     
 
Common stock issued to settle second lien loan    
     
      33,465      
     
     
      61      
     
      61      
      61  
Stock-based compensation          
           
           
      178      
     
      178      
      178  
Preferred stock dividends paid with common stock    
     
      44,913      
     
     
      89       (89 )    
     
     
     
 
Net loss          
           
           
     
      (26,543 )    
      (26,543 )     (23 )     (26,566 )
Balances as of September 30, 2020     7     $ 3,559       121,727,542     $ 121       1,313,836     $ (11,603 )   $ 463,742     $ (457,481 )   $ (18 )   $ (1,680 )   $ (1,314 )   $ (2,994 )
Foreign exchange translation          
           
           
     
     
      (76 )     (76 )    
      (76 )
Common stock issued to settle second lien loan    
     
      3,228,783       5      
     
      2,185      
     
      2,190      
      2,190  
Preferred stock dividends paid with common stock    
     
      171,933      
     
     
      89       (89 )    
     
     
     
 
Stock compensation and expenses          
           
           
      794      
     
      794      
      794  
Issuance of Class A common stock to management    
     
      320,000      
     
     
      166      
     
      166      
      166  
Issuance of common stock in connection with performance stock units                 320,000                                                        
Issuance of common stock in connection with ATM raises, net    
     
      28,405,840       27      
     
      18,589      
     
      18,616      
      18,616  
Class A common stock to be issued in connection with asset acquisition          
           
           
      1,853      
     
      1,853      
      1,853  
Net loss          
           
           
     
      (9,644 )    
     

(9,644

)     (23 )     (9,667 )
Balances as of December 31, 2020     7     $ 3,559       154,174,098     $ 153       1,313,836     $ (11,603 )   $ 487,418     $ (467,214 )   $ (94 )   $ 12,219     $ (1,337 )   $ 10,882  

 

See accompanying Notes to Condensed Consolidated Financial Statements

5

 

  

CINEDIGM CORP.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(In thousands)

 

   

Nine Months Ended

December 31,

 
    2020     2019  
Cash flows from operating activities:            
Net loss   $ (56,103 )   $ (10,289 )
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:                
Depreciation and amortization of property and equipment and amortization of intangible assets     5,469       7,155  
Changes in fair value of equity investment in Starrise     42,377      
 
Loss on extinguishment of notes payable     852      
 
Loss from sale of property and equipment     62      
 
Amortization of debt issuance costs included in interest expense     140       992  
(Recovery) provision for doubtful accounts     (123 )     321  
Recovery for inventory reserve     (1,147 )     (460 )
Stock-based compensation     2,172       367  
Accretion and PIK interest expense added to note payable     294       1,189  
Changes in operating assets and liabilities;                
Accounts receivable     9,820       (5,713 )
Inventory     1,506       535  
Unbilled revenue     (1,085 )     654  
Prepaids and other current assets     2,045       (381 )
Accounts payable and accrued expenses     (21,831 )     12,014  
Deferred revenue     (1,224 )     (1,066 )
Net cash (used in) provided by operating activities     (16,776 )     5,318  
Cash flows from investing activities:                
Purchases of property and equipment     (339 )     (367 )
Sale of equipment     156        
Sale of equity investment in Starrise     815      
 
Purchases of intangible assets     (742 )     (10 )
Net cash used in investing activities     (110 )     (377 )
Cash flows from financing activities:                
Payment of notes payable     (22,365 )     (15,413 )
Proceeds under revolving credit agreement, net     12,823       1,224  
Proceeds from PPP Loan     2,152      
 
Proceeds from issuance of Class A common stock, net     36,189       5,850  
Net cash provided by (used in) in financing activities     28,799       (8,339 )
Net change in cash and cash equivalents     11,913       (3,398 )
Cash, cash equivalents, and restricted cash at beginning of period     15,294       18,872  
Cash, cash equivalents, and restricted cash at end of period   $ 27,207     $ 15,474  

 

See accompanying Notes to Condensed Consolidated Financial Statements

 

6

 

 

CINEDIGM CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(In thousands, except share information)

 

1. NATURE OF OPERATIONS AND LIQUIDITY

 

Cinedigm Corp. (“Cinedigm,” the “Company,” “we,” “us,” or similar pronouns) was incorporated in Delaware on March 31, 2000. We are (i) a distributor and aggregator of independent movie, television and other short form content managing a library of distribution rights to thousands of titles and episodes released across digital, physical, theatrical, home and mobile entertainment platforms and (ii) a servicer of digital cinema assets for over 12,000 movie screens in both North America and several international countries.

 

Risks and Uncertainties

 

The COVID-19 pandemic and related economic repercussions have created significant volatility, uncertainty, and turmoil in certain industries. Closures of certain entertainment facilities and retail locations have significantly impacted consumers’ behaviors as a result of the virus outbreak and corresponding preventative measures taken around the world to mitigate the spread of the virus. As part of our Content & Entertainment business, we sell physical goods, including DVDs and Blu-ray discs, at brick-and-mortar stores. Many of such stores in the United States closed during the spring of 2020 due to COVID-19 restrictions, and many of those have not yet re-opened, or have re-opened on a limited basis. We expect that we will experience a loss of sales of such physical goods due to such closures, and we cannot predict the extent of such losses, or how long the closures or limited openings of the stores may last. As part of our Cinema Equipment business, we earn revenues that are generated when movies are exhibited by theatres. Many movie theatres in the United States closed during the spring of 2020 due to COVID-19 restrictions and many of those have not yet re-opened, or have re-opened on a limited basis. The majority of major studios moved releases originally scheduled for the three months ended December 31, 2020 to future dates with the exception of two Studios that had theatrical releases that opened in theatres on the same day as becoming available on a streaming channel. To the extent movies are not shown in movie theatres due to the closures, we have not received, and will not receive, related revenue. The studios that produce movies may elect to delay the release of movies until theatres re-open, or to bypass exhibiting movies in theatres at all and distribute the movies through other means, such as on streaming platforms, in which case we would not earn revenues at all from such movies.

 

The East West Bank (“EWB”) credit facility has a maturity date of June 30, 2021. The Company intends to negotiate another extension of the EWB maturity date but in the event it is unable to do so successfully, the Company has the funds to pay the debt in full when due.

 

The Prospect Loan matures on March 31, 2021. The Company and Prospect are negotiating to extend the maturity date to March 31, 2022 which may include a prepayment amount on the principal upon execution of an amendment.

 

These events have negatively affected, and are expected to continue to negatively affect, our business and results of operations. Given the dynamic nature of these events, we cannot reasonably estimate the period of time that the COVID-19 pandemic and related closures and market conditions will persist, or the extent of the impact they will have on our business or results of operations and financial condition.

 

Liquidity

 

We have incurred net losses historically and have an accumulated deficit of $467.2 million and negative working capital of $16.6 million as of December 31, 2020. We may continue to generate net losses for the foreseeable future. In addition, we have significant debt-related contractual obligations as of December 31, 2020 and beyond. Based on these conditions, the Company entered into the following transactions described below:

 

Capital Raise

 

On February 2, 2021, the Company entered into a securities purchase agreement (the “Securities Purchase Agreement”) with a single institutional investor for the purchase and sale of 5,600,000 shares (the “February Shares”) of the Company’s Class A common stock for net proceeds of $6.5 million. (see Note 11 – Subsequent events).

  

In July 2020, we entered into an At-the-Market sales agreement (the “ATM Sales Agreement”) with A.G.P./Alliance Global Partners (“A.G.P.”) and B. Riley FBR, Inc. (“B. Riley” and, together with A.G.P., the “Sales Agents”), pursuant to which the Company may offer and sell, from time to time, through the Sales Agents, shares of Common Stock at the market prices prevailing on The Nasdaq Global Market at the time of the sale of such shares. The Company is not obligated to sell any shares under the Sales Agreement. Any sales of shares made under the Sales Agreement will be made pursuant to an effective registration statement on Form S-3 filed by the Company with the Securities and Exchange Commission (“SEC”) on July 6, 2020, for an aggregate offering price of up to $30 million.

 

During the three months ended December 31, 2020, we sold 28,405,840 shares of Common Stock under the ATM Sales Agreement. Net proceeds from such sales totaled $18.6 million.

 

7

 

 

On July 16, 2020, the Company entered into a securities purchase agreement (the “July Securities Purchase Agreement”) for the sale of 7,213,334 shares (the “July Shares”) of Class A common stock at a purchase price of $1.50 per share, in a registered direct offering, pursuant to an effective shelf registration statement on Form S-3 (Reg. No. 333-239710) which was declared effective by the Securities and Exchange Commission on July 10, 2020 and an applicable prospectus supplement. This registration statement covers offerings of up to an aggregate offering price of $75.0 million.

 

The Company closed the transaction on July 20, 2020. The aggregated gross proceeds from the sale of the July Shares were approximately $10.8 million. The net proceeds to the Company from the sale of the July Shares, after deducting the fees of the placement agents but before paying the Company’s estimated offering expenses, was approximately $10.1 million.

 

On May 20, 2020, the Company entered into a securities purchase agreement (the “Securities Purchase Agreement”) with certain investors (the “Investors”) for the purchase and sale of 10,666,666 shares (the “Shares”) of the Company’s Class A common stock, par value $0.001 per share, (the “Common Stock” or “Class A common stock”), at a purchase price of $0.75 per share, in a registered direct offering, pursuant to an effective shelf registration statement on Form S-3 (Reg. No. 333-238183) which was declared effective by the Securities and Exchange Commission on May 14, 2020 and an applicable prospectus supplement.

 

The Company closed the transaction on May 22, 2020. The aggregate gross proceeds for the sale of the Shares was $8.0 million. The net proceeds to the Company from the sale of the Shares, after deducting the fees of the placement agents but before paying the Company’s estimated offering expenses, were approximately $7.1 million.

 

Equity Investment in Starrise, a related party transaction

 

On December 27, 2019, the Company entered into, and on February 14, 2020 amended, (see Note 2 - Summary of Significant Accounting Policies), a stock purchase agreement (as so amended, the “Starrise Stock Purchase Agreement”) with BeiTai Investment LP (“BeiTai”) and Aim Right Ventures Limited (“Aim Right”), two shareholders of Starrise Media Holdings Limited, a leading Chinese entertainment company (“Starrise”), to buy from them an aggregate of 410,901,000 outstanding Starrise ordinary shares (the “Share Acquisition”). On February 14, 2020, the Company purchased 162,162,162 of the Starrise ordinary shares from BeiTai and issued BeiTai 21,646,604 shares of Class A common stock as consideration.

 

On April 10, 2020, the Company, in accordance with the terms of the Starrise Stock Purchase Agreement, terminated its obligation to purchase Starrise ordinary shares from Aim Right under the December 27, 2019 stock purchase agreement. On April 10, 2020, the Company entered into another stock purchase agreement (the “April Stock Purchase Agreement”) with five (5) shareholders of Starrise - Bison Global Investment SPC - Bison Global No. 1 SP (“Bison Global”), Huatai Investment LP, Antai Investment LP, Mingtai Investment LP (“Mingtai”) and Shangtai Asset Management LP - to buy an aggregate of 223,380,000 outstanding Starrise ordinary shares from them and for the Company to issue to them an aggregate of 29,855,081 shares of its Class A common stock in consideration therefore (the “April Share Acquisition”). On April 15, 2020, the April Share Acquisition was consummated and recorded as an equity investment in Starrise and is a related party transaction.

 

Starrise’s ordinary shares (HK 1616) are listed on the main board of the Stock Exchange of Hong Kong Limited. Based on the closing price of HKD 0.163 per share on February 19, 2021, calculated at an exchange rate of $7.75 Hong Kong Dollars to 1 US dollar, the market value of Cinedigm’s ownership in Starrise ordinary shares was approximately $7.6 million.

 

8

 

 

Borrowings

 

On April 15, 2020, the Company received $2.2 million from East West Bank, the Company’s existing lender, pursuant to the Paycheck Protection Program (the “PPP Loan”) of the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”). The PPP Loan matures on April 10, 2022 (the “PPP Maturity Date”), accrues interest at 1% per annum and may be prepaid in whole or in part without penalty. No interest payments are due within the initial six months of the PPP Loan. The interest accrued during the initial six-month period is due and payable, together with the principal, on the PPP Maturity Date. The Company used all proceeds from the PPP Loan to retain employees, maintain payroll and make lease and utility payments to support business continuity throughout the COVID-19 pandemic, which amounts are intended to be eligible for forgiveness, subject to the provisions of the CARES Act and could be subject to repayment.

 

On June 24, 2020, the Company entered into an exchange agreement (the “Exchange Agreement”) pursuant to which the Company issued 329,501 shares of its Class A common stock, in exchange for $842 thousand principal amount and accrued and unpaid interest of outstanding Second Lien Loans (as defined in Note 6 - Notes Payable). The surrendered Second Lien Loans were immediately canceled. The exchange was consummated on June 24, 2020.

 

On June 26, 2020, the Company signed a consent agreement with the holders of the Second Lien loans to extend the maturity date to September 30, 2020 and grant the Company options to extend further to March 31, 2021 and then to June 30, 2021. A consent fee of $100,000 was paid in connection with this extension. On September 21, 2020, the Company exercised its option to extend to March 31, 2021.

 

In a separate exchange with another holder of Second Lien Notes, on November 19, 2020, the Company issued 452,499 shares of Common Stock in exchange for $247,108 principal amount of Second Lien Notes. The exchanged Second Lien Notes were immediately cancelled.

 

On December 4, 2020, the Company entered into exchange agreements (the “December Exchange Agreements”) with certain holders of notes under its Second Lien Loan Agreement dated as of July 14, 2016 among the Company, the lenders party thereto, and Cortland Capital Market Services LLC, as Agent (“Second Lien Notes”). Pursuant to the December Exchange Agreements, the Company issued an aggregate of 2,776,284 shares of its Class A common stock, par value $0.001 per share Common Stock in exchange for an aggregate of $1,386,106 of principal amount of Second Lien Notes. The exchanged Second Lien Notes were immediately cancelled.

 

In January 2021, the Company entered into exchange agreements with holders of the Second Lien Loan to exchange $2,389,650 of Second Lien Loans for 2,517,574 of Class A Common Stock. (see Note 11 – Subsequent events).

 

On February 9, 2021, the Company prepaid substantially all of the outstanding Second Lien Loans (see Note 11 – Subsequent Events).

  

On April 15, 2020, the Company executed a letter amendment (the “Letter Amendment”) to the Bison Convertible Note (as defined in Note 6 - Notes Payable). Among other things, the Letter Amendment amended the Note, effective as of March 4, 2020, to extend the maturity date of the Bison Convertible note to March 4, 2021.

 

On October 9, 2019, the Company signed an extension to the Ming Tai Note of $5.0 million for the first of two (2) permitted additional (1) year extensions at the Company’s option from the original maturity date to October 9, 2020. This note will continue in full force and effect in accordance with its terms, including the Company’s reservation of its right to further extend the maturity date of this note, if it so elects.

 

On June 25, 2020, the Company signed an amendment to extend the maturity date of the East West Credit Facility (as defined in Note 6 - Notes Payable) with East West Bank from March 30, 2021 to June 30, 2021.

 

On September 11. 2020, the Bison and Mingtai Notes, having an aggregate of $15 million principal amount (the “Notes”) were converted in full into an aggregate of 10,000,000 shares of Common Stock at a conversion price of $1.50 per share in accordance with the terms of the Notes. Accordingly, the Notes have been extinguished. The Notes were held by Bison Global and, both of which are affiliates of Peixin Xu, the Chairman of Bison Capital Holding Company Limited, which is indirectly Cinedigm’s largest stockholder. See Note 6 - Notes Payable.

 

 

 

We believe the combination of: (i) our cash and cash equivalent balances as of December 31, 2020, (ii) expected cash flows from operations, (iii) cost cutting measures including payroll expense reduction and real estate occupancy cost reductions, and (iv) the extension or extinguishment of our borrowings, the Starrise equity investment, the capital raises during and the support or availability of funding from other capital resources and financings will be sufficient to satisfy our contractual obligations, as well as liquidity for our operational and capital requirements, for twelve months from the filing of this document. Our capital requirements will depend on many factors, and we may need to use capital resources and obtain additional capital. Failure to generate additional revenues, obtain additional capital or manage discretionary spending could have an adverse effect on our financial position, results of operations and liquidity.

 

9

 

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

BASIS OF PRESENTATION AND CONSOLIDATION

 

The accompanying condensed consolidated financial statements are unaudited and include the accounts of the Company, its wholly owned and majority owned subsidiaries, and reflect all normal and recurring adjustments necessary for the fair presentation of its consolidated financial position, results of operations and cash flows. All material inter-company accounts and transactions have been eliminated in consolidation.

 

Investments in which we do not have a controlling interest or are not the primary beneficiary but have the ability to exert significant influence are accounted for under the equity method of accounting. Noncontrolling interests for which we have been determined to be the primary beneficiary are consolidated and recorded as net loss attributable to noncontrolling interest.

 

USE OF ESTIMATES

 

The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires us to make estimates and assumptions that affect the assets and liabilities, disclosures of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Such estimates include the adequacy of accounts receivable reserves, return reserves, inventory reserves, recovery of advances, assessment of goodwill impairment, intangible asset impairment, fair value for asset acquisition, and estimated amortization lives and valuation allowances for income taxes. Actual results could differ from these estimates.

 

Certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with GAAP have been omitted pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”), although we believe that the disclosures are adequate to make the information presented not misleading. The results of operations for the respective interim periods are not necessarily indicative of the results expected for the full year. These Condensed Consolidated Financial Statements and accompanying notes should be read in conjunction with our annual consolidated financial statements and the notes thereto, included in our Annual Report on Form 10-K for the fiscal year ended March 31, 2020.

 

SIGNIFICANT ACCOUNTING POLICES

 

The significant accounting policies used in the preparation of these condensed consolidated financial statements for the three and nine months ended December 31, 2020 are consistent with those disclosed in Note 2 to the consolidated financial statements in the Company’s Annual Report on Form 10-K for the year ended March 31, 2020.

 

CASH, CASH EQUIVALENTS, AND RESTRICTED CASH

 

We consider all highly liquid investments with an original maturity of three months or less to be “cash equivalents.” We maintain bank accounts with major banks, which from time to time may exceed the Federal Deposit Insurance Corporation’s insured limits. We periodically assess the financial condition of the institutions and believe that the risk of any loss is minimal. Our Prospect Loan (as defined below) requires that we maintain specified cash balances that are restricted to repayment of interest thereunder. See Note 6 - Notes Payable for information about our restricted cash balances.

 

10

 

 

Cash, cash equivalents, and restricted cash consisted of the following:

 

    As of  
(in thousands)   December 31,
2020
    March 31,
2020
 
Cash and Cash Equivalents   $ 26,207     $ 14,294  
Restricted Cash     1,000       1,000  
    $ 27,207     $ 15,294  

 

EQUITY INVESTMENT IN STARRISE, A RELATED PARTY

 

On February 14, 2020, the Company acquired an approximately 11.5% interest in Starrise Media Holdings Limited (“Starrise”), a leading publicly traded Chinese entertainment company whose ordinary shares are listed on the Stock Exchange of Hong Kong. The Company acquired such interest as a strategic investment and in a private transaction from a shareholder of Starrise that is related to our major shareholders. Our major shareholders also maintain a significant beneficial interest ownership in Starrise. Upon consummation of the transaction on February 14, 2020, the Company recorded an initial investment of approximately $25.1 million, which is the fair market value of the Starrise shares on the transaction date on the Stock Exchange of Hong Kong, in exchange for the Company’s common stock of $11.2 million, valued as of the date of the issuance of the Class A common stock of the Company. The difference in value of shares received in Starrise and shares issued by the Company is deemed as contributed capital and recorded in additional paid-in capital.

 

On April 10, 2020, the Company purchased an additional 15% interest in Starrise in a private transaction from shareholders of Starrise that are affiliated with the major shareholder of the Company. The Company recorded an additional equity investment of approximately $28.2 million, which is the fair market value of the Starrise shares on the transaction date on the Stock Exchange of Hong Kong, in exchange for the Company’s common stock of $11.0 million, valued at the date of the issuance of the Class A common stock of the Company. The difference in the value of shares received in Starrise and shares issued by the Company is deemed as contributed capital and recorded in additional paid-in capital. This transaction was also recorded as an equity investment in Starrise.

 

The Company has accounted for these investments under the equity method of accounting as the Company can exert significant influence over Starrise with its direct ownership and affiliation with the Company’s majority shareholders. The Company has made an irrevocable election to apply the fair value option under ASC 825-10, Financial Instruments, as it relates to its equity investment in Starrise.

 

During the nine months ended December 31, 2020, the Company sold 8,370,000 of Starrise shares for net proceeds of approximately $0.8 million which resulted in a loss on sale of approximately $73 thousand.

 

As of December 31, 2020 and March, 31, 2020, the value of our equity investment in Starrise, using the readily determinable fair value method from the quoted trading price of the Stock Exchange of Hong Kong, was approximately $7.6 million and $23.4 million, respectively, resulting in a change in fair value of approximately $42.4 million for the nine months ended December 31, 2020, on our condensed consolidated statement of operations.

 

NON-MONETARY TRANSACTIONS

 

During the three and nine months ended December 31, 2020, respectively, the Company entered into agreements with certain vendors to transfer 5,139,762 and 14,184,765 Starrise shares to satisfy outstanding liabilities with these vendors. Upon the sale of the Starrise shares by the vendors, with certain restrictions on sales unless the Company gives consent to sell, if the proceeds do not satisfy the amount due to the vendor, the Company is liable for the balance owed. Pursuant to such agreements, the Company reduced the amount payable to its vendors by $0.8 million as of December 31, 2020.

 

There was no gain or loss resulting from these transactions for the three and nine months ended December 31, 2020.

 

11

 

 

ACCOUNTS RECEIVABLE

 

We maintain reserves for potential credit losses on accounts receivable. We review the composition of accounts receivable and analyze historical bad debts, customer concentrations, customer credit worthiness, current economic trends and changes in customer payment patterns to evaluate the adequacy of these reserves. Reserves are recorded primarily on a specific identification basis.

 

We record accounts receivable, long-term in connection with activation fees that we earn from our digital cinema equipment (the “Systems”) deployments that have extended payment terms. Such accounts receivable are discounted to their present value at prevailing market rate.

 

ADVANCES

 

Advances, which are recorded within prepaid and other current assets on the condensed consolidated balance sheets, represent amounts prepaid to studios or content producers for which we provide content distribution services. We evaluate advances regularly for recoverability and record impairment charges for amounts that we expect may not be recoverable as of the consolidated balance sheet date. Impairments and accelerated amortization related to advances were $0.3 million and $0.3 million, for the three months ended December 31, 2020 and 2019. Impairments and accelerated amortization related to advances were $0.3 million and $0.7 million, respectively, for nine months ended December 31, 2020 and 2019.

 

PROPERTY AND EQUIPMENT

 

Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation expense is recorded using the straight-line method over the estimated useful lives of the respective assets as follows:

 

Computer equipment and software     3 - 5 years  
Internal use software     5 years  
Digital cinema projection systems     10 years  
Machinery and equipment     3 - 10 years  
Furniture and fixtures     3 - 6 years  

 

We capitalize costs associated with software developed or obtained for internal use when the preliminary project stage is completed, and it is determined that the software will provide significantly enhanced capabilities and modifications. These capitalized costs are included in property and equipment and include external direct cost of services procured in developing or obtaining internal-use software and personnel and related expenses for employees who are directly associated with, and who devote time to internal-use software projects. Capitalization of these costs ceases once the project is substantially complete and the software is ready for its intended use. Once the software is ready for its intended use, the costs are amortized over the useful life of the software. Post-configuration training and maintenance costs are expensed as incurred.

 

Leasehold improvements are amortized over the shorter of the lease term or the estimated useful life of the leasehold improvements. Repair and maintenance costs are charged to expense as incurred. Major renewals, improvements and additions are capitalized. Upon the sale or other disposition of any property and equipment, the cost and related accumulated depreciation and amortization are removed from the accounts and the gain or loss on disposal is included in the condensed consolidated statements of operations.

 

12

 

 

FAIR VALUE MEASUREMENTS

 

The fair value measurement disclosures are grouped into three levels based on valuation factors:

 

Level 1 – quoted prices in active markets for identical investments
Level 2 – other significant observable inputs (including quoted prices for similar investments and market corroborated inputs)
Level 3 – significant unobservable inputs (including our own assumptions in determining the fair value of investments)

 

Assets and liabilities measured at fair value on a recurring basis use the market approach, where prices and other relevant information are generated by market transactions involving identical or comparable assets or liabilities.

 

The equity investment in Starrise is in Hong Kong dollars and was translated into US dollars as of December 31, 2020 and March 31, 2020 at an exchange rate of 7.75 and 7.8 Hong Kong Dollars to 1 US Dollar, respectively. The fair value of this equity investment is measured by the quoted market price of Starrise on the Stock Exchange of Hong Kong.

 

The following tables summarize the levels of fair value measurements of our financial assets and liabilities as of December 31, 2020 and March 31, 2020:

 

As of December 31, 2020                        
                         
(in thousands)   Level 1     Level 2     Level 3     Total  
Restricted cash   $ 1,000     $
    $
    $ 1,000  
Equity investment in Starrise, at fair value     7,584      
     
      7,584  
    $ 8,584     $
     
    $

8,584

 

 

As of March 31, 2020                        
                         
(in thousands)   Level 1     Level 2     Level 3     Total  
Restricted cash   $ 1,000     $
    $
    $ 1,000  
Equity investment in Starrise, at fair value     23,433      
     
      23,433  
    $ 24,433     $
    $
    $ 24,433  

 

Our cash and cash equivalents, accounts receivable, unbilled revenue and accounts payable and accrued expenses are financial instruments and are recorded at cost in the condensed consolidated balance sheets. The estimated fair values of these financial instruments approximate their carrying amounts because of their short-term nature.  At December 31, 2020 and March 31, 2020, the estimated fair value of our fixed rate debt approximated its carrying amounts. We estimated the fair value of debt based upon current interest rates available to us at the respective balance sheet dates for arrangements with similar terms and conditions. Based on borrowing rates currently available to us for loans with similar terms, the fair value of the variable rate debt is $11.8 million and lease obligations approximates fair value.

 

IMPAIRMENT OF LONG-LIVED AND FINITE-LIVED ASSETS

 

We review the recoverability of our long-lived assets and finite-lived intangible assets, when events or conditions occur that indicate a possible impairment exists. The assessment for recoverability is based primarily on our ability to recover the carrying value of our long-lived and finite-lived assets from expected future undiscounted net cash flows. If the total of expected future undiscounted net cash flows is less than the total carrying value of the asset, the asset is deemed not to be recoverable and possibly impaired. We then estimate the fair value of the asset to determine whether an impairment loss should be recognized. An impairment loss will be recognized if the asset’s fair value is determined to be less than its carrying value. Fair value is determined by computing the expected future discounted cash flows. During the three months and nine months ended December 31, 2020 and 2019, no impairment charge was recorded from operations for long-lived assets or finite-lived assets.

 

13

 

  

ASSET ACQUISITIONS

 

An asset acquisition is an acquisition of an asset, or a group of assets, that does not meet the definition of a business. Asset acquisitions are accounted for by using the cost accumulation model whereby the cost of the acquisition, including certain transaction costs, is allocated to the assets acquired on the basis of relative fair values.

 

GOODWILL

 

Goodwill is the excess of the purchase price paid over the fair value of the net assets of an acquired business. Goodwill is tested for impairment on an annual basis or more often if warranted by events or changes in circumstances indicating that the carrying value may exceed fair value, also known as impairment indicators.

 

Inherent in the fair value determination for each reporting unit are certain judgments and estimates relating to future cash flows, including management’s interpretation of current economic indicators and market conditions, and assumptions about our strategic plans with regard to its operations. To the extent additional information arises, market conditions change, or our strategies change, it is possible that the conclusion regarding whether our remaining goodwill is impaired could change and result in future goodwill impairment charges that will have a material effect on our consolidated financial position or results of operations.

 

No goodwill impairment charge was recorded in the three and nine months ended December 31, 2020 and 2019.

 

Gross amounts of goodwill and accumulated impairment charges that we have recorded are as follows:

 

(In thousands)      
Goodwill   $ 32,701  
Accumulated impairment charges     (24,000 )
Goodwill at December 31, 2020 and March 31, 2020   $ 8,701  

 

REVENUE RECOGNITION

 

We determine revenue recognition by:

 

identifying the contract, or contracts, with the customer;
identifying the performance obligations in the contract;
determining the transaction price;
allocating the transaction price to performance obligations in the contract; and
recognizing revenue when, or as, we satisfy performance obligations by transferring the promised goods or services.

 

We recognize revenue in the amount that reflects the consideration we expect to receive in exchange for the services provided, sales of physical products (DVDs and Blu-ray Discs) or when the content is available for subscription on the digital platform or available on the point-of-sale for transactional and video on demand services which is when the control of the promised products and services is transferred to our customers and our performance obligations under the contract have been satisfied. Revenues that might be subject to various taxes are recorded net of transaction taxes assessed by governmental authorities such as sales value-added taxes and other similar taxes.

 

Payment terms and conditions vary by customer and typically provide net 30 to 90 day terms. We do not adjust the promised amount of consideration for the effects of a significant financing component when we expect, at contract inception, that the period between our transfer of a promised product or service to our customer and payment for that product or service will be one year or less. We have in the past entered into arrangements in connection with activation fees due from our System deployments that had extended payment terms. The outstanding balances on these arrangements are insignificant and hence the impact of significant financing would be insignificant.

 

14

 

 

Cinema Equipment Business

 

Virtual print fees (“VPFs”) are earned, net of administrative fees, pursuant to contracts with movie studios and distributors, whereby amounts are payable by a studio to Cinedigm Digital Funding I, LLC. (“Phase 1 DC”) and to Access Digital Cinema Phase 2 Corp. (“Phase 2 DC”) when movies distributed by the studio are displayed on screens utilizing our Systems installed in movie theatres. VPFs are earned and payable to Phase 1 DC based on a defined fee schedule until the end of the VPF term. One VPF is payable for every digital title initially displayed per System. The amount of VPF revenue is dependent on the number of movie titles released and displayed using the Systems in any given accounting period. VPF revenue is recognized in the period in which the digital title first plays on a System for general audience viewing in a digitally equipped movie theatre, as Phase 1 DC’s and Phase 2 DC’s performance obligations have been substantially met at that time.

 

Phase 2 DC’s agreements with distributors require the payment of VPFs, according to a defined fee schedule, for ten years from the date each system is installed; however, Phase 2 DC may no longer collect VPFs once “cost recoupment,” as defined in the contracts with movie studios and distributors, is achieved. Cost recoupment will occur once the cumulative VPFs and other cash receipts collected by Phase 2 DC have equaled the total of all cash outflows, including the purchase price of all Systems, all financing costs, all “overhead and ongoing costs”, as defined, and including service fees, subject to maximum agreed upon amounts during the three-year rollout period and thereafter. Further, if cost recoupment occurs before the end of the eighth contract year, the studios will pay us a one-time “cost recoupment bonus.” The Company evaluated the constraining estimates related to the variable consideration, i.e., the one-time bonus and determined that it is not probable to conclude at this point in time that a significant reversal in the amount of cumulative revenue recognized will occur when the uncertainty associated with the variable consideration is subsequently resolved. 

 

Under the terms of our standard cinema equipment licensing agreements, exhibitors will continue to have the right to use our Systems through the end of the term of the licensing agreement, after which time, they have the option to: (1) return the Systems to us; (2) renew their license agreement for successive one-year terms; or (3) purchase the Systems from us at fair market value. As permitted by these agreements, we typically pursue the sale of the Systems to such exhibitors. Such sales were as originally contemplated as the conclusion of the digital cinema deployment plan. Cinedigm completed the sale of 15 and 24 digital projection Systems, respectively, for an aggregate sales price of approximately $150 thousand and $240 thousand, and recognized revenue of $66 thousand and $240 thousand, during the three months ended December 31, 2020 and 2019, respectively. Cinedigm completed the sale of 45 and 136 digital projection Systems, respectively, for an aggregate sales price of approximately $345 thousand and $1.5 million, and recognized revenue of $157 thousand and $1.3 million, during the nine months ended December 31, 2020 and 2019, respectively.

 

Revenues earned in connection with up front exhibitor contributions are deferred and recognized over the expected cost recoupment period.

 

Exhibitors who purchased and own Systems using their own financing in the Cinema Equipment Business paid us an upfront activation fee of approximately $2.0 thousand per screen (the “Exhibitor-Buyer Structure”). Upfront activation fees were recognized in the period in which these Systems were delivered and ready for content, as we had no further obligations to the customer after that time and collection was reasonably assured. In addition, we recognize activation fee revenue of between $1.0 thousand and $2.0 thousand on Phase 2 DC Systems and for Systems installed by CDF2 Holdings, a related party, (See Note 3 - Other Interests) upon installation and such fees are generally collected upfront upon installation. Our services segment manages and collects VPFs on behalf of exhibitors, for which it earns an administrative fee equal to 10% of the VPFs collected.

 

The Cinema Equipment Business earns an administrative fee of approximately 5% of VPFs collected and, in addition, earns an incentive service fee equal to 2.5% of the VPFs earned by Phase 1 DC. This administrative fee is related to the collection and remittance of the VPF’s and the performance obligation is satisfied at that time the related VPF fees are due which is at the time the movies are displayed on screens utilizing our Systems installed in movie theatres. The service fees are recognized as a point in time revenue when the corresponding VPF fees are due from the movie studios and distributors.

 

15

 

 

Content & Entertainment Business

 

CEG earns fees for the distribution of content in the home entertainment markets via several distribution channels, including digital, video on demand (“VOD”), and physical goods (e.g., DVD and Blu-ray Discs). Fees earned are typically based on the gross amounts billed to our customers less the amounts owed to the media studios or content producers under distribution agreements, and gross media sales of owned or licensed content. Depending upon the nature of the agreements with the platform and content providers, the fee rate that we earn varies. The Company’s performance obligations include the delivery of content for subscription on the digital platform, shipment of DVD and Blu-ray Discs, or make available at point-of-sale for transactional and VOD services. Revenue is recognized at the point in time when the performance obligation is satisfied which is when the content is available for subscription on the digital platform, at the time of shipment for physical goods, or point-of-sale for transactional and VOD services as the control over the content or the physical title is transferred to the customer. The Company considers the delivery of content through various distribution channels to be a single performance obligation. Revenue is recognized after deducting the reserves for product returns and other allowances, which are accounted for as variable consideration.

 

Reserves for product returns and other allowances are recorded based upon historical experience. If actual future returns and allowances differ from past experience, adjustments to our allowances may be required.

 

CEG also has contracts for the theatrical distribution of third party feature movies and alternative content. CEG’s distribution fee revenue and CEG’s participation in box office receipts is recognized at the time a feature movie and alternative content are viewed. CEG has the right to receive or bill a portion of the theatrical distribution fee in advance of the exhibition date, and therefore such amount is recorded as a receivable at the time of execution, and all related distribution revenue is deferred until the third party feature movies’ or alternative content’s theatrical release date.

 

Principal Agent Considerations

 

We determine whether revenue should be reported on a gross or net basis based on each revenue stream. Key indicators that we use in evaluating gross versus net treatment include, but are not limited to, the following:

 

which party is primarily responsible for fulfilling the promise to provide the specified good or service; and
which party has discretion in establishing the price for the specified good or service.

 

Shipping and Handling

 

Shipping and handling costs are incurred to move physical goods (e.g., DVD and Blu-ray Discs) to customers. We recognize all shipping and handling costs as an expense in cost of goods sold because we are responsible for delivery of the product to our customers prior to transfer of control to the customer.

 

Contract Liabilities

 

We generally record a receivable related to revenue when we have an unconditional right to invoice and receive payment, and we record deferred revenue (contract liability) when cash payments are received or due in advance of our performance, even if amounts are refundable.

 

We maintain reserves for potential credit losses on accounts receivable. We review the composition of accounts receivable and analyze historical bad debts, customer concentrations, customer credit worthiness, current economic trends and changes in customer payment patterns to evaluate the adequacy of these reserves. Reserves are recorded primarily on a specific identification basis.

 

Our CEG segment recognizes accounts receivable, net of an estimated allowance for product returns and customer chargebacks, at the time that it recognizes revenue from a sale. Reserves for product returns and other allowances is variable consideration as part of the transaction price. If actual future returns and allowances differ from past experience, adjustments to our allowances may be required.

 

16

 

 

We record accounts receivable, long-term in connection with activation fees that we earn from Systems deployments that have extended payment terms. Such accounts receivable are discounted to their present value at prevailing market rates. The outstanding balances on these arrangements are insignificant and hence the impact of significant financing would be insignificant.

 

Deferred revenue pertaining to our Content & Entertainment Business includes amounts related to the sale of DVDs with future release dates.

 

Deferred revenue relating to our Cinema Equipment Business pertains to revenues earned in connection with up front exhibitor contributions that are deferred and recognized over the expected cost recoupment period. It also includes unamortized balances in connection with activation fees due from the Systems deployments that have extended payment terms.

 

The ending deferred revenue balance, including current and non-current balances, as of December 31, 2020 was $1.3 million. For the three months ended December 31, 2020, the additions to our deferred revenue balance were primarily due to cash payments received or due in advance of satisfying performance obligations, while the reductions to our deferred revenue balance were primarily due to the recognition of revenue upon fulfillment of our performance obligations, both of which were in the ordinary course of business.

 

During the three and nine months ended December 31, 2020, $1.2 million and $2.5 million, respectively of revenue was recognized that was included in the deferred revenue balance at the beginning of the period. As of December 31, 2020, the aggregate amount of contract revenue allocated to unsatisfied performance obligations was $0.1 million. We expect to recognize approximately $1.3 million of this balance over the next 12 months, and the remainder thereafter.

 

Disaggregation of Revenue

 

The Company disaggregates revenue into different revenue categories for the Cinema Equipment and CEG Businesses. The Cinema Equipment Business revenue categories are: Phase I Deployment revenue, Phase II Deployment revenue, Services, and Digital System Sales, and the Content & Entertainment Business revenue categories are: Base Distribution Business and OTT Streaming and Digital.

 

The following tables present the Company’s revenue categories for the three and nine months ended December 31, 2020 and 2019: (in thousands):

 

    Three Months Ended
December 31,
    Nine Months Ended
December 31,
 
    2020     2019     2020     2019  
Cinema Equipment Business:                        
Phase I Deployment   $ 281     $ 1,402     $ 424     $ 4,797  
Phase II Deployment     367       444       1,067       1,326  
Services     196       1,043       481       3,378  
Digital System Sales     66       240       186       1,266  
Total Cinema Equipment Business revenue   $ 910     $ 3,129     $ 2,158     $ 10,767  
                                 
Content & Entertainment Business:                                
Base Distribution Business   $ 4,152     $ 5,286     $ 9,218     $ 11,944  
OTT Streaming and Digital     4,892       3,097       11,778       8,845  
Total Content & Entertainment Business revenue   $ 9,044     $ 8,383     $ 20,996     $ 20,789  

 

17

 

 

STOCK-BASED COMPENSATION

 

Employee and director stock-based compensation expense related to our stock-based awards was as follows:

 

    Three Months Ended
December 31,
    Nine Months Ended
December 31,
 
(In thousands)   2020     2019     2020     2019  
                         
Selling, general and administrative   $ 960     $ 178     $ 2,172     $ 367  
    $ 960     $ 178     $ 2,172     $ 367  

 

During the three and nine months ended December 31, 2020 and 2019, the Company granted 5,550,000 stock appreciation rights (“SARs”). The SARs were granted under the Company’s 2017 Equity Incentive Plan (the “2017 Plan. All SARs issued have an exercise price equal to the fair value of the Company’s common stock on the date of grant and a maturity date of 10 years. The SARs were valued on the grant date utilizing an option pricing model, as follows:

 

Grant Date: November 19, 2020 – December 23, 2020

Maturity Date: November 19, 2030 – December 31, 2030

Fair value of class A common stock on grant date: $0.54 - $0.74

Volatility: 91.05% - 91.71%

Discount rate: 0.88% - 0.96%

 

There was $739 thousand and $111 thousand, of stock-based compensation recorded for the three months ended December 31, 2020 and 2019, respectively and $961 thousand and $332 thousand for the nine months ended December 31, 2020 and 2019 respectively, relating to these SARs.

 

Total SARs outstanding are as follows:

 

   

Nine Months Ended December 31,
2020

 
SARs Outstanding March 31, 2020     1,462,610  
Issued     5,550,000  
Forfeited    
 
Total SARs Outstanding December 31, 2020     7,012,610  

 

There are 696,050 units of performance stock units (“PSU”) which were granted on July 26, 2018 fully vested but not paid yet. There was no stock-based compensation recorded related to these units for the nine months ended December 31, 2020 and there was a cumulative adjustment of $166 thousand of stock-based compensation recorded for the nine months ended December 31, 2019. During the nine months ended December 31, 2020, the vested PSU’s were settled for 693,647 shares of Class A Common Stock. In addition, the Company issued 689,364 shares of Class A Common Stock as a bonus to employees. The Company recorded $786 thousand as stock compensation expense related to the bonus awards based on the $1.14 Class A common share value on the date of grant during the nine months ended December 31, 2020.

 

In addition, during the three months ended December 31, 2020, the Company granted and issued 320,000 shares of Class A common stock to the Company’s Chief Executive Officer as a compensatory bonus. The shares were valued on the date of grant utilizing the fair value of the Company’s class A common stock. The Company recognized stock compensation of $166 thousand for the issuance.

 

18

 

 

There was $1 thousand and $4 thousand of stock-based compensation recorded for both the three and nine months ended December 31, 2020 and 2019, respectively, related to employees’ restricted stock awards.

 

There was $54 thousand and $0 of stock-based compensation recorded for the three months ended December 31, 2020 and 2019 respectively related to the board of directors. There was $188 thousand and $0 of stock-based compensation for the nine months ended December 31, 2020 and 2019 related to board of directors.

 

On September 1, 2020, we issued 80,000 shares of Class A common stock to Ronald L. Chez as a bonus payable to him under the Strategic Investor Agreement between the Company and him dated as of April 3, 2017. During the nine months ended December 31, 2020, we recognized an expense of $71 thousand based on the stock price of the Class A common stock on the date of grant.

 

INCOME TAXES

 

The Company accounts for income taxes using the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to operating loss and tax credit carryforwards and for differences between the carrying amounts of existing assets and liabilities and their respective tax bases.

 

Valuation allowances are established when management is unable to conclude that it is more likely than not that some portion, or all, of the deferred tax asset will ultimately be realized. The Company is primarily subject to income taxes in the United States.

 

The Company accounts for uncertain tax positions in accordance with an amendment to ASC Topic 740-10, Income Taxes (Accounting for Uncertainty in Income Taxes), which clarified the accounting for uncertainty in tax positions. This amendment provides that the tax effects from an uncertain tax position can be recognized in the financial statements only if the position is “more-likely-than-not” to be sustained were it to be challenged by a taxing authority. The assessment of the tax position is based solely on the technical merits of the position, without regard to the likelihood that the tax position may be challenged. If an uncertain tax position meets the “more-likely-than-not” threshold, the largest amount of tax benefit that is more than 50% likely to be recognized upon ultimate settlement with the taxing authority is recorded. The Company has no uncertain tax positions.

 

NET LOSS PER SHARE ATTRIBUTABLE TO COMMON SHAREHOLDERS

 

Basic and diluted net loss per common share has been calculated as follows:

 

Basic and diluted net loss per common share
attributable to common stockholders =
Net loss attributable to common stockholders
Weighted average number of common stock
 outstanding during the period

 

Stock issued and treasury stock repurchased during the period are weighted for the portion of the period that they are outstanding. Shares issued and any shares that are reacquired during the period are weighted for the portion of the period that they are outstanding.

 

We incurred net losses for the three and nine months ended December 31, 2020 and 2019, and therefore the impact of potentially dilutive common shares from outstanding stock options and warrants, totaling 9,040,138 shares and 4,066,172 shares as of December 31, 2020 and 2019, respectively, were excluded from the computations of loss per share as their impact would have been anti-dilutive.

 

19

 

 

COMPREHENSIVE LOSS

 

As of the three and nine months ended December 31, 2020 and 2019, comprehensive loss consisted of net loss and foreign currency translation adjustments.

 

RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

 

Not yet adopted

 

In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”), which provides new guidance regarding the measurement and recognition of credit impairment for certain financial assets. Such guidance will impact how the Company determines its allowance for estimated uncollectible receivables and evaluates its available-for-sale investments for impairment. ASU 2016-13 is effective for the Company in the first quarter of 2023. The Company is currently evaluating the effect that ASU 2016-13 will have on its consolidated financial statements and related disclosures.

 

In August 2018, the FASB issued ASU No. 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement”. The amendments in ASU 2018-13 modify the disclosure requirements associated with fair value measurements based on the concepts in the Concepts Statement, including the consideration of costs and benefits. The amendments on changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. All other amendments should be applied retrospectively to all periods presented upon their effective date. The amendments are effective for all entities for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. Early adoption is permitted, including adoption in an interim period. We are currently assessing the impact this pronouncement may have on our consolidated financial statements

 

On December 18, 2019, the FASB issued ASU 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes,” which simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The update also simplifies GAAP for other areas of Topic 740 by clarifying and amending existing guidance to improve consistent application. The amendment in this update is effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. Early adoption is permitted. We are currently assessing the impact this pronouncement may have on our consolidated financial statements.

 

In March 2020, the FASB issued ASU No. 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” ASU 2020-04 provides optional expedients and exceptions to account for contracts, hedging relationships and other transactions that reference LIBOR or another reference rate if certain criteria are met. The amendments of ASU No. 2020-04 are effective immediately, as of March 12, 2020, and may be applied prospectively to contract modifications made and hedging relationships entered into on or before December 31, 2022. We are currently assessing the impact this pronouncement may have on our consolidated financial statements

 

3. OTHER INTERESTS

 

Investment in CDF2 Holdings

 

We indirectly own 100% of the common equity of CDF2 Holdings, LLC (“CDF2 Holdings”), which was created for the purpose of capitalizing on the conversion of the exhibition industry from film to digital technology. CDF2 Holdings assists its customers in procuring the equipment necessary to convert their systems to digital technology by providing financing, equipment, installation and related ongoing services.

 

CDF2 Holdings is a Variable Interest Entity (“VIE”), as defined in Accounting Standards Codification Topic 810 (“ASC 810”), “Consolidation.” ASC 810 requires the consolidation of VIEs by an entity that has a controlling financial interest in the VIE which entity is thereby defined as the primary beneficiary of the VIE. To be a primary beneficiary, an entity must have the power to direct the activities of a VIE that most significantly impact the VIE’s economic performance, among other factors. Although we indirectly, wholly own CDF2 Holdings, we, a third party that also has a variable interest in CDF2 Holdings, and an independent third party manager must mutually approve all business activities and transactions that significantly impact CDF2 Holdings’ economic performance. We have therefore assessed our variable interests in CDF2 Holdings and determined that we are not the primary beneficiary of CDF2 Holdings. As a result, CDF2 Holdings’ financial position and results of operations are not consolidated in our financial position and results of operations. In completing our assessment, we identified the activities that we consider most significant to the economic performance of CDF2 Holdings and determined that we do not have the power to direct those activities, and therefore we account for our investment in CDF2 Holdings under the equity method of accounting.

 

As of December 31, 2020 and March 31, 2020, our maximum exposure to loss, as it relates to the non-consolidated CDF2 Holdings entity, represents accounts receivable for service fees under a master service agreement with CDF2 Holdings. Such accounts receivable was $0.2 million and $0.4 million as of December 31, 2020 and March 31, 2020 which are included in accounts receivable, net on the accompanying condensed consolidated balance sheets.

 

The accompanying Condensed Consolidated Statements of Operations include $47 thousand and $83 thousand of digital cinema servicing revenue from CDF2 Holdings for each of the three months and nine months ended December 31, 2020, respectively. The accompanying Condensed Consolidated Statements of Operations include $0.3 million and $0.9 million of digital cinema servicing revenue from CDF2 Holdings for each of three months and nine months ended December 31, 2019.

 

20

 

 

Total Stockholders’ Deficit of CDF2 Holdings at December 31, 2020 and March 31, 2020 was $43.3 million and $31.8 million, respectively. We have no obligation to fund the operating loss or the stockholders’ deficit beyond our initial investment of $2.0 million and, accordingly, our investment in CDF2 Holdings as of December 31, 2020 and March 31, 2020 is carried at $0.

 

Majority Interest in CONtv

 

We own an 85% interest in CON TV, LLC, a worldwide digital network that creates original content, and sells and distributes on-demand digital content on the Internet and other consumer digital distribution platforms, such as gaming consoles, set-top boxes, handsets, and tablets.

 

4. ASSET ACQUISTION

 

On December 21, 2020, the Company acquired substantially all of the assets of The Film Detective, LLC (“TFD”), a leading content distributor and streaming channel company focused on classic film and television programming. The purchase price for the TFD acquisition was $750,000 in cash and 2,504,592 shares of the Company’s class A common stock at $0.74 per share or $1,853,000, as of the acquisition date (physical stock certificates were issued by the Company’s transfer agent subsequently on January 11, 2021). In addition, TFD may be entitled to receive earnout amounts of up to an aggregate of $1,600,000 for the four years beginning on April 1, 2021, payable in cash or with respect to a portion thereof, at the Company’s discretion and subject to certain conditions, in shares of Common Stock. This acquisition is accounted for as an asset acquisition as substantially all of the value acquired resides in a single group of assets. Accordingly, the acquisition cost related to the transaction is capitalized and the potential earnout will only be recognized when the contingency is probable and estimable in the future. Acquired intangible assets include TFD’s content library, distribution contracts, trade name and other and the final fair value allocation was as follows:

 

Asset   Amount in ($000)     Useful Life  
Content Library   $ 2,471       20 years  
Distribution Contracts     124       2 years  
Trade Name     24       2 years  
Other     32       3 years  
Total   $ 2,651          

 

5. INCOME TAXES

 

We calculate income tax expense based upon an annual effective tax rate forecast, including estimates and assumptions. We recorded an income tax benefit (expense) of approximately $0 and $181 for the three and nine months ended December 31, 2020. We recorded income tax expense of approximately $136 thousand and $210 thousand, respectively, for the three and nine months ended December 31, 2019. We have not recorded tax benefits on our loss before income taxes because we have provided for a full valuation allowance that offsets potential deferred tax assets resulting from net operating loss carry forwards, reflecting our inability to use such loss carry forwards.

 

Our effective tax rate for the nine months ended December 31, 2020 and 2019 was 0.3% and negative 2.09%, respectively.

 

On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security (CARES) Act was signed into law. The Act contains several new or changed income tax provisions, including but not limited to the following: increased limitation threshold for determining deductible interest expense; class life changes to qualified improvements (in general, from 39 years to 15 years); and the ability to carry back net operating losses incurred from tax years 2018 through 2020 up to the five preceding tax years. The Company has evaluated the new tax provisions of the CARES Act and determined the impact to be either immaterial or not applicable.

 

21

 

 

6. NOTES PAYABLE

 

Notes payable consisted of the following:

 

    December 31, 2020     March 31, 2020  
(In thousands)   Current Portion     Long Term Portion     Current Portion     Long Term Portion  
Prospect Loan   $ 12,036     $
    —
    $ 12,205     $
    —
 
Total non-recourse notes payable     12,036      
      12,205      
 
Less: Unamortized debt issuance costs and debt discounts     (146 )    
      (763 )    
 
Total non-recourse notes payable, net of unamortized debt issuance costs and debt discounts   $ 11,890     $
    $ 11,442     $
 
Bison Note Payable   $
     
    $ 10,000     $
 
Second Lien Loans     6,040      
      8,222      
 
Credit Facility     5,113      
      14,487      
 
Mingtai Convertible Note    
     
      5,000      
 
PPP Loan    
      2,152      
     
 
Total recourse notes payable     11,153       2,152       37,709      
 
Less: Unamortized debt issuance costs and debt discounts    
     
      (460 )    
 
Total recourse notes payable, net of unamortized debt issuance costs and debt discounts   $ 11,153     $ 2,152     $ 37,249     $
 
Total notes payable, net of unamortized debt issuance costs   $ 23,043     $ 2,152     $ 48,691     $
 

 

Non-recourse debt is generally defined as debt whereby the lenders’ sole recourse with respect to defaults, is limited to the value of the asset, which is collateral for the debt. Certain of our subsidiaries are liable with respect to, and their assets serve as collateral for, certain indebtedness for which our assets and the assets of our other subsidiaries that are not parties to the transaction are generally not liable. We have referred to this indebtedness as “non-recourse debt” because the recourse of the lenders is limited to the assets of specific subsidiaries. Such indebtedness includes the Prospect Loan.

 

Prospect Loan

 

In February 2013, our DC Holdings, AccessDM and Phase 2 DC subsidiaries entered into a term loan agreement (the “Prospect Loan”) with Prospect Capital Corporation (“Prospect”), pursuant to which DC Holdings borrowed $70.0 million. The Prospect Loan bears interest at LIBOR plus 9.0% (with a 2.0% LIBOR floor), which is payable in cash, and at an additional 2.50% to be accrued as an increase to the aggregate principal amount of the Prospect Loan until the Prospect Loan is paid off, at which time all accrued interest will be payable in cash.

 

Collections of DC Holdings accounts receivable are deposited into accounts designated to pay certain operating expenses, principal, interest, fees, costs and expenses relating to the Prospect Loan. On a quarterly basis, if there is excess cash flow, it is used for prepayment of the Prospect Loan. We also maintain a debt service fund under the Prospect Loan for future principal and interest payments. As of December 31, 2020, and March 31, 2020, the debt service fund had a balance of $1.0 million, which is classified as part of restricted cash on our Condensed Consolidated Balance Sheets.

 

22

 

 

The Prospect Loan matures on March 31, 2021 and may be accelerated upon a change in control (as defined in the agreement) or other events of default as set forth therein and would be subject to mandatory acceleration upon insolvency of DC Holdings. We are permitted to pay the full outstanding balance of the Prospect Loan at any time after the second anniversary of the initial borrowing, subject to the following prepayment penalties:

 

5.0% of the principal amount prepaid between the second and third anniversaries of issuance;

 

4.0% of the principal amount prepaid between the third and fourth anniversaries of issuance;

 

3.0% of the principal amount prepaid between the fourth and fifth anniversaries of issuance;

 

2.0% of the principal amount prepaid between the fifth and sixth anniversary of issuance;

 

1.0% of the principal amount prepaid between the sixth and seventh anniversaries of issuance; and

 

No penalty if the balance of the Prospect Loan, including accrued interest, is prepaid thereafter.

 

The Prospect Loan is secured by, among other things, a first priority pledge of the stock of CDF2 Holdings, our wholly owned unconsolidated subsidiary, the stock of AccessDM, owned by DC Holdings, and the stock of our Phase 2 DC subsidiary, and is also guaranteed by AccessDM and Phase 2 DC. We provide limited financial support to the Prospect Loan not to exceed $1.5 million per year in the event financial performance does not meet certain defined benchmarks.

 

The Prospect Loan contains customary representations, warranties, affirmative covenants, negative covenants and events of default.

 

The following table summarizes the activity related to the Prospect Loan:

 

    As of  
(In thousands)   December 31,
2020
    March 31,
2020
 
Prospect Loan, at issuance   $ 70,000     $ 70,000  
PIK Interest     4,778       4,778  
Payments to date     (62,888 )     (62,573 )
Prospect Loan, gross   $ 11,890     $ 12,205  
Less unamortized debt issuance costs and debt discounts    
      (763 )
Prospect Loan, net     11,890       11,442  
Less current portion     (11,890 )     (11,442 )
Total long term portion   $
    $
 

 

Bison Note Payable

 

In December 2017, the Company entered into a loan with Bison for $10.0 million (the “Bison Loan”) and issued Warrants to purchase 1,400,000 shares of the Company’s Class A common stock. See Note 7 - Stockholders’ Deficit for further discussion of the warrants.

 

The loan was made in accordance with the Stock Purchase Agreement between the Company and Bison Entertainment Investment Limited, another affiliate of Bison, entered into on June 29, 2017.

 

On July 20, 2018, the Company entered into a term loan agreement (the “2018 Loan Agreement”) with Bison Global, pursuant to which the Company borrowed from Bison Global $10.0 million (the “2018 Loan”), the proceeds of which were used to pay off the Bison Loan. The 2018 Loan has a one (1) year term that may be extended by mutual agreement of Bison Global and the Company and bears interest at 5% per annum, payable quarterly in cash. On July 12, 2019, we entered into a Termination Agreement for the 2018 Loan and at the same time entered into a $10.0 million convertible note with Bison Global (the “Bison Convertible Note”).

 

23

 

 

Bison Convertible Note

 

The Bison Convertible Note has a term ending on March 4, 2021, and bears interest at 5% per annum. The principal is due on March 4, 2021, in cash or in shares of Common Stock, or a combination of cash and Common Stock, at the Company’s option. The Bison Convertible Note is convertible at the Company’s option, at any time prior to payment in full of the principal balance and all accrued interest of the note, to convert this note in whole or in part, into fully paid and nonassessable shares of the Company’s Class A common stock. The Bison Convertible Note is Convertible into 6,666,666 shares of Company’s Class A common stock, based on initial conversion price of $1.50 per share.

 

The Bison Convertible Note is unsecured and may be prepaid without premium or penalty, and contains customary covenants, representations and warranties. The proceeds of the Bison Convertible Note were used to repay the 2018 Loan. On April 15, 2020, the Company executed a letter amendment to the Bison Convertible Note dated July 12, 2019, amending the Bison Convertible Note, effective as of March 4, 2020, to change the maturity date of the note to March 4, 2021.

 

The Bison Convertible Note, offset by the concurrent payoff and termination of the 2018 Loan, did not result in any increase to the Company’s outstanding debt balance.

 

On September 11. 2020, Bison Global converted the Bison Convertible Note in full into an aggregate of 6,666,667 shares of Common Stock at a conversion price of $1.50 per share. Accordingly, the Bison Convertible Note has been extinguished. In accordance with ASC 470, the Company recognized a loss on extinguishment of $285 thousand related to unamortized debt issuance costs for the nine months ended December 31, 2020.

 

Second Secured Lien Loans

 

On July 14, 2016, we entered into a Second Lien Loan Agreement (the “Second Lien Loan Agreement”), under which we may borrow up to $15.0 million (the “Second Lien Loans”), subject to certain limitations imposed on us regarding the number of shares that we may issue in connection with the loans. As of December 31, 2020 we have an outstanding balance of $6.0 million which includes $4.7 million borrowed from Ronald L. Chez, at that time a member of the Board of Directors. Mr. Chez resigned from the Board of Directors in April 2017, and became a strategic advisor to the Company through September 2020. The Second Lien Loans bear interest at 12.75%, payable 7.5% in cash and 5.25% in cash or in kind at our option. Before the June 30, 2019 maturity date, on June 28, 2019, the Company entered into a consent agreement with lenders of the Second Lien Loans to an extension of the Second Lien Loans pursuant to which (i) the Company paid down a portion of the outstanding principal amount plus accrued interest to date, and (ii) the maturity date of the remaining outstanding principal amount of the Second Lien Loans was extended to September 30, 2019.

 

In addition, under the terms of the Second Lien Loan Agreement, we are required to issue 98,000 shares of our Class A common stock for every $1.0 million borrowed, subject to pro rata adjustments. As of December 31, 2020, we have issued 906,450 shares of Class A common stock cumulatively under the Second Lien Loan Agreement. The Second Lien Loans may be prepaid without premium or penalty and contain customary covenants, representations and warranties. The obligations under the Second Lien Loans are guaranteed by certain of our existing and future subsidiaries. We have pledged substantially all of our assets, except those assets related to our digital cinema deployment business, to secure payment on the Second Lien Loans.

 

On June 24, 2020, the Company entered into an exchange agreement (the “Exchange Agreement”) pursuant to which the Company issued 329,501 shares of its Class A common stock in exchange for $842 thousand principal amount and accrued and unpaid interest of Second Lien Loans with the holders of such notes. The surrendered notes were immediately canceled and the Company recognized a gain on extinguishment of $23 thousand.

 

The Exchange Agreement included a true-up clause. The true-up clause stated that if the gross proceeds from the sale of the Company’s Class A common stock are less than $758 thousand, the Company shall pay up to an aggregate maximum of $50 thousand of such shortfall in cash, and, with respect to any balance of the shortfall remaining after the cash payment, shall issue such additional number of shares of common stock not to exceed, together with the Shares, 1,000,000 shares equal in value, based on the closing price of the common stock.

 

24

 

 

On July 2, 2020, in accordance with the true-up clause, an additional 33,465 shares of Class A common stock ($61 thousand based on the stock price of the Company’s Class A common stock on the date of issue) were issued as a true-up adjustment pursuant to the Exchange Agreement. In addition, the Company paid an additional $50 thousand in July 2020.

 

On June 26, 2020, the Company entered into a consent agreement to extend the maturity date to September 30, 2020 and grant the Company options to extend further to March 31, 2021 and then to June 30, 2021.There was a consent fee of $100,000 paid in connection with this extension. On September 21, 2020, the Company extended the maturity date to March 31, 2021 upon payment of a fee of $50,000.

 

On November 19, 2020, the Company issued 452,500 shares of Common Stock in exchange for $250 thousand of principal and interest of Second Lien Notes. The exchanged Second Lien Notes were immediately cancelled and the Company recorded a gain on extinguishment of $5 thousand.

 

On December 4, 2020, the Company entered into exchange agreements (the “December Exchange Agreements”) with certain holders of notes under its Second Lien Loan Agreement dated as of July 14, 2016 among the Company, the lenders party thereto, and Cortland Capital Market Services LLC, as Agent (“Second Lien Notes”). Pursuant to the December Exchange Agreements, the Company issued an aggregate of 2,776,283 shares of its Class A common stock, par value $0.001 per share Common Stock in exchange for an aggregate of $1,400 thousand of principal and interest of Second Lien Notes. The exchanged Second Lien Notes were immediately cancelled and the Company recorded a loss on extinguishment of $545 thousand.

 

See Note 11 – Subsequent Events for exchange agreements subsequent to December 31, 2020.

 

Credit Facility and Cinedigm Revolving Loans

 

On March 30, 2018, the Company entered into the Loan, Guaranty and Security Agreement, dated as of March 30, 2018, by and between the Company, East West Bank and the Guarantors named therein (the “Credit Facility”) for a maximum of $19.0 million in revolving loans outstanding at any one time with a maturity date of March 31, 2020, which may be extended for two successive one-year periods at the sole discretion of the lender, subject to certain conditions.

 

Interest under the Credit Facility is due monthly at a rate elected by the Company of either 0.5% plus Prime Rate or 3.25% above LIBOR Rate established by the lender.

 

As of December 31, 2020 and March 31, 2020, there was $5.1 million and $14.5 million outstanding, respectively, and there was $4.0 million available, under the Credit Facility based on the Company’s borrowing base as of December 31, 2020. On July 3, 2019, the Company entered into the EWB Amendment to the Credit Facility. The EWB Amendment reduced the size of the facility to $18.0 million, required certain prepayments and daily cash sweeps from collections of receivables to be made, changed in certain respects how the borrowing base is calculated, and extended the maturity date to June 30, 2020. In connection with the EWB Amendment, three of our subsidiaries became Guarantors under the Credit Facility. On June 25, 2020, the Company signed amendment No. 4 with East West Bank to extend the maturity of the Credit Facility to June 30, 2021 and waive events of default provisions. This amendment also includes a financial covenant that began on August 31, 2020. For the three months ended December 31, 2020, the Company was in compliance with this financial covenant.

 

Mingtai Convertible Note

 

On October 9, 2018, the Company issued a subordinated convertible note (the “Mingtai Convertible Note”) to Mingtai for $5.0 million. All proceeds from the Mingtai Convertible Note were used to pay the then-outstanding $5.0 million 2013 Notes. The $5.0 million in aggregate principal bears interest at 8% maturing on October 9, 2019 with two one year extensions at the Company’s option. The Mingtai Convertible Note is convertible into 3,333,333 shares of the Company’s Class A common stock, based on initial conversion price of $1.50 per share. On October 9, 2019, the Company signed an extension, for one additional year from the original maturity date to be due on October 9, 2020.

 

25

 

 

The Mingtai Convertible Note is convertible at the option of the Lender, or the Company, at any time prior to payment in full of the principal balance, and all accrued interest of this Convertible Note in whole, or in part, into fully paid and non-assessable shares of Company’s Class A common stock at the conversion rate of $1.50.

 

Upon conversion prior to maturity by Mingtai, or the Company, we may elect to settle such conversion in shares of our Class A common stock, cash or a combination thereof. Upon the maturity date, the Company has the option to pay in Class A common shares convertible at the greater of the closing price of the Class A common stock or $1.10. As a result of our cash conversion option, we separately accounted for the value of the embedded conversion option as a debt discount (with an offset to additional paid-in capital) of $270 thousand. The value of the embedded conversion option was determined based on the estimated fair value of the debt without the conversion feature, which was determined using market comparables to estimate the fair value similar nonconvertible debt; the debt discount is being amortized to interest expense using the effective interest method over the one year term of the Mingtai Convertible Note.

 

On September 11, 2020, Mingtai converted the Notes in full into an aggregate of 3,333,333 shares of Common Stock at a conversion price of $1.50 per share. Accordingly, the Note has been extinguished. In accordance with ASC 470, the Mingtai Convertible Note was analyzed for potential debt extinguishment. The discount on the note had been fully accreted prior to conversion, resulting in no gain or loss from extinguishment.

 

PPP Loan

 

On April 15, 2020, the Company received $2.2 million from East West Bank, the Company’s existing lender. The PPP Loan matures on April 10, 2022 (the “PPP Maturity Date”), accrues interest at 1% per annum and may be prepaid in whole or in part without penalty. No interest payments are due within the initial six months of the PPP Loan. The interest accrued during the initial six-month period is due and payable, together with the principal, on the PPP Maturity Date. The Company used all proceeds from the PPP Loan to retain employees, maintain payroll and make lease and utility payments to support business continuity throughout the COVID-19 pandemic, which amounts are intended to be eligible for forgiveness, subject to the provisions of the CARES Act and could be subject to repayment.

 

7. STOCKHOLDERS’ DEFICIT

 

COMMON STOCK

 

During the nine months ended December 31, 2020, we issued 92,236,505 shares of Class A common stock which consists of the sale of 28,405,840 shares of our Class A common stock, 29,855,081 in connection with the Starrise transaction, settlement of a portion of the outstanding second lien loan, issuance of restricted shares to employees and consultants, and the issuances of Class A common stock for warrants exercised and preferred stock dividends. See Note - 9 Supplemental Cash Flow Disclosure.

 

In July 2020, we entered into an At-the-Market sales agreement (the “ATM Sales Agreement”) with A.G.P./Alliance Global Partners (“A.G.P.”) and B. Riley FBR, Inc. (“B. Riley” and, together with A.G.P., the “Sales Agents”), pursuant to which the Company may offer and sell, from time to time, through the Sales Agents, shares of Common Stock at the market prices prevailing on The Nasdaq Global Market at the time of the sale of such shares. The Company is not obligated to sell any shares under the Sales Agreement. Any sales of shares made under the Sales Agreement will be made pursuant to an effective registration statement on Form S-3 filed by the Company with the SEC on July 6, 2020, for an aggregate offering price of up to $30 million.

 

During the quarter ended December 31, 2020, we sold 28,405,840 shares of Common Stock under the ATM Sales Agreement. Net proceeds from such sales totaled $18.6 million. Proceeds were used to strengthen our liquidity and working capital position.

 

On September 1, 2020, we issued 80,000 shares of Class A common stock to Ronald L. Chez as a bonus payable to him under the Strategic Investor Agreement between the Company and him dated as of April 3, 2017. We recognized an expense of $71 thousand based on the stock price of the Class A common stock on the date of grant.

 

On October 23, 2020, the Company filed a Certificate of Amendment to the Fifth Amended and Restated Certificate of Incorporation, pursuant to which the number of shares of Class A common stock authorized for issuance was increased to 200,000,000 shares.

 

On November 19, 2020, the Company issued 452,499 shares of Common Stock in exchange for $247,108 of principal amount of Second Lien Notes. The exchanged Second Lien Notes were immediately cancelled.

 

On December 4, 2020, the Company entered into Exchange Agreements with certain holders of the Second Lien Loans. Pursuant to the Exchange Agreements, the Company issued an aggregate of 2,776,284 shares of its Class A common stock, par value $0.001 per share Common Stock in exchange for an aggregate of $1,386,106 of principal amount of Second Lien Notes. The exchanged Second Lien Notes were immediately cancelled. The exchange was consummated on December 4, 2020.

 

26

 

 

PREFERRED STOCK

 

Cumulative dividends in arrears on preferred stock were $0.1 million as of December 31, 2020 and 2019. In January 2021, we paid the preferred stock dividends in arrears in the form of 171,933 shares of Class A common stock.

 

TREASURY STOCK

 

We have treasury stock, at a cost, consisting of 1,313,836 shares of Class A common stock at December 31, 2020 and March 31, 2020.

 

CINEDIGM’S EQUITY INCENTIVE PLANS

 

Stock Based Compensation Awards

 

Awards issued under our 2000 Equity Incentive Plan (the “2000 Plan”) may be in any of the following forms (or a combination thereof) (i) stock option awards; (ii) stock appreciation rights; (iii) stock or restricted stock or restricted stock units; or (iv) performance awards. The 2000 Plan provides for the granting of incentive stock options (“ISOs”) with exercise prices not less than the fair market value of our Class A Common Stock on the date of grant. ISOs granted to shareholders having more than 10% of the total combined voting power of the Company must have exercise prices of at least 110% of the fair market value of our Class A Common Stock on the date of grant. ISOs and non-statutory stock options granted under the 2000 Plan are subject to vesting provisions, and exercise is subject to the continuous service of the participant. The exercise prices and vesting periods (if any) for non-statutory options are set at the discretion of our compensation committee. On November 1, 2017, upon the consummation of the initial equity investment in Cinedigm by Bison, as a result of which there was a change of control of the Company, all stock options (incentive and non-statutory) and shares of restricted stock were vested immediately and the options became fully exercisable.

 

In connection with the grants of stock options and shares of restricted stock under the 2000 Plan, we and the participants have executed stock option agreements and notices of restricted stock awards setting forth the terms of the grants. The 2000 Plan provided for the issuance of up to 2,380,000 shares of Class A Common Stock to employees, outside directors and consultants.

 

As of December 31, 2020, there were 265,887 stock options outstanding in the Plan with weighted average exercise price of $15.02 and a weighted average contract life of 2.36 years. As of March 31, 2020, there were 272,766 shares pursuant to stock options outstanding in the Plan with weighted average exercise price of $15.00 and a weighted average contract life of 3.11 years.

 

27

 

 

In August 2017, the Company adopted the 2017 Plan. The 2017 Plan replaced the 2000 Plan, and applies to employees and directors of, and consultants to, the Company. The 2017 Plan provided for the issuance of up to 2,108,270 shares of Class A common stock, in the form of various awards, including stock options, stock appreciation rights, stock, restricted stock, restricted stock units, performance awards and cash awards. The Compensation Committee of the Company’s Board of Directors (the “Board”) is authorized to administer the 2017 Plan and make grants thereunder. The approval of the 2017 Plan does not affect awards already granted under the 2000 Plan. On December 4, 2019, upon shareholder approval, the 2017 Plan was amended to increase the maximum number of shares of Class A common stock authorized for issuance thereunder from 2,108,270 shares to 4,098,270.

 

On October 23, 2020, the Company amended its 2017 Equity Incentive Plan to increase the number of shares authorized for issuance thereunder from 4,098,270 to 14,098,270.

 

The analysis of all options outstanding under the 2000 Plan as of December 31, 2020 is as follows:

 

As of December 31, 2020  
Range of Prices     Options Outstanding     Weighted Average Remaining Life in Years     Weighted Average Exercise Price     Aggregate Intrinsic Value (In thousands)  
$1.16 - $7.40       5,000       4.5     $ 7.40     $
 
$13.70 - $24.40       253,387       2.37       14.72      
 
$30.00 - $50.00       7,500       0.63       30.00      
 
        265,887                     $
 

 

OPTIONS GRANTED OUTSIDE CINEDIGM’S EQUITY INCENTIVE PLAN

 

In October 2013, we issued options outside of the 2000 Plan to 10 individuals who became employees as a result of a business combination. The employees received options to purchase an aggregate of 62,000 shares of our Class A Common Stock at an exercise price of $17.50 per share. The options were fully vested as of October 2017 and expire 10 years from the date of grant, if unexercised. As of December 31, 2020, 12,500 of such options remained outstanding.

 

In December 2010, we issued options to purchase 450,000 shares of Class A Common Stock outside of the 2000 Plan as part of our Chief Executive Officer’s initial employment agreement with the Company. Such options have exercise prices per share between $15.00 and $50.00, were vested as of December 2013 and expired in December 2020. As of December 31, 2020, none of such options remained outstanding.

 

WARRANTS

 

The following table presents information about outstanding warrants to purchase shares of our Class A common stock as of December 31, 2020. All of the outstanding warrants are fully vested and exercisable.

 

Recipient   Amount outstanding     Expiration     Exercise price per share  
Strategic management service provider     52,500     July 2021     $  17.20 - $30.00  
Warrants issued in connection with Convertible Notes exchange transaction     244,141     December 2021     $ 1.31  
5-year Warrant issued to BEMG in connection with a term loan agreement     1,400,000     December 2022     $ 1.80  

 

28

 

 

Certain warrants issued in connection with the Second Lien Loans (See Note 6 - Notes Payable) to Ronald L. Chez, at the time a member of our Board of Directors, contain a cashless exercise provision and customary anti-dilution rights. On June 4, 2020, Ronald L. Chez exercised all such warrants to purchase 236,899 shares of Class A common stock in connection with the Second Lien Loans, resulting in gross proceeds of $301 thousand.

 

8. COMMITMENTS AND CONTINGENCIES

 

We operate from leased properties under non-cancelable operating lease agreements, certain of which contain escalating lease clauses.

 

During the first quarter of 2019, the Company adopted ASU No. 2016-02, “Leases (Topic 842),” which requires leases with durations greater than twelve months to be recognized on the balance sheet. The Company adopted the standard using the modified retrospective approach with an effective date as of April 1, 2019. The Company did not apply the new standard to comparative periods and therefore, those amounts are not presented below.

 

The Company elected the package of three practical expedients. As such, the Company did not reassess whether expired or existing contracts are or contain a lease and did not need to reassess the lease classifications or reassess the initial direct costs associated with expired or existing leases. The Company did not elect the hindsight practical expedient. The land easement practical expedient was not applicable to the Company. Also, the Company has elected to take the practical expedient to not separate lease and non-lease components for all asset classes. The Company made an accounting policy election to continue not to recognize leases with durations of twelve months or less on the consolidated balance sheet.

 

The Company leases office space under operating leases. The Company’s portfolio of leases is primarily related to real estate and since most of our leases do not provide a readily determinable implicit rate, the Company estimated its incremental borrowing rate to discount the lease payments based on information available at either the implementation date of Topic 842 or at lease commencement for leases entered into thereafter.

 

The table below presents the lease-related assets and liabilities recorded on the balance sheet as of December 31, 2020

 

(In thousands)   Classification on the Balance Sheet    December 31, 2020  
Assets          
           
Noncurrent   Operating lease right-of-use asset   $
          —
 
           
Liabilities            
             
Current   Operating leases - current portion     117  
Noncurrent   Operating leases - long-term portion     17  
Total operating lease liabilities       $ 134  

 

Weighted-average discount rate (1)

 

(1) Upon adoption of the new lease standard, discount rates used for existing leases were established at April 1, 2019.

 

29

 

 

Lease Costs

 

The table below presents certain information related to lease costs for leases:

 

    Three Months Ended     Nine Months Ended  
(In thousands)   December 31, 2020  
Operating lease cost   $ 37     $ 160  
Total lease cost   $ 37     $ 160  

 

Other Information

 

The table below presents supplemental cash flow information related to leases:

  

    Three Months Ended     Nine Months Ended  
(In thousands)   December 31, 2020  
Cash paid for amounts included in the measurement of lease liabilities            
Operating cash flows used for operating leases   $ 37     $ 162  

  

The Company terminated an office lease in Los Angeles in April 2020 and a lease for office equipment was terminated in June 2020. The Company removed the right-of-use assets of $927 thousand and the lease liabilities of $1.0 million as of June 30, 2020. The estimated future lease liabilities are not expected to be material for the remaining outstanding office and equipment leases.

 

9. SUPPLEMENTAL CASH FLOW INFORMATION

 

    Nine Months Ended
December 31,
 
(In thousands)   2020     2019  
Cash interest paid   $ 3,014     $ 3,934  
Accrued dividends on preferred stock     89       89  
Issuance of Class A common stock for payment of preferred stock dividends     267       267  
Issuance of Class A common stock to Starrise, a related party     11,046      
 
Contributed capital under the Starrise transaction, a related party     17,187      
 
Settlement of second lien loan with Class A common stock     3,008      
 
Conversion of note payable     15,000      
 
Class A common stock to be issued in connection with the asset acquisition     1,853        
Right-of-use assets and operating lease liability recorded upon adoption of ASU 842, net    
      90  
Amounts accrued in connection with addition of property and equipment           232  
Starrise shares used to pay down vendors     897      
 

 

30

 

 

10. SEGMENT INFORMATION

 

We operate in two reportable segments: Cinema Equipment Business and Content & Entertainment Business. Our segments were determined based on the economic characteristics of our products and services, our internal organizational structure, the manner in which our operations are managed and the criteria used by our CODM to evaluate performance, which is generally the segment’s operating income (loss) before depreciation and amortization.

 

Operations of:   Products and services provided:
Cinema Equipment Business  

Financing vehicles and administrators for 3,313 Systems installed nationwide in our first deployment phase (“Phase I Deployment”) to theatrical exhibitors and for 3,104 Systems installed domestically and internationally in our second deployment phase (“Phase II Deployment”).

 

We retain ownership of the Systems and the residual cash flows related to the Systems in Phase I Deployment after the repayment of all non-recourse debt at the expiration of exhibitor master license agreements. For certain Phase II Deployment Systems, we do not retain ownership of the residual cash flows and digital cinema equipment in Phase II Deployment after the completion of cost recoupment and at the expiration of the exhibitor master license agreements.

 

The Cinema Equipment Business also provides monitoring, collection, verification and management services to this segment, as well as to exhibitors who purchase their own equipment, and also collects and disburses VPFs from motion picture studios, distributors and ACFs from alternative content providers, movie exhibitors and theatrical exhibitors (collectively, “Services”).

     
Content & Entertainment Business   Leading distributor of independent content, and collaborates with producers and other content owners to market, source, curate and distribute independent content to targeted and profitable audiences in theatres and homes, and via mobile and emerging platforms.

  

The following tables present certain financial information related to our reportable segments and Corporate:

 

    As of December 31, 2020  
(In thousands)   Intangible Assets, net       Goodwill     Total Assets     Notes Payable, Non-Recourse     Notes Payable     Operating lease liabilities  
Cinema Equipment Business   $
    $
    $ 17,160     $ 11,153     $
    $
       —
 
Content & Entertainment Business     8,036       8,701       48,868      
     
      98  
Corporate     3      
      25,661             11,890       36  
Total   $ 8,039     $ 8,701     $ 91,689     $ 11,153     $ 11,890     $ 134  

 

    As of March 31, 2020  
(In thousands)   Intangible Assets, net     Goodwill     Total Assets     Notes Payable, Non-Recourse     Notes Payable     Operating lease liabilities  
Cinema Equipment Business   $ 23     $
    $ 34,465     $ 11,442     $
    $ 594  
Content & Entertainment Business     6,895       8,701       49,923      
     
      73  
Corporate     6      
      26,052      
      37,249       610  
Total   $ 6,924     $ 8,701     $ 110,440     $ 11,442     $ 37,249     $ 1,277  

 

31

 

 

    Statements of Operations  
    Three Months Ended December 31, 2020  
    (Unaudited, in thousands)  
    Cinema Equipment Business     Content & Entertainment
Business
    Corporate     Consolidated  
Revenues   $ 910     $ 9,044     $
    $ 9,954  
Direct operating (exclusive of depreciation and amortization shown below)     150       4,235      
      4,385  
Selling, general and administrative     524       2,244       2,593       5,361  
Allocation of corporate overhead     143       964       (1,107 )    
 
Provision for doubtful accounts     70      
     
      70  
Depreciation and amortization of property and equipment     706       108       8       822  
Amortization of intangible assets     8       588       1       597  
Total operating expenses     1,601       8,139       1,495       11,235  
Loss from operations   $ (691 )   $ 905     $ (1,495 )   $ (1,281 )

 

Employee and director stock-based compensation expense related to the Company’s stock-based awards was negative $1.0 million for the three months ended December 31, 2020.

 

(In thousands)   Cinema Equipment Business     Content & Entertainment
Business
    Corporate     Consolidated  
Direct operating   $
    —
    $
    —
    $
    —
    $
    —
 
Selling, general and administrative    
      39       921       960  
Total stock-based compensation   $
    $ 39     $ 921     $ 960  

 

    Statements of Operations  
    Three Months Ended December 31, 2019  
    (Unaudited, in thousands)  
    Cinema Equipment Business     Content & Entertainment Business     Corporate     Consolidated  
Revenues   $ 3,129     $ 8,383     $
    $ 11,512  
Direct operating (exclusive of depreciation and amortization shown below)     312       5,414      
      5,726  
Selling, general and administrative     536       2,294       167       2,997  
Allocation of Corporate overhead     200       1,249       (1,449 )    
 
Provision (recovery) for doubtful accounts     (5 )    
     
      (5 )
Depreciation and amortization of property and equipment     1,475       77       42       1,594  
Amortization of intangible assets     11       576       2       589  
Total operating expenses     2,529       9,610       (1,238 )     10,901  
Income (loss) from operations   $ 600     $ (1,227 )   $ 1,238     $ 611  

 

Employee and director stock-based compensation expense related to the Company’s stock-based awards was $0.2 million for the three months ended December 31, 2019.

 

(In thousands)   Cinema Equipment Business     Content & Entertainment
Business
    Corporate     Consolidated  
Direct operating   $
    $
    $
    $
 
Selling, general and administrative    
      26       152       178  
Total stock-based compensation   $
    $ 26     $ 152     $ 178  

 

32

 

 

    Statements of Operations  
    Nine Months Ended December 31, 2020  
    (Unaudited, in thousands)  
    Cinema Equipment Business     Content & Entertainment
Business
    Corporate     Consolidated  
Revenues   $ 2,158     $ 20,996     $
    $ 23,154  
Direct operating (exclusive of depreciation and amortization shown below)     504       10,890      
      11,394  
Selling, general and administrative     1,704       6,667       6,998       15,369  
Allocation of corporate overhead     438       2,883       (3,321 )    
 
Recovery for doubtful accounts     (123 )    
     
      (123 )
Depreciation and amortization of property and equipment     3,348       312       31       3,691  
Amortization of intangible assets     23       1,752       3       1,778  
Total operating expenses     5,894       22,504       3,711       32,109  
Loss from operations   $ (3,736 )   $ (1,508 )   $ (3,711 )   $ (8,955 )

 

Employee and director stock-based compensation expense related to the Company’s stock-based awards was $2.1 million for the nine months ended December 31, 2020.

 

(In thousands)   Cinema Equipment Business     Content & Entertainment
Business
    Corporate     Consolidated  
Direct operating   $
    $
    $
    $
 
Selling, general and administrative    
      91       2,081       2,172  
Total stock-based compensation   $
    $ 91     $ 2,081     $ 2,172  

 

    Statements of Operations  
    Nine Months Ended December 31, 2019  
    (Unaudited, in thousands)  
    Cinema Equipment Business     Content & Entertainment
Business
    Corporate     Consolidated  
Revenues   $ 10,767     $ 20,789     $
    $ 31,556  
Direct operating (exclusive of depreciation and amortization shown below)     908       12,517      
      13,425  
Selling, general and administrative     1,636       8,109       4,090       13,834  
Allocation of corporate overhead     605       3,785       (4,390 )    
 
Provision (recovery) for doubtful accounts     322       (1 )    
      321  
Depreciation and amortization of property and equipment     4,612       239       126       4,977  
Amortization of intangible assets     34       2,140       4       2,178  
Total operating expenses     8,117       26,789       (170 )     34,735  
Loss from operations   $ 2,650     $ (6,000 )   $ 170     $ (3,179 )

   

33

 

 

Employee and director stock-based compensation expense related to the Company’s stock-based awards was $0.4 million for the nine months ended December 31, 2019.

 

(In thousands)   Cinema Equipment Business     Content & Entertainment
Business
    Corporate     Consolidated  
Direct operating   $
    $
    $
    $
 
Selling, general and administrative     (6 )     29       344       367  
Total stock-based compensation   $ (6 )   $ 29     $ 344     $ 367  

 

11. SUBSEQUENT EVENTS

 

On January 21, 2021, the Company entered into an exchange agreement (the “Exchange Agreement”) with a holder of notes under its Second Lien Loan Agreement dated as of July 14, 2016 among the Company, the lenders party thereto, and Cortland Capital Market Services LLC, as Agent (“Second Lien Notes”). Pursuant to the Exchange Agreement, the Company issued an aggregate of 1,247,626 shares of its Class A common stock, par value $0.001 per share Common Stock in exchange for an aggregate of $1,289,650 of principal amount of Second Lien Notes. The exchanged Second Lien Notes were immediately cancelled.

 

In two separate exchanges with another holder of Second Lien Notes, on January 14, 2021 and January 21, 2021, the Company issued 689,500 shares and 580,448 shares (an aggregate of 1,269,948 shares) of Class A Common Stock in exchange for $500,000 and $600,000 (an aggregate of $1,100,000) principal amount of Second Lien Notes. The exchanged Second Lien Notes were immediately cancelled.

 

On February 9, 2021, the Company prepaid substantially all of the outstanding obligations in respect of principal, interest, fees and expenses under the Second Lien Loan Agreement, among the Company, certain lenders and Cortland Capital Market Services LLC. The payoff amount of approximately $3.18 million was comprised of (i) $3.1 million of principal, (2) accrued payment-in-kind interest of $.018 million, (3) accrued current interest of $0.007 million, and (4) fees and expenses of $0.004 million. Upon such prepayment, the Second Lien Loan Agreement was terminated effective February 9, 2021.

 

On February 2, 2021, the Company entered into a Securities Purchase Agreement with a single institutional investor for the purchase and sale of 5,600,000 shares the Company’s Class A common stock, par value $0.001 per share, at a purchase price of $1.25 per share, in a registered direct offering, pursuant to an effective shelf registration statement on Form S-3 which was declared effective by the Securities and Exchange Commission on July 10, 2020 (File No. 333-239710) and an applicable prospectus supplement.

 

The closing of the sale of the February Shares under the Securities Purchase Agreement occurred on February 5, 2021. The aggregate gross proceeds for the sale of the February Shares was approximately $7.0 million. The net proceeds to the Company from the sale of the Shares, after deducting the fees of the placement agent but before paying the Company’s estimated offering expenses, was approximately $6.5 million.

 

34

 

  

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion and analysis should be read in conjunction with our historical consolidated financial statements and the related notes included elsewhere in this document.

 

This report contains forward-looking statements within the meaning of the federal securities laws. These include statements about our expectations, beliefs, intentions or strategies for the future, which are indicated by words or phrases such as “believes,” “anticipates,” “expects,” “intends,” “plans,” “will,” “estimates,” and similar words. Forward-looking statements represent, as of the date of this report, our judgment relating to, among other things, future results of operations, growth plans, sales, capital requirements and general industry and business conditions applicable to us. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, assumptions and other factors, some of which are beyond our control that could cause actual results to differ materially from those expressed or implied by such forward-looking statements.

 

OVERVIEW

 

Since our inception, we have played a significant role in the digital distribution revolution that continues to transform the media landscape. In addition to our pioneering role in transitioning approximately 12,000 movie screens from traditional analog film prints to digital distribution, we have become a leading distributor of independent content, both through organic growth and acquisitions. We distribute products for major brands such as the NFL, Hallmark and Scholastic, as well as leading international and domestic content creators, movie producers, television producers and other short form digital content producers. We collaborate with producers, major brands and other content owners to market, source, curate and distribute quality content to targeted audiences through (i) existing and emerging digital home entertainment platforms, including but not limited to, iTunes, Amazon Prime, Netflix, Hulu, Xbox, Sony PlayStation, Tubi and cable video-on-demand (“VOD”), and (ii) physical goods, including DVD and Blu-ray Discs.

 

We report our financial results in two primary segments as follows: (1) cinema equipment business and (2) media content and entertainment business (“Content & Entertainment” or “CEG”). The cinema equipment business segment consists of the non-recourse, financing vehicles and administrators for our digital cinema equipment (the “Systems”) installed in movie theatres throughout North America and several international countries. It also provides fee-based support to over 12,000 movie screens as well as directly to exhibitors and other third party customers in the form of monitoring, billing, collection and verification services. Our Content & Entertainment segment is a market leader in: (1) ancillary market aggregation and distribution of entertainment content and; (2) branded and curated over-the-top (“OTT”) digital network business providing entertainment channels and applications.

 

Beginning in December 2015, certain of our cinema equipment began to reach the conclusion of their 10-year deployment payment period with certain distributors and, therefore, Virtual Print Fees (“VPF”) revenues ceased to be recognized on such Systems, related to such distributors. Furthermore, because the Phase I Deployment installation period ended in November 2007, a majority of the VPF revenue associated with the Phase I Deployment Systems has ended. The reduction in VPF revenue on cinema equipment business systems approximately coincided with the conclusion of certain of our non-recourse debt obligations and, therefore, the reduced cash outflows related to such non-recourse debt obligations partially offset the reduced VPF revenue since November 2017.

 

Under the terms of our standard cinema equipment licensing agreements, exhibitors will continue to have the right to use our Systems through the end of the term of the licensing agreement, after which time, they have the option to: (1) return the Systems to us; (2) renew their license agreement for successive one-year terms; or (3) purchase the Systems from us at fair market value. As permitted by these agreements, we typically pursue the sale of the Systems to such exhibitors. Such sales were as originally contemplated as the conclusion of the digital cinema deployment plan.

 

We are structured so that our cinema equipment business segment operates independently from our Content & Entertainment business. As of December 31, 2020, we had approximately $11.9 million of non-recourse outstanding debt principal that relates to, and is serviced by, our cinema equipment business. We also have approximately $13.3 million of outstanding debt principal, as of December 31, 2020 that is attributable to our Content & Entertainment and Corporate segments.

 

Risks and Uncertainties

 

The COVID-19 pandemic and related economic repercussions have created significant volatility, uncertainty, and turmoil in certain industries. Closures of certain entertainment facilities and retail locations have significantly impacted consumers’ behaviors as a result of the virus outbreak and corresponding preventative measures taken around the world to mitigate the spread of the virus. As part of our Content & Entertainment business, we sell physical goods, including DVDs and Blu-ray discs, at brick-and-mortar stores. Many of such stores in the United States closed during the spring of 2020 due to COVID-19 restrictions, and many of those have not yet re-opened, or have re-opened on a limited basis. We expect that we will experience a loss of sales of such physical goods due to such closures, and we cannot predict the extent of such losses, or how long the closures or limited openings of the stores may last. As part of our Cinema Equipment business, we earn revenues that are generated when movies are exhibited by theatres. Many movie theatres in the United States closed during the spring of 2020 due to COVID-19 restrictions and many of those have not yet re-opened, or have re-opened on a limited basis. The majority of major studios moved releases originally scheduled for the three months ended December 31, 2020 to future dates with the exception of two Studios that had theatrical releases that opened in theatres on the same day as becoming available on a streaming channel. To the extent movies are not shown in movie theatres due to the closures, we have not received, and will not receive, related revenue. The studios that produce movies may elect to delay the release of movies until theatres re-open, or to bypass exhibiting movies in theatres at all and distribute the movies through other means, such as on streaming platforms, in which case we would not earn revenues at all from such movies.

 

35

 

 

These events have negatively affected, and are expected to continue to negatively affect, our business and results of operations. Given the dynamic nature of these events, we cannot reasonably estimate the period of time that the COVID-19 pandemic and related closures and market conditions will persist, or the extent of the impact they will have on our business or results of operations and financial condition.

 

Results of Operations for the Three Months Ended December 31, 2020 and 2019

 

Revenues

 

    Three Months Ended December 31,  
($ in thousands)   2020     2019     $ Change     % Change  
Cinema Equipment Business   $ 910     $ 3,129     $ (2,219 )     (71 )%
Content & Entertainment Business     9,044       8,383       661       8 %
    $ 9,954     $ 11,512     $ (1,558 )     (14 )%

 

Revenues generated by our Cinema Equipment Business segment decreased primarily as a result of the reduced number of Systems earning VPF revenue and commissions for Phase II Deployment Systems. In addition, as a result of COVID-19, during the three months ended December 31, 2020, theatres in many major markets remained closed throughout the third quarter causing the majority of major studios to move wide releases scheduled for the three months ended December 31, 2020 to future dates.  Only two major studios had wide theatrical releases in November/December, however, the theatrical window before the streaming debut was shortened or eliminated to accommodate the lack of theatrical venues. Because our digital cinema business earns a VPF when a movie is first played on a system, the temporary theatre closures resulting from the COVID-19 pandemic resulted in reduced revenues. The revenues in the Content & Entertainment Business segment increased by 8% for the three months ended December 31, 2020 compared to the three months ended December 31, 2019. The increase is due to the addition of five new third-party OTT channels and an increase in the number of advertising partners.

 

Direct Operating Expenses

  

    Three Months Ended December 31,  
($ in thousands)   2020     2019     $ Change     % Change  
Cinema Equipment Business   $ 150     $ 312     $ (162 )     (52 )%
Content & Entertainment Business     4,235       5,414       (1,179 )     (22 )%
    $ 4,385     $ 5,726     $ (1,341 )     (23 )%

 

The decrease in direct operating expenses in the three months ended December 31, 2020 for the Content & Entertainment Business compared to the prior period was primarily due to transition credits received related to a new third-party DVD distributor. These credits mainly offset fulfillment and freight expenses. In addition, there was a significant decrease in manufacturing costs between the distributor in place in the prior period and the inventory reserve has decreased. The decrease in direct operating expenses in the three months ended December 31, 2020 for the Cinema Equipment Business compared to the prior period was primarily due to a reduction in head count and shifting of certain employees from full time to part time as a result of the negative impact of the Covid 19 pandemic.

 

Selling, General and Administrative Expenses

 

    Three Months Ended December 31,  
($ in thousands)   2020     2019     $ Change     % Change  
Cinema Equipment Business   $ 524     $ 536     $ (12 )     (2 )%
Content & Entertainment Business     2,244       2,294       (50 )     (2 )%
Corporate     2,593       167       2,426       1453 %
    $ 5,361     $ 2,997     $ 2,364       79 %

 

36

 

 

Selling, general and administrative expenses for the three month ended December 31, 2020 increase by $2.4 million, primarily due to increase in share based compensation expense of $0.8 million and a bonus expense of $1.4 million.

 

Depreciation and Amortization Expense on Property and Equipment

 

    Three Months Ended December 31,  
($ in thousands)   2020     2019     $ Change     %  Change  
Cinema Equipment Business   $ 706     $ 1,475     $ (769 )     (52 )%
Content & Entertainment Business     108       77       31       40 %
Corporate     8       42       (34 )   (81 )%
    $ 822     $ 1,594     $ (772 )     (48 )%

 

Depreciation and amortization expense decreased in our Cinema Equipment Business segment as additional digital cinema projection Systems reached the conclusion of their ten-year useful lives during fiscal year 2020.

 

Interest expense, net

 

    Three Months Ended December 31,  
($ in thousands)   2020     2019     $ Change     %  Change  
Cinema Equipment Business   $ 629     $ 640     $ (11 )     (2 )%
Content & Entertainment Business     9       -       9       - %
Corporate     310     $ 978     $ (668 )     (68 )%
    $ 948     $ 1,618     $ (670 )     (41 )%

 

Interest expense in the Cinema Equipment Business segment decreased primarily as a result of reduced note payable balances compared to the prior period, solely on the Prospect Term Loan. Interest expense in our Corporate Segment decreased as a result of lower loan balances from our Credit Facility and Second Lien Loans settled with Class A common stock and the conversion of the Bison Convertible Note and the Mingtai Convertible Note into shares of Class A Common Stock.

 

Change in fair value of equity investment in Starrise, a related party

 

Our investment in Starrise is accounted for at fair value with changes in fair value recognized in the statement of operations. The loss of $6.8 million during the three months ended December 31, 2020 reflects the decrease during the period in the market price of Starrise’s stock.

 

Income Tax Expense

 

We recorded an income tax benefit of $0 for the three months ended December 31, 2020. We recorded income tax expense of approximately $0.1 million for the three months ended December 31, 2019.

 

Our effective tax rate for the three months ended December 31, 2020 and 2019 was 0% and negative 2.0%, respectively.

 

Adjusted EBITDA

 

We define Adjusted EBITDA to be earnings before interest, taxes, depreciation and amortization, other income, net, stock-based compensation and expenses, merger and acquisition costs, restructuring, transition and acquisitions expense, net, goodwill impairment and certain other items.

 

Consolidated Adjusted EBITDA (including the results of Cinema Equipment Business segment) for the three months ended December 31, 2020 decreased by $1.8 million compared to the three months ended December 31, 2019. Adjusted EBITDA from our Cinema Equipment Business segment decreased primarily due to state mandated theater closures due to COVID-19, the temporary halt of distribution of major studio releases and the expected decline of the Cinema Equipment Business. Adjusted EBITDA from our Content & Entertainment Business and corporate increased for the three months ended December 31, 2020 compared to the three months ended December 31, 2019 by $0.2 million due to the addition of five new third-party OTT channels and an increase in the number of advertising partners.

 

37

 

 

Adjusted EBITDA is not a measurement of financial performance under GAAP and may not be comparable to other similarly titled measures of other companies. We use Adjusted EBITDA as a financial metric to measure the financial performance of the business because management believes it provides additional information with respect to the performance of its fundamental business activities. For this reason, we believe Adjusted EBITDA will also be useful to others, including its stockholders, as a valuable financial metric.

 

We present Adjusted EBITDA because we believe that Adjusted EBITDA is a useful supplement to net loss from continuing operations as an indicator of operating performance. We also believe that Adjusted EBITDA is a financial measure that is useful both to management and investors when evaluating our performance and comparing our performance with that of our competitors. We also use Adjusted EBITDA for planning purposes and to evaluate our financial performance because Adjusted EBITDA excludes certain incremental expenses or non-cash items, such as stock-based compensation charges, that we believe are not indicative of our ongoing operating performance.

 

We believe that Adjusted EBITDA is a performance measure and not a liquidity measure, and therefore a reconciliation between net loss from continuing operations and Adjusted EBITDA has been provided in the financial results. Adjusted EBITDA should not be considered as an alternative to income from operations or net loss from continuing operations as an indicator of performance or as an alternative to cash flows from operating activities as an indicator of cash flows, in each case as determined in accordance with GAAP, or as a measure of liquidity. In addition, Adjusted EBITDA does not take into account changes in certain assets and liabilities as well as interest and income taxes that can affect cash flows. We do not intend the presentation of these non-GAAP measures to be considered in isolation or as a substitute for results prepared in accordance with GAAP. These non-GAAP measures should be read only in conjunction with our consolidated financial statements prepared in accordance with GAAP.

 

Following is the reconciliation of our consolidated net loss to Adjusted EBITDA:

 

    Three Months Ended
December 31,
 
($ in thousands)   2020     2019  
Net loss   $ (9,667 )   $ (2,162 )
Add Back:                
Income tax expense           136  
Depreciation and amortization of property and equipment     822       1,594  
Amortization of intangible assets     597       589  
Loss on extinguishment of notes payable     540        
Interest expense, net     948       1,618  
Changes in fair value on equity investment in Starrise     6,751        
Other (income) expense, net     (66 )     777  
Stock-based compensation and expenses     960       178  
Net income (loss) attributable to noncontrolling interest     23       (7 )
Adjusted EBITDA   $ 908     $ 2,723  
                 
Adjustments related to the Cinema Equipment Business                
                 
Depreciation and amortization of property and equipment   $ (706 )   $ (1,475 )
Amortization of intangible assets     (8 )     (11 )
Other income and expense     (32 )      
Income (loss) from operations     691       (600 )
Adjusted EBITDA from Content & Entertainment business and corporate segment   $ 885     $ 637  

 

38

 

 

Results of Operations for the Nine Months Ended Months Ended December 31, 2020 and 2019

 

Revenues

 

    Nine Months Ended December 31,  
($ in thousands)   2020     2019     $ Change     %  Change  
Cinema Equipment Business   $ 2,158     $ 10,767     $ (8,609 )     (80 )%
Content & Entertainment Business     20,996       20,789       207     1 %
    $ 23,154     $ 31,556     $ (8,402 )     (27 )%

 

Revenues generated by our Cinema Equipment Business segment decreased primarily as a result of the reduced number of Systems earning VPF revenue and commissions for Phase II Deployment Systems. In addition, as a result of COVID-19, during the nine months ended December 31, 2020, theatres in many major markets remained closed throughout the third quarter causing the majority of major studios to move wide releases scheduled for the three months ended December 31, 2020 to future dates.  Only two major studios had wide theatrical releases in November/December, however, the theatrical window before the streaming debut was shortened or eliminated to accommodate the lack of theatrical venues. Because our digital cinema business earns a VPF when a movie is first played on a system, the temporary theatre closures resulting from the COVID-19 pandemic resulted in reduced revenues. The revenues in the Content & Entertainment Business segment increased by 1% for the nine months ended December 31, 2020 compared to the nine months ended December 31, 2019. The increase is due to the addition of five new OTT third-party channels and an increase in the number of advertising partners. 

 

Direct Operating Expenses

  

    Nine Months Ended December 31,  
($ in thousands)   2020     2019     $ Change     %  Change  
Cinema Equipment Business   $ 504     $ 908     $ (404 )     (44 )%
Content & Entertainment Business     10,890       12,517       (1,627 )     (13 )%
    $ 11,394     $ 13,425     $ (2,031 )   (15 )%

 

The decrease in direct operating expenses in the nine months ended December 31, 2020 for the Content & Entertainment Business compared to the prior period was primarily due to a decrease in overall revenue partially offset by an increase due to transition expenses related to a new third party DVD distributor. These costs were mainly fulfillment and freight expenses. The decrease in direct operating expenses in the nine months ended December 31, 2020 for the Cinema Equipment Business compared to the prior period was primarily due to a reduction in head count and shifting of certain employees from full time to part time as a result of the negative impact of the Covid 19 pandemic.

  

Selling, General and Administrative Expenses

 

    Nine Months Ended December 31,  
($ in thousands)   2020     2019     $ Change     %  Change  
Cinema Equipment Business   $ 1,704     $ 1,636     $ 68       4 %
Content & Entertainment Business     6,667       8,108       (1,441 )     (18 )%
Corporate     6,998       4,090       2,908       71 %
    $ 15,369     $ 13,834     $ 1,535     11 %

 

39

 

 

Selling, general and administrative expenses for the nine months ended December 31, 2020 increased by $1.5 million primarily due to a $1.2 million increase in bonus expense and a $1.7 million increase in stock based compensation, for Corporate, partially offset by decreases of $650 thousand related to personnel expenses as a result of the company-wide downsizing program and $660 thousand related to occupancy costs as a result of the company-wide program to downsize office space and move to a more remote workforce, in the Content & Entertainment Business segment.

 

Depreciation and Amortization Expense on Property and Equipment

 

    Nine Months Ended December 31,  
($ in thousands)   2020     2019     $ Change     %  Change  
Cinema Equipment Business   $ 3,348     $ 4,612     $ (1,264 )     (27 )%
Content & Entertainment Business     312       239       73       31 %
Corporate     31       126       (95 )   (75 )%
    $ 3,691     $ 4,977     $ (1,286 )     (26 )%

 

Depreciation and amortization expense decreased in our Cinema Equipment Business segment as additional digital cinema projection Systems reached the conclusion of their ten-year useful lives during the nine months ended December 31, 2020.

 

Interest expense, net

 

    Nine Months Ended December 31,  
($ in thousands)   2020     2019     $ Change     %  Change  
Cinema Equipment Business   $ 1,830     $ 2,159     $ (329 )   (15 )%
Content & Entertainment Business     9             9        
Corporate     1,593       3,554       (1,961 )     (55 )%
    $ 3,432     $ 5,713     $ (2,281 )     (40 )%

 

Interest expense in the Cinema Equipment Business segment decreased primarily as a result of reduced debt balances compared to the prior period on the Prospect Term Loan. Interest expense in our Corporate Segment decreased as a result of lower loan balances from our Credit Facility and Second Lien Loans settled for Class A common stock and the conversion of the Bison Convertible Note and the Mingtai Convertible Note into shares of Class A Common Stock.

 

Change in fair value of equity investment in Starrise, a related party

 

Our investment in Starrise is accounted for at fair value with changes in fair value recognized in the statement of operations. The loss of $42.4 million during the nine months ended December 31, 2020 reflects the decrease during the period in the market price of Starrise’s stock.

 

Income Tax Expense

 

We recorded an income tax benefit of approximately $181 thousand for the nine months ended December 31, 2020.

 

We recorded income tax expense of approximately $0.2 million nine months ended December 31, 2019.

 

40

 

 

Adjusted EBITDA

 

We define Adjusted EBITDA to be earnings before interest, taxes, depreciation and amortization, other income, net, stock-based compensation and expenses, merger and acquisition costs, restructuring, transition and acquisitions expense, net, goodwill impairment and certain other items.

 

Consolidated Adjusted EBITDA (including the results of Cinema Equipment Business segment) for the nine months ended December 31, 2020 decreased by $5.1 million compared to the nine months ended December 31, 2019. Adjusted EBITDA from our Cinema Equipment Business segment decreased primarily due to state mandated theater closures due to COVID-19, the temporary halt of distribution of major studio releases and the expected decline of the Cinema Equipment Business. Negative Adjusted EBITDA from the Content & Entertainment business and corporate segment increased by $2.6 million for the nine months ended December 31, 2020 compared to the nine months ended December 31, 2019, due to growth of OTT Streaming & Digital revenues based on higher volume for streaming due to the pandemic and adding additional channels and content compared to the prior period.

 

Adjusted EBITDA is not a measurement of financial performance under GAAP and may not be comparable to other similarly titled measures of other companies. We use Adjusted EBITDA as a financial metric to measure the financial performance of the business because management believes it provides additional information with respect to the performance of its fundamental business activities. For this reason, we believe Adjusted EBITDA will also be useful to others, including its stockholders, as a valuable financial metric.

 

We present Adjusted EBITDA because we believe that Adjusted EBITDA is a useful supplement to net loss from continuing operations as an indicator of operating performance. We also believe that Adjusted EBITDA is a financial measure that is useful both to management and investors when evaluating our performance and comparing our performance with that of our competitors. We also use Adjusted EBITDA for planning purposes and to evaluate our financial performance because Adjusted EBITDA excludes certain incremental expenses or non-cash items, such as stock-based compensation charges, that we believe are not indicative of our ongoing operating performance.

 

We believe that Adjusted EBITDA is a performance measure and not a liquidity measure, and therefore a reconciliation between net loss from continuing operations and Adjusted EBITDA has been provided in the financial results. Adjusted EBITDA should not be considered as an alternative to income from operations or net loss from continuing operations as an indicator of performance or as an alternative to cash flows from operating activities as an indicator of cash flows, in each case as determined in accordance with GAAP, or as a measure of liquidity. In addition, Adjusted EBITDA does not take into account changes in certain assets and liabilities as well as interest and income taxes that can affect cash flows. We do not intend the presentation of these non-GAAP measures to be considered in isolation or as a substitute for results prepared in accordance with GAAP. These non-GAAP measures should be read only in conjunction with our consolidated financial statements prepared in accordance with GAAP.

 

Following is the reconciliation of our consolidated net loss to Adjusted EBITDA:

 

    Nine Months Ended
December 31,
 
($ in thousands)   2020     2019  
Net loss     (56,103 )     (10,289 )
Add Back:                
Income tax (benefit) expense     (181 )     210  
Depreciation and amortization of property and equipment     3,691       4,977  
Amortization of intangible assets     1,778       2,178  
Loss on extinguishment of notes payable     852        
Interest expense, net     3,432       5,713  
Changes in fair value on equity investment in Starrise     42,377        
Other expense, net     1,539       1,536  
Stock-based compensation     2,172       367  
Net loss (income) attributable to noncontrolling interest     60       (8 )
Adjusted EBITDA   $ (383 )   $ 4,684  
                 
Adjustments related to the Cinema Equipment Business                
Depreciation and amortization of property and equipment     (3,348 )     (4,612 )
Amortization of intangible assets     (23 )     (34 )
Stock-based compensation and expenses           7  
Other income and expense     (32 )      
Income (loss) from operations     3,736       (2,650 )
Adjusted EBITDA from Content & Entertainment business and corporate segment   $ (50 )   $ (2,605 )

 

41

 

  

Critical Accounting Policies and Estimates

 

Our consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). In connection with the preparation of our consolidated financial statements, we are required to make assumptions and estimates about future events and apply judgments that affect the reported amounts of assets, liabilities, revenue, expenses and the related disclosures. We base our assumptions, estimates and judgments on historical experience, current trends and other factors that management believes to be relevant at the time our consolidated financial statements are prepared. On a regular basis, management reviews the accounting policies, assumptions, estimates and judgments to ensure that our financial statements are presented fairly and in accordance with GAAP. However, because future events and their effects cannot be determined with certainty, actual results could differ from our assumptions and estimates, and such differences could be material.

 

There have been no material changes to the critical accounting policies previously disclosed in our Annual Report on Form 10-K for the fiscal year ended March 31, 2020, filed with the SEC on July 6, 2020.

 

Recent Accounting Pronouncements

 

See Note 2 - Summary of Significant Accounting Policies to our condensed consolidated financial statements included herein.

 

Liquidity and Capital Resources

 

We incurred consolidated net loss of $56.3 million and $10.3 million for the nine months ended December 31, 2020 and 2019, respectively. We have incurred net losses historically and have an accumulated deficit of $467.2 million, and negative working capital of $16.6 million as of December 31, 2020. We may continue to generate net losses for the foreseeable future. In addition, we have significant debt-related contractual obligations as of December 31, 2020 and beyond. Based on these conditions, the Company entered into the following transactions described below:

 

The East West Bank (“EWB”) credit facility has a maturity date of June 30, 2021. The Company intends to negotiate another extension of the EWB maturity date but in the event it is unable to do so successfully, the Company has the funds to pay the debt in full when due.

 

The Prospect Loan matures on March 31, 2021. The Company and Prospect are negotiating to extend the maturity date to March 31, 2022 which may include a prepayment amount on the principal upon execution of an amendment.

 

Capital Raise

 

On February 2, 2021, the Company entered into a securities purchase agreement (the “Securities Purchase Agreements”) with a single institutional investor for the purchase and sale of 5,600,000 shares (the “February Shares”) of the Company’s Class A common stock. (see Note 11 – Subsequent events).

 

The closing of the sale of the February Shares under the Securities Purchase Agreement occurred on February 5, 2021. The aggregate gross proceeds for the sale of the February Shares was approximately $7.0 million.

 

The net proceeds to the Company from the sale of the Shares, after deducting the fees of the placement agent but before paying the Company’s estimated offering expenses, was approximately $6.5 million.

 

In July 2020, we entered into an At-the-Market sales agreement (the “ATM Sales Agreement”) with A.G.P./Alliance Global Partners (“A.G.P.”) and B. Riley FBR, Inc. (“B. Riley” and, together with A.G.P., the “Sales Agents”), pursuant to which the Company may offer and sell, from time to time, through the Sales Agents, shares of Common Stock at the market prices prevailing on The Nasdaq Global Market at the time of the sale of such shares. The Company is not obligated to sell any shares under the Sales Agreement. Any sales of shares made under the Sales Agreement will be made pursuant to an effective registration statement on Form S-3 filed by the Company with the SEC on July 6, 2020, for an aggregate offering price of up to $30 million.

 

During the quarter ended December, 2020, we sold 28,405,840 shares of Common Stock under the ATM Sales Agreement. Net proceeds from such sales totaled $18.6 million.

 

42

 

 

On July 16, 2020, the Company entered into a securities purchase agreement (the “July Securities Purchase Agreement” for the sale of 7,213,334 shares (the “July Shares”) of Class A common stock at a purchase price of $1.50 per share, in a registered direct offering, pursuant to an effective shelf registration statement on Form S-3 (Reg. No. 333-239710) which was declared effective by the Securities and Exchange Commission on July 10, 2020 and an applicable prospectus supplement. This registration statement covers offerings of up to an aggregate offering price of $75.0 million.

 

The Company closed the transaction on July 20, 2020. The aggregated gross proceeds from the sale of the July Shares were approximately $10.8 million. The net proceeds to the Company from the sale of the July Shares, after deducting the fees of the placement agents but before paying the Company’s estimated offering expenses, was approximately $10.1 million.

 

On May 20, 2020, the Company entered into a securities purchase agreement (the “May Securities Purchase Agreement”) with certain investors for the purchase and sale of 10,666,666 shares (the “May Shares”) of Common Stock, at a purchase price of $0.75 per share, in a registered direct offering, pursuant to an effective shelf registration statement on Form S-3 (Reg. No. 333-238183) which was declared effective by the Securities and Exchange Commission on May 14, 2020 and an applicable prospectus supplement.

 

The aggregate gross proceeds for the sale of the May Shares was $8.0 million. The net proceeds to the Company from the sale of the May Shares, after deducting the fees of the placement agents but before paying the Company’s estimated offering expenses, were approximately $7.1 million.

 

Equity Investment in Starrise, a related party transaction

 

On December 27, 2019, the Company entered into, and on February 14, 2020 amended, (see Note 2 - Summary of Significant Accounting Policies), a stock purchase agreement (as so amended, the “Starrise Stock Purchase Agreement”) with BeiTai Investment LP (“BeiTai”) and Aim Right Ventures Limited (“Aim Right”), two shareholders of Starrise Media Holdings Limited, a leading Chinese entertainment company (“Starrise”), to buy from them an aggregate of 410,901,000 outstanding Starrise ordinary shares (the “Share Acquisition”). On February 14, 2020, the Company purchased 162,162,162 of the Starrise ordinary shares from BeiTai and issued BeiTai 21,646,604 shares of Class A common stock as consideration.

 

On April 10, 2020, the Company, in accordance with the terms of the Starrise Stock Purchase Agreement, terminated its obligation to purchase Starrise ordinary shares from Aim Right under the December 27, 2019 stock purchase agreement. On April 10, 2020, the Company entered into another stock purchase agreement (the “April Stock Purchase Agreement”) with five (5) shareholders of Starrise-Bison Global Investment SPC - Bison Global No. 1 SP, Huatai Investment LP, Antai Investment LP, Mingtai Investment LP and Shangtai Asset Management LP, to buy an aggregate of 223,380,000 outstanding Starrise ordinary shares from them and for the Company to issue to them an aggregate of 29,855,081 shares of its Class A common stock in consideration therefore (the “April Share Acquisition”). On April 15, 2020, the April Share Acquisition was consummated and recorded as an equity investment in Starrise and is a related party transaction.

 

Starrise’s ordinary shares (HK 1616) are listed on the main board of the Stock Exchange of Hong Kong Limited. Based on the closing price of HKD 0.163 per share on February 19, 2021, calculated at an exchange rate of $7.75 Hong Kong Dollars to 1 US dollar, the market value of Cinedigm’s ownership in Starrise ordinary shares was approximately $7.6 million.

 

Borrowings

 

On April 15, 2020, the Company received $2.2 million from East West Bank, the Company’s existing lender, pursuant to the Paycheck Protection Program (the “PPP Loan”) of the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”). The PPP Loan matures on April 10, 2022 (the “PPP Maturity Date”), accrues interest at 1% per annum and may be prepaid in whole or in part without penalty. No interest payments are due within the initial six months of the PPP Loan. The interest accrued during the initial six-month period is due and payable, together with the principal, on the PPP Maturity Date. The Company used all proceeds from the PPP Loan to retain employees, maintain payroll and make lease and utility payments to support business continuity throughout the COVID-19 pandemic, which amounts are intended to be eligible for forgiveness, subject to the provisions of the CARES Act and could be subject to repayment.

 

On June 24, 2020, the Company entered into an exchange agreement (the “Exchange Agreement”) pursuant to which the Company issued 329,501 shares of its Class A common stock, in exchange for $842 thousand principal amount and accrued and unpaid interest of outstanding Second Lien Loans (as defined in Note 6 - Notes Payable). The surrendered Second Lien Loans were immediately canceled. The exchange was consummated on June 24, 2020.

 

On June 26, 2020, the Company signed a consent agreement with the holders of the Second Lien loans to extend the maturity date to September 30, 2020 and grant the Company options to extend further to March 31, 2021 and then to June 30, 2021. A consent fee of $100,000 was paid in connection with this extension. On September 21, 2020, the Company extended the maturity date to March 31, 2021 upon payment of a fee of $50,000.

 

In a separate exchange with another holder of Second Lien Notes, on November 19, 2020, the Company issued 452,499 shares of Common Stock in exchange for $247,108 principal amount of Second Lien Notes. The exchanged Second Lien Notes were immediately cancelled.

 

43

 

 

On December 4, 2020, the Company entered into exchange agreements (the “December Exchange Agreements”) with certain holders of notes under its Second Lien Loan Agreement dated as of July 14, 2016 among the Company, the lenders party thereto, and Cortland Capital Market Services LLC, as Agent (“Second Lien Notes”). Pursuant to the December Exchange Agreements, the Company issued an aggregate of 2,776,284 shares of its Class A common stock, par value $0.001 per share Common Stock in exchange for an aggregate of $1,386,106 of principal amount of Second Lien Notes. The exchanged Second Lien Notes were immediately cancelled. The exchange was consummated on December 4, 2020.

 

On January 21, 2021, the Company entered into an exchange agreement (the “Exchange Agreement”) with a holder of notes under its Second Lien Loan Agreement dated as of July 14, 2016. (see Note 11 – Subsequent events)

 

In two separate exchanges with another holder of Second Lien Notes, on January 14, 2021 and January 21, 2021, the Company issued 689,500 shares and 580,448 shares of Common Stock in exchange for $500,000 and $600,000 principal amount, respectively, of Second Lien Notes. The exchanged Second Lien Notes were immediately cancelled.

 

On February 9, 2021, the Company prepaid substantially all of the outstanding obligations in respect of principal, interest, fees and expenses under the Second Lien Loan Agreement, dated as of July 14, 2016 (as amended, amended and restated, supplemented or otherwise modified, the “Second Lien Loan Agreement”), among the Company, certain lenders and Cortland Capital Market Services LLC. The payoff amount of approximately $3.18 million was comprised of (i) $3.1 million of principal, (2) accrued payment-in-kind interest of $.018 million, (3) accrued current interest of $0.007 million, and (4) fees and expenses of $0.004 million. Upon such prepayment, the Second Lien Loan Agreement was terminated effective February 9, 2021.

 

On April 15, 2020, the Company executed a letter amendment to the Bison Convertible Note (as defined in Note 6 - Notes Payable), which amended the Note, effective as of March 4, 2020, to extend the maturity date of the Bison Convertible note to March 4, 2021.

 

On October 9, 2019, the Company signed an extension to the Ming Tai Note of $5.0 million for the first of two (2) permitted additional (1) year extensions at the Company’s option from the original maturity date to October 9, 2020. This note will continue in full force and effect in accordance with its terms, including the Company’s reservation of its right to further extend the maturity date of this note, if it so elects.

 

On June 25, 2020, the Company signed an amendment to extend the maturity date of the East West Credit Facility (as defined in Note 6 - Notes Payable) with East West Bank from March 30, 2021 to June 30, 2021.

 

On September 11. 2020, the Bison and Ming Tai Notes, having an aggregate of $15 million principal amount (the “Notes”) were converted in full into an aggregate of 10,000,000 shares of Common Stock at a conversion price of $1.50 per share in accordance with the terms of the Notes. Accordingly, the Notes have been extinguished. The Notes were held by Bison Global and Mingtai, both of which are affiliates of Peixin Xu, the Chairman of Bison Capital Holding Company Limited, which is indirectly Cinedigm’s largest stockholder.

 

Changes in our cash flows were as follows:

 

Cash Flows

 

    Nine Months Ended
December 31,
 
($ in thousands)   2020     2019  
Net cash (used) provided by operating activities   $ (16,776 )   $ 5,318  
Net cash used in investing activities     (110 )     (377 )
Net cash provided (used) in financing activities     28,799       (8,339 )
Net change in cash, cash equivalents and restricted cash   $ 11,913     $ (3,398 )

 

As of December 31, 2020, we had cash and restricted cash balances of $27.2 million.

 

As of December 31, 2019, we had cash and restricted cash balances of $15.5 million.

 

44

 

 

For the nine months ended December 31, 2020, net cash provided by operating activities is primarily driven by loss from operations, excluding non-cash expenses such as depreciation, amortization, recovery for doubtful accounts and stock-based compensation, offset by changes in working capital. Additionally, during the nine months ended December 31, 2020, the Company paid down $22.0 million to vendors at both CEG and Corporate. Cash received from VPFs declined from the previous period as Phase I Deployment Systems in our Cinema Equipment Business reached the conclusion of their deployment payment period with certain major studios. Changes in accounts receivable from our studio customers largely impact cash flows from operating activities and vary based on the seasonality of movie release schedules by the major studios. Operating cash flows from CEG are typically higher during our fiscal third and fourth quarters, resulting from revenues earned during the holiday season, and lower in the other two quarters as we pay royalties on such revenues. In addition, we make advances on theatrical releases and to certain home entertainment distribution clients for which initial expenditures are generally recovered within six to twelve months. Cash flows were also impacted as a result of COVID-19, during the nine months ended December 31, 2020, theatres in many major markets remained closed throughout the third quarter causing the majority of major studios to move wide releases scheduled for the three months ended December 31, 2020 to future dates.  Only two major studios had wide theatrical releases in November/December, however, the theatrical window before the streaming debut was shortened or eliminated to accommodate the lack of theatrical venues. Because our digital cinema business earns a VPF when a movie is first played on a system, the temporary theatre closures resulting from the COVID-19 pandemic resulted in reduced revenues.

 

For the nine months ended December 31, 2019, net cash provided by operating activities is primarily driven by loss from operations, excluding non-cash expenses such as depreciation, amortization, provision for doubtful accounts and stock-based compensation, offset by changes in working capital. Cash received from VPFs declined from the previous period as Phase I and Phase II Deployment Systems in our Cinema Equipment Business reached the conclusion of their deployment payment period with certain major studios. Changes in accounts receivable from our studio customers largely impact cash flows from operating activities and vary based on the seasonality of movie release schedules by the major studios. Operating cash flows from CEG are typically higher during our fiscal third and fourth quarters, resulting from revenues earned during the holiday season, and lower in the other two quarters as we pay royalties on such revenues. In addition, we make advances on theatrical releases and to certain home entertainment distribution clients for which initial expenditures are generally recovered within six to twelve months.

 

For the nine months ended December 31, 2020, cash flows used in investing activities consisted of proceeds from the sale of Starrise shares of $0.8 million, purchases of property and equipment of $0.3 million, the sale of property and equipment of $0.2 million, and the purchase of intangible assets of $0.7 million related to the asset acquisition.

 

For the nine months ended December 31, 2019, cash flows used in investing activities mainly consisted of purchases of property and equipment of $0.3 million.

 

For the nine months ended December 31, 2020, cash flows provided by financing activities consisted of payments of approximately $22.4 million in notes payable, offset by $12.8 million from Credit Facility draws, $36.2 million received in connection with the issuance Class A common stock and the exercise of warrants, and $2.2 million received pursuant to the Payment Protection Program of the Coronavirus Aid, Relief and Economic Security Act.

 

For the nine months ended December 31, 2019, cash flows used in financing activities reflects payments of $8.1 million for the 2013 Prospect Loan, net payments of approximately $2.7 million for the Credit Facility, and $3.3 million for the Second Lien Loans offset by $5.8 million received in connection with the sale of 3,900,000 shares of our Common Stock.

 

We have contractual obligations that primarily consist of term notes payable, credit facilities, and non-cancelable operating leases related to office space.

 

We may continue to generate net losses for the foreseeable future primarily due to depreciation and amortization, interest on our debt obligations, marketing and promotional activities and content acquisition and marketing costs. Certain of these costs, including costs of content acquisition, marketing and promotional activities, could be reduced if necessary. The restrictions imposed by the terms of our debt obligations may limit our ability to obtain financing, make it more difficult to satisfy our debt obligations or require us to dedicate a substantial portion of our cash flow to payments on our existing debt obligations. We feel we are adequately financed for at least the next twelve months; however, we may need to raise additional capital for working capital as deemed necessary. Failure to generate additional revenues, raise additional capital or manage discretionary spending could have an adverse effect on our financial position, results of operations or liquidity.

 

We believe the combination of: (i) our cash and cash equivalent balances as of December 31, 2020, (ii) expected cash flows from operations, (iii) cost cutting measures including payroll expense reduction and real estate occupancy cost reductions, and (iv) the extension of maturity dates or extinguishment of our borrowings, the Starrise equity investment, the capital raises during and the support or availability of funding from other capital resources and financings will be sufficient to satisfy our contractual obligations, as well as liquidity for our operational and capital requirements, for twelve months from the filing of this document. Our capital requirements will depend on many factors, and we may need to use capital resources and obtain additional capital. Failure to generate additional revenues, obtain additional capital or manage discretionary spending could have an adverse effect on our financial position, results of operations and liquidity.

 

45

 

 

Seasonality

 

Revenues from our Cinema Equipment Business segment derived from the collection of VPFs from motion picture studios are seasonal, coinciding with the timing of releases of movies by the motion picture studios. Generally, motion picture studios release the most marketable movies during the summer and the winter holiday season. The unexpected emergence of a hit movie during other periods can alter the traditional trend. The timing of movie releases can have a significant effect on our results of operations, and the results of one quarter are not necessarily indicative of results for the next quarter or any other quarter. Our CEG segment benefits from the winter holiday season, and as a result, revenues in the segment are typically highest in our fiscal third quarter; however, we believe the seasonality of motion picture exhibition is becoming less pronounced as the motion picture studios are releasing movies more evenly throughout the year. For the nine months ended December 31, 2020, the pandemic caused theaters to close and distributors to move their theatrical releases to future dates or release their content on streaming platforms. Therefore, the normal seasonality for the Cinema Equipment Business was not an impact for this period.

 

Off-balance sheet arrangements

 

We are not a party to any off-balance sheet arrangements, other than operating leases in the ordinary course of business, which are disclosed above in the table of our significant contractual obligations, and CDF2 Holdings, LLC (“CDF2 Holdings”), our wholly-owned unconsolidated subsidiary. As discussed further in Note 3 - Other Interests to the Condensed Consolidated Financial Statements included in Item 1 of this Report on Form 10-Q, we hold a 100% equity interest in CDF2 Holdings, which is an unconsolidated variable interest entity (“VIE”), which wholly owns Cinedigm Digital Funding 2, LLC; however, we are not the primary beneficiary of the VIE.

 

Impact of Inflation

 

The impact of inflation on our operations has not been significant to date.  However, there can be no assurance that a high rate of inflation in the future would not have an adverse impact on our operating results.

 

Item 4. CONTROLS AND PROCEDURES

 

A control system, no matter how well conceived and operated, can provide only reasonable assurance, not absolute assurance, that the objective of the control system will be met. Further, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the company have been detected. Because of the inherent limitations in a cost-effective control system, misstatement due to error or fraud may occur and not be detected. However, our disclosure controls and procedures are designed to provide reasonable assurance of achieving their objectives.

 

The management of the Company, under the supervision and with the participation of our Chief Executive Officer and principal financial officer, has evaluated the effectiveness of the Company’s disclosure controls and procedures (as such term is defined in Rule 13a-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), as of December 31, 2020. Based on such evaluation, our principal executive officer and principal financial officer have concluded that, as of the end of such period, the Company’s disclosure controls and procedures are effective in recording, processing, summarizing and reporting, on a timely basis, information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act and are effective in ensuring that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the Company’s management, including the Company’s principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.

 

There have been no changes in the Company’s internal control over financial reporting during this fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

46

 

 

PART II. OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

None.

 

ITEM 1A. RISK FACTORS

 

There have been no material changes to the Risk Factors disclosed in Item 1A of our Annual Report on Form 10-K for the fiscal year ended March 31, 2020.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

On December 21, 2020, the Company acquired substantially all of the assets of The Film Detective, LLC (“TFD”), a leading content distributor and streaming channel company focused on classic film and television programming. As part of the purchase price for the TFD acquisition, the Company issued 2,504,592 shares of Common Stock pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”).

 

In an exchange with a holder of Second Lien Notes, on February 2, 2021, the Company issued 425,290 shares of Common Stock in exchange for $500,000 principal amount of Second Lien Notes. The exchanged Second Lien Notes were immediately cancelled. The shares of Common Stock were issued pursuant to Section 3(a)(9) of the Securities Act.

 

On February 11, 2021, the Company acquired Screambox, constituting substantially all of the assets of Scream Entertainment, LLC (“Scream”), a popular enthusiast streaming service targeting the highly lucrative horror genre. As part of the purchase price for the Scream acquisition, the Company issued 593,534 shares of Common Stock pursuant to Section 4(a)(2) of the Securities Act.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not Applicable.

 

ITEM 5. OTHER INFORMATION

 

None.

 

ITEM 6. EXHIBITS

 

The exhibits are listed in the Exhibit Index on page 48 herein.

 

47

 

 

EXHIBIT INDEX

 

Exhibit
Number
  Description of Document
10.1   Exchange Agreement dated as of January 21, 2021 among Cinedigm Corp. and Wolverine Flagship Fund Trading Limited.
31.1   Officer’s Certificate Pursuant to 15 U.S.C. Section 7241, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2   Officer’s Certificate Pursuant to 15 U.S.C. Section 7241, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1   Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2   Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS   XBRL Instance Document.
101.SCH   XBRL Taxonomy Extension Schema.
101.CAL   XBRL Taxonomy Extension Calculation.
101.DEF   XBRL Taxonomy Extension Definition.
101.LAB   XBRL Taxonomy Extension Label.
101.PRE   XBRL Taxonomy Extension Presentation.

 

48

 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

      CINEDIGM CORP.
         
Date: February 22, 2021   By: /s/ Christopher J. McGurk
        Christopher J. McGurk
Chief Executive Officer and
Chairman of the Board of Directors
(Principal Executive Officer)
         
Date: February 22, 2021   By: /s/ Gary S. Loffredo
        Gary S. Loffredo
President, Chief Operating Officer,
General Counsel and Secretary
(Principal Financial Officer)

  

 

49

 

false --03-31 Q3 2021 0001173204 0001173204 2020-04-01 2020-12-31 0001173204 2021-02-19 0001173204 2020-12-31 0001173204 2020-03-31 0001173204 us-gaap:SeriesAPreferredStockMember 2020-12-31 0001173204 us-gaap:SeriesAPreferredStockMember 2020-03-31 0001173204 us-gaap:CommonClassAMember 2020-12-31 0001173204 us-gaap:CommonClassAMember 2020-03-31 0001173204 2020-10-01 2020-12-31 0001173204 2019-10-01 2019-12-31 0001173204 2019-04-01 2019-12-31 0001173204 us-gaap:SeriesAPreferredStockMember 2019-03-31 0001173204 us-gaap:CommonClassAMember 2019-03-31 0001173204 us-gaap:TreasuryStockMember 2019-03-31 0001173204 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0001173204 us-gaap:RetainedEarningsMember 2019-03-31 0001173204 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0001173204 us-gaap:ParentMember 2019-03-31 0001173204 us-gaap:NoncontrollingInterestMember 2019-03-31 0001173204 2019-03-31 0001173204 us-gaap:SeriesAPreferredStockMember 2019-04-01 2019-06-30 0001173204 us-gaap:CommonClassAMember 2019-04-01 2019-06-30 0001173204 us-gaap:TreasuryStockMember 2019-04-01 2019-06-30 0001173204 us-gaap:AdditionalPaidInCapitalMember 2019-04-01 2019-06-30 0001173204 us-gaap:RetainedEarningsMember 2019-04-01 2019-06-30 0001173204 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-04-01 2019-06-30 0001173204 us-gaap:ParentMember 2019-04-01 2019-06-30 0001173204 us-gaap:NoncontrollingInterestMember 2019-04-01 2019-06-30 0001173204 2019-04-01 2019-06-30 0001173204 us-gaap:SeriesAPreferredStockMember 2019-06-30 0001173204 us-gaap:CommonClassAMember 2019-06-30 0001173204 us-gaap:TreasuryStockMember 2019-06-30 0001173204 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0001173204 us-gaap:RetainedEarningsMember 2019-06-30 0001173204 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-30 0001173204 us-gaap:ParentMember 2019-06-30 0001173204 us-gaap:NoncontrollingInterestMember 2019-06-30 0001173204 2019-06-30 0001173204 us-gaap:SeriesAPreferredStockMember 2019-07-01 2019-09-30 0001173204 us-gaap:CommonClassAMember 2019-07-01 2019-09-30 0001173204 us-gaap:TreasuryStockMember 2019-07-01 2019-09-30 0001173204 us-gaap:AdditionalPaidInCapitalMember 2019-07-01 2019-09-30 0001173204 us-gaap:RetainedEarningsMember 2019-07-01 2019-09-30 0001173204 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-07-01 2019-09-30 0001173204 us-gaap:ParentMember 2019-07-01 2019-09-30 0001173204 us-gaap:NoncontrollingInterestMember 2019-07-01 2019-09-30 0001173204 2019-07-01 2019-09-30 0001173204 us-gaap:SeriesAPreferredStockMember 2019-09-30 0001173204 us-gaap:CommonClassAMember 2019-09-30 0001173204 us-gaap:TreasuryStockMember 2019-09-30 0001173204 us-gaap:AdditionalPaidInCapitalMember 2019-09-30 0001173204 us-gaap:RetainedEarningsMember 2019-09-30 0001173204 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-09-30 0001173204 us-gaap:ParentMember 2019-09-30 0001173204 us-gaap:NoncontrollingInterestMember 2019-09-30 0001173204 2019-09-30 0001173204 us-gaap:SeriesAPreferredStockMember 2019-10-01 2019-12-31 0001173204 us-gaap:CommonClassAMember 2019-10-01 2019-12-31 0001173204 us-gaap:TreasuryStockMember 2019-10-01 2019-12-31 0001173204 us-gaap:AdditionalPaidInCapitalMember 2019-10-01 2019-12-31 0001173204 us-gaap:RetainedEarningsMember 2019-10-01 2019-12-31 0001173204 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-10-01 2019-12-31 0001173204 us-gaap:ParentMember 2019-10-01 2019-12-31 0001173204 us-gaap:NoncontrollingInterestMember 2019-10-01 2019-12-31 0001173204 us-gaap:SeriesAPreferredStockMember 2019-12-31 0001173204 us-gaap:CommonClassAMember 2019-12-31 0001173204 us-gaap:TreasuryStockMember 2019-12-31 0001173204 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001173204 us-gaap:RetainedEarningsMember 2019-12-31 0001173204 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001173204 us-gaap:ParentMember 2019-12-31 0001173204 us-gaap:NoncontrollingInterestMember 2019-12-31 0001173204 2019-12-31 0001173204 us-gaap:TreasuryStockMember 2020-03-31 0001173204 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001173204 us-gaap:RetainedEarningsMember 2020-03-31 0001173204 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0001173204 us-gaap:ParentMember 2020-03-31 0001173204 us-gaap:NoncontrollingInterestMember 2020-03-31 0001173204 us-gaap:SeriesAPreferredStockMember 2020-04-01 2020-06-30 0001173204 us-gaap:CommonClassAMember 2020-04-01 2020-06-30 0001173204 us-gaap:TreasuryStockMember 2020-04-01 2020-06-30 0001173204 us-gaap:RetainedEarningsMember 2020-04-01 2020-06-30 0001173204 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-04-01 2020-06-30 0001173204 us-gaap:ParentMember 2020-04-01 2020-06-30 0001173204 us-gaap:NoncontrollingInterestMember 2020-04-01 2020-06-30 0001173204 2020-04-01 2020-06-30 0001173204 us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2020-06-30 0001173204 us-gaap:SeriesAPreferredStockMember 2020-06-30 0001173204 us-gaap:CommonClassAMember 2020-06-30 0001173204 us-gaap:TreasuryStockMember 2020-06-30 0001173204 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001173204 us-gaap:RetainedEarningsMember 2020-06-30 0001173204 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 0001173204 us-gaap:ParentMember 2020-06-30 0001173204 us-gaap:NoncontrollingInterestMember 2020-06-30 0001173204 2020-06-30 0001173204 us-gaap:SeriesAPreferredStockMember 2020-07-01 2020-09-30 0001173204 us-gaap:CommonClassAMember 2020-07-01 2020-09-30 0001173204 us-gaap:TreasuryStockMember 2020-07-01 2020-09-30 0001173204 us-gaap:RetainedEarningsMember 2020-07-01 2020-09-30 0001173204 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-07-01 2020-09-30 0001173204 us-gaap:ParentMember 2020-07-01 2020-09-30 0001173204 us-gaap:NoncontrollingInterestMember 2020-07-01 2020-09-30 0001173204 2020-07-01 2020-09-30 0001173204 us-gaap:AdditionalPaidInCapitalMember 2020-07-01 2020-09-30 0001173204 us-gaap:SeriesAPreferredStockMember 2020-09-30 0001173204 us-gaap:CommonClassAMember 2020-09-30 0001173204 us-gaap:TreasuryStockMember 2020-09-30 0001173204 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001173204 us-gaap:RetainedEarningsMember 2020-09-30 0001173204 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-09-30 0001173204 us-gaap:ParentMember 2020-09-30 0001173204 us-gaap:NoncontrollingInterestMember 2020-09-30 0001173204 2020-09-30 0001173204 us-gaap:SeriesAPreferredStockMember 2020-10-01 2020-12-31 0001173204 us-gaap:CommonClassAMember 2020-10-01 2020-12-31 0001173204 us-gaap:TreasuryStockMember 2020-10-01 2020-12-31 0001173204 us-gaap:AdditionalPaidInCapitalMember 2020-10-01 2020-12-31 0001173204 us-gaap:RetainedEarningsMember 2020-10-01 2020-12-31 0001173204 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-10-01 2020-12-31 0001173204 us-gaap:ParentMember 2020-10-01 2020-12-31 0001173204 us-gaap:NoncontrollingInterestMember 2020-10-01 2020-12-31 0001173204 us-gaap:TreasuryStockMember 2020-12-31 0001173204 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001173204 us-gaap:RetainedEarningsMember 2020-12-31 0001173204 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001173204 us-gaap:ParentMember 2020-12-31 0001173204 us-gaap:NoncontrollingInterestMember 2020-12-31 0001173204 us-gaap:SubsequentEventMember 2021-02-01 2021-02-02 0001173204 2020-07-06 0001173204 2020-07-01 2020-07-16 0001173204 2020-07-16 0001173204 2020-07-01 2020-07-20 0001173204 2020-05-01 2020-05-20 0001173204 2020-05-20 0001173204 2020-05-01 2020-05-22 0001173204 2019-12-01 2019-12-27 0001173204 2020-02-01 2020-02-14 0001173204 2020-04-01 2020-04-10 0001173204 2020-04-10 0001173204 us-gaap:SubsequentEventMember 2021-02-19 0001173204 2020-04-01 2020-04-15 0001173204 2020-04-15 0001173204 2020-06-01 2020-06-24 0001173204 cidm:SecondLienLoansMember 2020-06-24 0001173204 cidm:SecondLienLoansMember 2020-06-01 2020-06-26 0001173204 2020-11-19 0001173204 2020-11-01 2020-11-19 0001173204 2020-12-01 2020-12-04 0001173204 2020-12-04 0001173204 cidm:SecondLienLoansMember us-gaap:SubsequentEventMember 2021-01-01 2021-01-31 0001173204 2019-10-01 2019-10-09 0001173204 2020-09-02 2020-09-11 0001173204 cidm:StarisseMember 2020-02-14 0001173204 2020-02-14 0001173204 us-gaap:CommonClassAMember 2020-02-14 2020-02-14 0001173204 cidm:StarisseMember 2020-04-10 0001173204 2020-04-10 2020-04-10 0001173204 cidm:StarisseMember 2020-12-31 0001173204 cidm:StarisseMember 2020-03-31 0001173204 us-gaap:UpFrontPaymentArrangementMember 2020-12-31 0001173204 cidm:ServicesMember 2020-12-31 0001173204 us-gaap:StockAppreciationRightsSARSMember 2020-10-01 2020-12-31 0001173204 us-gaap:StockAppreciationRightsSARSMember 2019-10-01 2019-12-31 0001173204 us-gaap:StockAppreciationRightsSARSMember 2020-04-01 2020-12-31 0001173204 us-gaap:StockAppreciationRightsSARSMember 2019-04-01 2019-12-31 0001173204 us-gaap:StockAppreciationRightsSARSMember cidm:TwoThousandSeventeenIncentivePlanMember 2020-04-01 2020-12-31 0001173204 srt:MaximumMember 2020-04-01 2020-12-31 0001173204 srt:MinimumMember us-gaap:CommonClassAMember 2020-12-31 0001173204 srt:MaximumMember us-gaap:CommonClassAMember 2020-12-31 0001173204 srt:MinimumMember 2020-04-01 2020-12-31 0001173204 us-gaap:PerformanceSharesMember 2018-07-16 2018-07-26 0001173204 us-gaap:PerformanceSharesMember 2020-04-01 2020-12-31 0001173204 us-gaap:CommonClassAMember 2020-04-01 2020-12-31 0001173204 srt:ChiefExecutiveOfficerMember 2020-10-01 2020-12-31 0001173204 us-gaap:RestrictedStockMember 2020-10-01 2020-12-31 0001173204 us-gaap:RestrictedStockMember 2020-04-01 2020-12-31 0001173204 srt:BoardOfDirectorsChairmanMember 2020-10-01 2020-12-31 0001173204 srt:BoardOfDirectorsChairmanMember 2019-10-01 2019-12-31 0001173204 srt:BoardOfDirectorsChairmanMember 2020-04-01 2020-12-31 0001173204 srt:BoardOfDirectorsChairmanMember 2019-04-01 2019-12-31 0001173204 cidm:StrategicInvestorAgreementMember us-gaap:CommonClassAMember 2020-08-26 2020-09-01 0001173204 cidm:StrategicInvestorAgreementMember us-gaap:CommonClassAMember 2020-04-01 2020-12-31 0001173204 cidm:StockOptionsAndWarrantsMember 2020-04-01 2020-12-31 0001173204 cidm:StockOptionsAndWarrantsMember 2019-04-01 2019-12-31 0001173204 srt:MinimumMember us-gaap:ComputerEquipmentMember 2020-04-01 2020-12-31 0001173204 srt:MaximumMember us-gaap:ComputerEquipmentMember 2020-04-01 2020-12-31 0001173204 cidm:InternalUseSoftwareMember 2020-04-01 2020-12-31 0001173204 cidm:DigitalCinemaProjectionSystemsMember 2020-04-01 2020-12-31 0001173204 srt:MinimumMember us-gaap:MachineryAndEquipmentMember 2020-04-01 2020-12-31 0001173204 srt:MaximumMember us-gaap:MachineryAndEquipmentMember 2020-04-01 2020-12-31 0001173204 srt:MinimumMember us-gaap:FurnitureAndFixturesMember 2020-04-01 2020-12-31 0001173204 srt:MaximumMember us-gaap:FurnitureAndFixturesMember 2020-04-01 2020-12-31 0001173204 us-gaap:FairValueInputsLevel1Member 2020-12-31 0001173204 us-gaap:FairValueInputsLevel2Member 2020-12-31 0001173204 us-gaap:FairValueInputsLevel3Member 2020-12-31 0001173204 us-gaap:FairValueInputsLevel1Member 2020-03-31 0001173204 us-gaap:FairValueInputsLevel2Member 2020-03-31 0001173204 us-gaap:FairValueInputsLevel3Member 2020-03-31 0001173204 cidm:PhaseIDeploymentMember cidm:CinemaEquipmentBusinessOneMember 2020-10-01 2020-12-31 0001173204 cidm:PhaseIDeploymentMember cidm:CinemaEquipmentBusinessOneMember 2019-10-01 2019-12-31 0001173204 cidm:PhaseIDeploymentMember cidm:CinemaEquipmentBusinessOneMember 2020-04-01 2020-12-31 0001173204 cidm:PhaseIDeploymentMember cidm:CinemaEquipmentBusinessOneMember 2019-04-01 2019-12-31 0001173204 cidm:PhaseIIDeploymentMember cidm:CinemaEquipmentBusinessOneMember 2020-10-01 2020-12-31 0001173204 cidm:PhaseIIDeploymentMember cidm:CinemaEquipmentBusinessOneMember 2019-10-01 2019-12-31 0001173204 cidm:PhaseIIDeploymentMember cidm:CinemaEquipmentBusinessOneMember 2020-04-01 2020-12-31 0001173204 cidm:PhaseIIDeploymentMember cidm:CinemaEquipmentBusinessOneMember 2019-04-01 2019-12-31 0001173204 us-gaap:ServiceMember cidm:CinemaEquipmentBusinessOneMember 2020-10-01 2020-12-31 0001173204 us-gaap:ServiceMember cidm:CinemaEquipmentBusinessOneMember 2019-10-01 2019-12-31 0001173204 us-gaap:ServiceMember cidm:CinemaEquipmentBusinessOneMember 2020-04-01 2020-12-31 0001173204 us-gaap:ServiceMember cidm:CinemaEquipmentBusinessOneMember 2019-04-01 2019-12-31 0001173204 cidm:DigitalSystemSalesMember cidm:CinemaEquipmentBusinessOneMember 2020-10-01 2020-12-31 0001173204 cidm:DigitalSystemSalesMember cidm:CinemaEquipmentBusinessOneMember 2019-10-01 2019-12-31 0001173204 cidm:DigitalSystemSalesMember cidm:CinemaEquipmentBusinessOneMember 2020-04-01 2020-12-31 0001173204 cidm:DigitalSystemSalesMember cidm:CinemaEquipmentBusinessOneMember 2019-04-01 2019-12-31 0001173204 cidm:CinemaEquipmentBusinessOneMember 2020-10-01 2020-12-31 0001173204 cidm:CinemaEquipmentBusinessOneMember 2019-10-01 2019-12-31 0001173204 cidm:CinemaEquipmentBusinessOneMember 2020-04-01 2020-12-31 0001173204 cidm:CinemaEquipmentBusinessOneMember 2019-04-01 2019-12-31 0001173204 cidm:BaseDistributionBusinessMember cidm:ContentAndEntertainmentSegmentMember 2020-10-01 2020-12-31 0001173204 cidm:BaseDistributionBusinessMember cidm:ContentAndEntertainmentSegmentMember 2019-10-01 2019-12-31 0001173204 cidm:BaseDistributionBusinessMember cidm:ContentAndEntertainmentSegmentMember 2020-04-01 2020-12-31 0001173204 cidm:BaseDistributionBusinessMember cidm:ContentAndEntertainmentSegmentMember 2019-04-01 2019-12-31 0001173204 cidm:OTTStreamingandDigitalMember cidm:ContentAndEntertainmentSegmentMember 2020-10-01 2020-12-31 0001173204 cidm:OTTStreamingandDigitalMember cidm:ContentAndEntertainmentSegmentMember 2019-10-01 2019-12-31 0001173204 cidm:OTTStreamingandDigitalMember cidm:ContentAndEntertainmentSegmentMember 2020-04-01 2020-12-31 0001173204 cidm:OTTStreamingandDigitalMember cidm:ContentAndEntertainmentSegmentMember 2019-04-01 2019-12-31 0001173204 cidm:ContentAndEntertainmentSegmentMember 2020-10-01 2020-12-31 0001173204 cidm:ContentAndEntertainmentSegmentMember 2019-10-01 2019-12-31 0001173204 cidm:ContentAndEntertainmentSegmentMember 2020-04-01 2020-12-31 0001173204 cidm:ContentAndEntertainmentSegmentMember 2019-04-01 2019-12-31 0001173204 us-gaap:ShareBasedPaymentArrangementEmployeeMember 2020-10-01 2020-12-31 0001173204 us-gaap:ShareBasedPaymentArrangementEmployeeMember 2019-10-01 2019-12-31 0001173204 us-gaap:ShareBasedPaymentArrangementEmployeeMember 2020-04-01 2020-12-31 0001173204 us-gaap:ShareBasedPaymentArrangementEmployeeMember 2019-04-01 2019-12-31 0001173204 2020-12-01 2020-12-21 0001173204 us-gaap:CommonClassAMember 2020-12-21 0001173204 2021-12-31 0001173204 2021-04-01 2021-12-31 0001173204 cidm:TwoThousandThirteenProspectTermLoanAgreementMember 2013-02-28 0001173204 cidm:TwoThousandThirteenProspectTermLoanAgreementMember 2013-02-01 2013-02-28 0001173204 cidm:TwoThousandThirteenProspectTermLoanAgreementMember us-gaap:LondonInterbankOfferedRateLIBORMember 2013-02-28 0001173204 cidm:TwoThousandThirteenProspectTermLoanAgreementMember 2020-12-31 0001173204 cidm:TwoThousandThirteenProspectTermLoanAgreementMember 2020-03-31 0001173204 cidm:TwoThousandThirteenProspectTermLoanAgreementMember us-gaap:DebtInstrumentRedemptionPeriodTwoMember 2020-12-31 0001173204 cidm:TwoThousandThirteenProspectTermLoanAgreementMember us-gaap:DebtInstrumentRedemptionPeriodThreeMember 2020-12-31 0001173204 cidm:TwoThousandThirteenProspectTermLoanAgreementMember us-gaap:DebtInstrumentRedemptionPeriodFourMember 2020-12-31 0001173204 cidm:TwoThousandThirteenProspectTermLoanAgreementMember us-gaap:DebtInstrumentRedemptionPeriodFiveMember 2020-12-31 0001173204 cidm:TwoThousandThirteenProspectTermLoanAgreementMember us-gaap:DebtInstrumentRedemptionPeriodOneMember 2020-12-31 0001173204 cidm:TwoThousandThirteenProspectTermLoanAgreementMember 2020-12-31 0001173204 cidm:BisonNotePayableMember 2017-12-31 0001173204 cidm:BisonNotePayableMember 2018-07-20 0001173204 cidm:BisonNotePayableMember 2018-07-01 2018-07-20 0001173204 cidm:BisonNotePayableMember 2019-07-12 0001173204 us-gaap:ConvertibleNotesPayableMember us-gaap:ConvertibleDebtMember 2019-07-12 0001173204 us-gaap:ConvertibleNotesPayableMember us-gaap:ConvertibleDebtMember 2019-07-05 2019-07-12 0001173204 us-gaap:ConvertibleNotesPayableMember us-gaap:ConvertibleDebtMember cidm:BisonGlobalMember 2020-09-02 2020-09-11 0001173204 us-gaap:ConvertibleNotesPayableMember us-gaap:ConvertibleDebtMember cidm:BisonGlobalMember 2020-09-11 0001173204 cidm:SecondLienLoanAgreementMember us-gaap:ConvertibleDebtMember 2016-07-14 0001173204 cidm:SecondLienLoanAgreementMember us-gaap:ConvertibleDebtMember 2020-12-31 0001173204 cidm:RonaldLChezMember cidm:SecondLienLoanAgreementMember us-gaap:ConvertibleDebtMember 2020-12-31 0001173204 cidm:SecondLienLoanAgreementMember 2016-07-14 0001173204 cidm:SecondLienLoanAgreementMember us-gaap:SecuredDebtMember 2016-07-14 0001173204 cidm:SecondLienLoanAgreementMember us-gaap:PaymentInKindPIKNoteMember 2016-07-14 0001173204 cidm:SecondLienLoanAgreementMember us-gaap:SecuredDebtMember 2016-07-02 2016-07-14 0001173204 cidm:SecondLienLoanAgreementMember us-gaap:SecuredDebtMember 2020-04-01 2020-12-31 0001173204 cidm:SecondLienLoanAgreementMember 2020-06-24 0001173204 cidm:SecondLienLoanAgreementMember 2020-06-01 2020-06-24 0001173204 cidm:SecondLienLoanAgreementMember 2020-06-01 2020-07-02 0001173204 cidm:SecondLienLoanAgreementMember 2020-07-01 2020-07-31 0001173204 cidm:SecondLienLoanAgreementMember 2020-06-01 2020-06-26 0001173204 cidm:SecondLienLoanAgreementMember 2020-09-04 2020-09-21 0001173204 cidm:SecondLienLoanAgreementMember 2020-11-05 2020-11-19 0001173204 2020-11-05 2020-11-19 0001173204 cidm:SecondLienLoanAgreementMember 2020-11-05 2020-12-04 0001173204 cidm:SecondLienLoanAgreementMember us-gaap:SecuredDebtMember 2020-12-04 0001173204 2020-11-05 2020-12-04 0001173204 us-gaap:RevolvingCreditFacilityMember 2018-03-30 0001173204 us-gaap:RevolvingCreditFacilityMember cidm:CinedigmCreditFacilityMember us-gaap:PrimeRateMember 2018-03-03 2018-03-30 0001173204 us-gaap:RevolvingCreditFacilityMember cidm:CinedigmCreditFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-03-03 2018-03-30 0001173204 us-gaap:LineOfCreditMember 2020-12-31 0001173204 us-gaap:LineOfCreditMember 2020-03-31 0001173204 us-gaap:LineOfCreditMember 2019-07-03 0001173204 us-gaap:ConvertibleNotesPayableMember us-gaap:ConvertibleDebtMember 2018-10-09 0001173204 us-gaap:ConvertibleNotesPayableMember us-gaap:ConvertibleDebtMember 2018-09-09 2018-10-09 0001173204 us-gaap:ConvertibleNotesPayableMember us-gaap:ConvertibleDebtMember cidm:MingtaiConvertibleNotesMember 2018-10-09 0001173204 us-gaap:ConvertibleNotesPayableMember 2020-12-31 0001173204 us-gaap:ConvertibleNotesPayableMember us-gaap:ConvertibleDebtMember 2020-04-01 2020-12-31 0001173204 us-gaap:ConvertibleNotesPayableMember us-gaap:ConvertibleDebtMember 2020-12-31 0001173204 us-gaap:ConvertibleNotesPayableMember us-gaap:ConvertibleDebtMember cidm:MingtaiConvertibleNotesMember 2020-09-02 2020-09-11 0001173204 us-gaap:ConvertibleNotesPayableMember us-gaap:ConvertibleDebtMember cidm:MingtaiConvertibleNotesMember 2020-09-11 0001173204 us-gaap:ConvertibleNotesPayableMember 2020-04-01 2020-04-15 0001173204 us-gaap:ConvertibleNotesPayableMember 2020-04-15 0001173204 cidm:TwoThousandThirteenProspectTermLoanAgreementMember 2020-03-31 0001173204 cidm:TwoThousandThirteenProspectTermLoanAgreementMember cidm:NonrecourseNotesPayableMember 2020-12-31 0001173204 cidm:TwoThousandThirteenProspectTermLoanAgreementMember cidm:NonrecourseNotesPayableMember 2020-03-31 0001173204 cidm:NonrecourseNotesPayableMember 2020-12-31 0001173204 cidm:NonrecourseNotesPayableMember 2020-03-31 0001173204 cidm:BisonNotePayableMember 2020-12-31 0001173204 cidm:BisonNotePayableMember 2020-03-31 0001173204 cidm:SecondSecuredLienNotesMember 2020-12-31 0001173204 cidm:SecondSecuredLienNotesMember 2020-03-31 0001173204 cidm:CreditFacilityMember 2020-12-31 0001173204 cidm:CreditFacilityMember 2020-03-31 0001173204 cidm:MingtaiConvertibleNotesMember 2020-12-31 0001173204 cidm:MingtaiConvertibleNotesMember 2020-03-31 0001173204 cidm:PPPLoanMember 2020-12-31 0001173204 cidm:PPPLoanMember 2020-03-31 0001173204 cidm:RecourseNotesPayableMember 2020-12-31 0001173204 cidm:RecourseNotesPayableMember 2020-03-31 0001173204 srt:DirectorMember cidm:StrategicInvestorAgreementMember us-gaap:CommonClassAMember 2020-08-26 2020-09-01 0001173204 us-gaap:CommonClassAMember 2020-10-23 0001173204 us-gaap:CommonClassAMember 2020-12-01 2020-12-04 0001173204 us-gaap:SubsequentEventMember 2021-01-01 2021-01-31 0001173204 cidm:CinedigmEquityIncentivePlanMember 2020-04-01 2020-12-31 0001173204 cidm:CinedigmEquityIncentivePlanMember us-gaap:CommonClassAMember 2020-12-31 0001173204 cidm:CinedigmEquityIncentivePlanMember us-gaap:CommonClassAMember 2020-04-01 2020-12-31 0001173204 cidm:CinedigmEquityIncentivePlanMember us-gaap:CommonClassAMember 2020-03-31 0001173204 cidm:CinedigmEquityIncentivePlanMember us-gaap:CommonClassAMember 2019-04-01 2020-03-31 0001173204 cidm:TwoThousandSeventeenPlanMember us-gaap:CommonClassAMember 2017-08-31 0001173204 cidm:TwoThousandSeventeenPlanMember us-gaap:CommonClassAMember 2019-12-04 0001173204 srt:MinimumMember cidm:TwoThousandSeventeenPlanMember 2020-10-23 0001173204 srt:MaximumMember cidm:TwoThousandSeventeenPlanMember 2020-10-23 0001173204 cidm:GaiamAmericasIncAndGaiamIncGVEMember 2013-10-01 2013-10-31 0001173204 cidm:GaiamAmericasIncAndGaiamIncGVEMember us-gaap:EmployeeStockOptionMember 2013-10-01 2013-10-31 0001173204 cidm:GaiamAmericasIncAndGaiamIncGVEMember 2020-12-31 0001173204 us-gaap:EmployeeStockOptionMember srt:ChiefExecutiveOfficerMember us-gaap:CommonClassAMember 2010-12-31 0001173204 srt:ChiefExecutiveOfficerMember us-gaap:CommonClassAMember 2010-12-01 2010-12-31 0001173204 cidm:RonaldLChezMember us-gaap:CommonStockMember 2020-06-04 0001173204 cidm:RonaldLChezMember 2020-06-01 2020-06-04 0001173204 cidm:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOneMember 2020-04-01 2020-12-31 0001173204 cidm:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOneMember 2020-12-31 0001173204 cidm:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeTwoMember 2020-04-01 2020-12-31 0001173204 cidm:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeTwoMember 2020-12-31 0001173204 cidm:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeThreeMember 2020-04-01 2020-12-31 0001173204 cidm:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeThreeMember 2020-12-31 0001173204 cidm:StrategicManagementServiceProviderMember 2020-12-31 0001173204 cidm:StrategicManagementServiceProviderMember 2020-04-01 2020-12-31 0001173204 srt:MinimumMember cidm:StrategicManagementServiceProviderMember 2020-12-31 0001173204 srt:MaximumMember cidm:StrategicManagementServiceProviderMember 2020-12-31 0001173204 cidm:WarrantsIssuedInConnectionWithConvertibleNotesExchangeTransactionMember 2020-12-31 0001173204 cidm:WarrantsIssuedInConnectionWithConvertibleNotesExchangeTransactionMember 2020-04-01 2020-12-31 0001173204 cidm:BEMGTermLoanAgreementMember 2020-12-31 0001173204 cidm:BEMGTermLoanAgreementMember 2020-04-01 2020-12-31 0001173204 us-gaap:CommonClassAMember 2019-04-01 2019-12-31 0001173204 cidm:PhaseIDeploymentMember 2020-04-01 2020-12-31 0001173204 cidm:PhaseIIDeploymentMember 2020-04-01 2020-12-31 0001173204 us-gaap:EmployeeStockMember 2020-04-01 2020-12-31 0001173204 srt:DirectorMember 2020-04-01 2020-12-31 0001173204 cidm:CinemaEquipmentBusinessMember 2020-12-31 0001173204 cidm:ContentEntertainmentBusinessMember 2020-12-31 0001173204 us-gaap:CorporateMember 2020-12-31 0001173204 cidm:CinemaEquipmentBusinessMember 2020-03-31 0001173204 cidm:ContentEntertainmentBusinessMember 2020-03-31 0001173204 us-gaap:CorporateMember 2020-03-31 0001173204 cidm:CinemaEquipmentBusinessMember 2020-10-01 2020-12-31 0001173204 cidm:ContentEntertainmentBusinessMember 2020-10-01 2020-12-31 0001173204 us-gaap:CorporateMember 2020-10-01 2020-12-31 0001173204 cidm:CinemaEquipmentBusinessMember 2019-10-01 2019-12-31 0001173204 cidm:ContentEntertainmentBusinessMember 2019-10-01 2019-12-31 0001173204 us-gaap:CorporateMember 2019-10-01 2019-12-31 0001173204 cidm:CinemaEquipmentBusinessMember 2020-04-01 2020-12-31 0001173204 cidm:ContentEntertainmentBusinessMember 2020-04-01 2020-12-31 0001173204 us-gaap:CorporateMember 2020-04-01 2020-12-31 0001173204 cidm:CinemaEquipmentBusinessMember 2019-04-01 2019-12-31 0001173204 cidm:ContentEntertainmentBusinessMember 2019-04-01 2019-12-31 0001173204 us-gaap:CorporateMember 2019-04-01 2019-12-31 0001173204 us-gaap:OperatingExpenseMember cidm:CinemaEquipmentBusinessMember 2020-10-01 2020-12-31 0001173204 us-gaap:OperatingExpenseMember cidm:ContentEntertainmentBusinessMember 2020-10-01 2020-12-31 0001173204 us-gaap:OperatingExpenseMember us-gaap:CorporateMember 2020-10-01 2020-12-31 0001173204 us-gaap:OperatingExpenseMember 2020-10-01 2020-12-31 0001173204 us-gaap:SellingGeneralAndAdministrativeExpensesMember cidm:CinemaEquipmentBusinessMember 2020-10-01 2020-12-31 0001173204 us-gaap:SellingGeneralAndAdministrativeExpensesMember cidm:ContentEntertainmentBusinessMember 2020-10-01 2020-12-31 0001173204 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:CorporateMember 2020-10-01 2020-12-31 0001173204 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-10-01 2020-12-31 0001173204 us-gaap:OperatingExpenseMember cidm:CinemaEquipmentBusinessMember 2019-10-01 2019-12-31 0001173204 us-gaap:OperatingExpenseMember cidm:ContentEntertainmentBusinessMember 2019-10-01 2019-12-31 0001173204 us-gaap:OperatingExpenseMember us-gaap:CorporateMember 2019-10-01 2019-12-31 0001173204 us-gaap:OperatingExpenseMember 2019-10-01 2019-12-31 0001173204 us-gaap:SellingGeneralAndAdministrativeExpensesMember cidm:CinemaEquipmentBusinessMember 2019-10-01 2019-12-31 0001173204 us-gaap:SellingGeneralAndAdministrativeExpensesMember cidm:ContentEntertainmentBusinessMember 2019-10-01 2019-12-31 0001173204 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:CorporateMember 2019-10-01 2019-12-31 0001173204 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-10-01 2019-12-31 0001173204 us-gaap:OperatingExpenseMember cidm:CinemaEquipmentBusinessMember 2020-04-01 2020-12-31 0001173204 us-gaap:OperatingExpenseMember cidm:ContentEntertainmentBusinessMember 2020-04-01 2020-12-31 0001173204 us-gaap:OperatingExpenseMember us-gaap:CorporateMember 2020-04-01 2020-12-31 0001173204 us-gaap:OperatingExpenseMember 2020-04-01 2020-12-31 0001173204 us-gaap:SellingGeneralAndAdministrativeExpensesMember cidm:CinemaEquipmentBusinessMember 2020-04-01 2020-12-31 0001173204 us-gaap:SellingGeneralAndAdministrativeExpensesMember cidm:ContentEntertainmentBusinessMember 2020-04-01 2020-12-31 0001173204 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:CorporateMember 2020-04-01 2020-12-31 0001173204 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-04-01 2020-12-31 0001173204 us-gaap:OperatingExpenseMember cidm:CinemaEquipmentBusinessMember 2019-04-01 2019-12-31 0001173204 us-gaap:OperatingExpenseMember cidm:ContentEntertainmentBusinessMember 2019-04-01 2019-12-31 0001173204 us-gaap:OperatingExpenseMember us-gaap:CorporateMember 2019-04-01 2019-12-31 0001173204 us-gaap:OperatingExpenseMember 2019-04-01 2019-12-31 0001173204 us-gaap:SellingGeneralAndAdministrativeExpensesMember cidm:CinemaEquipmentBusinessMember 2019-04-01 2019-12-31 0001173204 us-gaap:SellingGeneralAndAdministrativeExpensesMember cidm:ContentEntertainmentBusinessMember 2019-04-01 2019-12-31 0001173204 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:CorporateMember 2019-04-01 2019-12-31 0001173204 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-04-01 2019-12-31 0001173204 us-gaap:CommonClassAMember us-gaap:SubsequentEventMember 2021-01-21 0001173204 cidm:SecondLienLoansMember us-gaap:CommonClassAMember us-gaap:SubsequentEventMember 2021-01-21 0001173204 cidm:SecondLienLoansMember us-gaap:SubsequentEventMember 2021-01-14 0001173204 cidm:SecondLienLoansMember us-gaap:SubsequentEventMember 2021-01-21 0001173204 us-gaap:SubsequentEventMember 2021-01-14 0001173204 us-gaap:SubsequentEventMember 2021-01-21 0001173204 cidm:SecondLienLoansMember us-gaap:SubsequentEventMember 2021-02-01 2021-02-09 0001173204 cidm:SecondLienLoansMember us-gaap:SubsequentEventMember 2021-02-09 0001173204 us-gaap:SubsequentEventMember 2021-01-25 2021-02-02 0001173204 us-gaap:SubsequentEventMember 2021-02-02 0001173204 us-gaap:SubsequentEventMember 2021-01-25 2021-02-05 xbrli:shares iso4217:USD xbrli:pure iso4217:USD xbrli:shares

Exhibit 10.1

 

EXCHANGE AGREEMENT

 

THIS EXCHANGE AGREEMENT (the “Agreement”) is dated January 21, 2021, by and between Cinedigm Corp., a Delaware corporation (the “Company”) and Wolverine Flagship Fund Trading Limited (the “Holder”).

 

RECITALS:

 

WHEREAS, the Holder holds $1,289,650.37 principal amount (the “Notes”) of the Company’s second lien secured notes (“Second Lien Notes”) pursuant to the Company’s Second Lien Loan Agreement dated as of July 14, 2016 among the Company, Cortland Capital Market Services LLC, as Agent (the “Agent”), and the lenders party thereto, as amended to date (the “Second Lien Loan Agreement”), with accrued interest as set forth on Schedule A attached hereto;

 

WHEREAS, subject to the terms and conditions set forth in this Agreement, the Company and the Holder desire to exchange the Holder’s Notes for, as set forth on Schedule A attached hereto, an aggregate of 1,247,626 shares (the “Shares”) of Class A common stock of the Company, par value $0.001 per share (the “Common Stock”).

 

NOW, THEREFORE, IN CONSIDERATION of the mutual covenants and agreements contained herein, and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Company and the Holder hereby agree as follows:

 

ARTICLE I

DEFINITIONS

 

1.1 Definitions. In addition to the terms defined elsewhere in this Agreement, the following terms have the meanings set forth in this Section 1.1:

 

Affiliate” has the meaning ascribed thereto in Rule 405 promulgated under the Securities Act.

 

Agent” has the meaning ascribed thereto in the recitals.

 

Board of Directors” means the board of directors of the Company.

 

Business Day” means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day on which banking institutions in the State of New York are authorized or required by law or other governmental action to close.

 

Certificate of Incorporation” means the Company’s Fifth Amended and Restated Certificate of Incorporation, as amended to date.

 

Closing” means the closing of the Exchange pursuant to Article 2.

 

 

 

  

Closing Date” means the date of this Agreement, or such other date as is mutually agreed by the Company and the Holder.

 

Commission” means the United States Securities and Exchange Commission.

 

Common Stock” has the meaning ascribed thereto in the recitals.

 

Company 2020 Balance Sheet” has the meaning ascribed thereto in Section 3.6.

 

Company Consolidated Financial Statements” has the meaning ascribed thereto in Section 3.6.

 

Electronic Delivery” has the meaning ascribed thereto in Section 6.2.

 

Exchange” means the exchange of the Notes for the Shares.

 

Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

 

GAAP” has the meaning ascribed thereto in Section 3.6.

 

Interest Due” means, with respect to the Notes being exchanged by the Holder, the amount of accrued but unpaid PIK interest thereon, accrued through the Closing Date.

 

Material Adverse Effect” means an event that results in or causes a material adverse change in any of (a) the condition (financial or otherwise), business, performance, operations or property of the Company and its material subsidiaries, taken as a whole, (b) the ability of any of the Company to perform its obligations under this Agreement or (c) the validity or enforceability of this Agreement or the rights and remedies of the Holder.

 

Notes” has the meaning ascribed thereto in the recitals.

 

Person” means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

 

Rule 144” means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.

 

SEC Reports” has the meaning ascribed thereto in Section 3.6.

 

Second Lien Loan Agreement” has the meaning ascribed thereto in the recitals.

 

Second Lien Notes” has the meaning ascribed thereto in the recitals.

 

2

 

 

Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 

Shares” has the meaning ascribed thereto in the recitals.

 

Trading Market” means the primary one of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the New York Stock Exchange, NYSE MKT, the Nasdaq Global Market, the Nasdaq Capital Market, or any other recognized exchange or automated quotation system (or any successors to any of the foregoing), and which is initially the Nasdaq Global Market.

 

Transfer Agent” means American Stock Transfer & Trust Co., the current transfer agent of the Company, and any successor transfer agent of the Company.

 

ARTICLE II

EXCHANGE

 

2.1 The Exchange. At the Closing of the Exchange contemplated hereby, the Holder shall surrender to the Agent the Notes in exchange for the Shares. Upon the Closing Date that is mutually agreed upon by the parties, the Closing shall occur at the offices of the Company’s counsel or such other location as the parties shall mutually agree. Effective upon the Closing, the Holder shall have no further claim against the Company with respect to the Notes, and the Company shall have no further obligation to the Holder with respect to the Notes, under the Second Lien Loan Agreement.

 

2.2 Interest on Notes. The Interest Due shall be paid in Shares by including the Interest Due with the principal amount outstanding of the Notes being surrendered when calculating the number Shares to be issued. The parties acknowledge that the cash interest accrued through the Closing Date on the Notes will be paid by the Agent in accordance with ordinary payment procedures.

 

2.3 Closing Deliveries.

 

(a) At the Closing, the Company shall deliver or cause to be delivered to the Holder the following:

 

(i) this Agreement duly executed by the Company; and

 

(ii) irrevocable instructions to the Transfer Agent to effect a DWAC delivery of the Shares required to be issued under Section 2.1, to the account of the Holder or its nominee as indicated by the Holder.

 

(b) At the Closing, the Holder shall deliver or cause to be delivered to the Company, the following:

 

(i) this Agreement duly executed by each Holder; and

 

(ii) irrevocable instructions to the Agent with respect to the surrender of the Holder’s Notes.

 

3

 

 

2.4 No Additional Consideration. The Shares shall be issued to the Holder solely in exchange for the surrender of the Notes by the Holder, and the Holder shall not pay or be required to pay any additional consideration to the Company in order to effectuate the issuance of the Shares due to the Holder.

 

2.5 Extinguishment of Notes. It is intended that, upon the consummation of the Exchange, the Notes surrendered hereunder shall be cancelled and shall be null and void, and any and all rights arising thereunder shall be extinguished.

 

ARTICLE III

REPRESENTATIONS AND WARRANTIES OF THE COMPANY

 

As a material inducement to the Holder to enter into this Agreement and consummate the Exchange, the Company represents, warrants and covenants with and to the Holder as follows:

 

3.1 Authorization and Binding Obligation. The Company has the requisite power and authority to enter into and perform its obligations under this Agreement and to complete the Exchange, in accordance with the terms thereof. The execution and delivery of this Agreement by the Company, and the consummation by the Company of the Exchange, have been duly authorized by all necessary corporate action by the Company and no further consent or authorization is required. This Agreement has been duly executed and delivered by the Company, and constitutes the legal, valid and binding obligation of the Company, enforceable against the Company in accordance with their respective terms, except as such enforceability may be limited by general principles of equity or applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or similar laws relating to, or affecting generally, the enforcement of applicable creditors’ rights and remedies and except as rights to indemnification and to contribution may be limited by federal or state securities laws.

 

3.2 No Conflict. The execution, delivery and performance of this Agreement by the Company and the consummation by the Company of the Exchange will not (i) result in a violation of the Certificate of Incorporation, or other organizational document of the Company or any of its subsidiaries, any capital stock of the Company or any of its subsidiaries or bylaws of the Company or any of its subsidiaries, (ii) conflict with, or constitute a default (or an event which with notice or lapse of time or both would become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, or any claims or entitlements to the Shares (or other consideration) issuable to the Holder under this Agreement pursuant to, any agreement, indenture or instrument to which the Company or any of its subsidiaries is a party, for which a waiver or consent has not been obtained and is currently in effect, or (iii) result in a violation of any law, rule, regulation, order, judgment or decree (including foreign, federal and state securities laws) and applicable to the Company or any of its subsidiaries or by which any property or asset of the Company or any of its subsidiaries is bound or affected except, in the case of clause (ii) or (iii) above, to the extent such violations that could not reasonably be expected to have a material adverse effect on the Company or its subsidiaries or on the ability to consummate the transactions contemplated by this Agreement.

 

4

 

  

3.3 Securities Law Exemption. Assuming the accuracy of the representations and warranties of the Holder contained herein, the offer and issuance by the Company of the Shares as contemplated by this Agreement are exempt from registration under the Securities Act pursuant to Section 3(a)(9) thereunder. Rule 144(i) under the Securities Act does not apply to the Company, or the Company is otherwise in full compliance with the tests and standards set forth in Rule 144(i)(2) as of the date of this Agreement.

 

3.4 Issuance of Shares. Upon issuance of the Shares in accordance with the terms of this Agreement, the Shares will be validly issued, fully paid and non-assessable and free from all taxes, liens, charges and other encumbrances (including, for the avoidance of doubt, any claims or entitlements of others pursuant to the Second Lien Loan Agreement) and shall not be subject to any preemptive, participation, rights of first refusal and other similar rights.

 

3.5 No Integrated Offering. Except as contemplated by this Agreement and in connection with the exchange, if any, of Second Lien Notes held by other holders thereof, the Company has not sold or issued, nor will sell or issue any securities that would be integrated with the offering of the Shares contemplated by this Agreement pursuant to the Securities Act and the rules and regulations or the interpretations thereunder of the Commission.

 

3.6 SEC Reports; Financial Statements.

 

The Company has timely filed, or cured any defect relating to timely filing, all registration statements, forms, reports, definitive proxy statements, schedules and other documents and filings required to be filed by it under the Securities Act or the Exchange Act, as the case may be (the “SEC Reports”) since January 1, 2020. None of the Company’s subsidiaries is required to file periodic reports with the Commission pursuant to the Exchange Act. Each SEC Report (i) as of the time it was filed (or if subsequently amended, when amended), complied in all material respects with the requirements of the Securities Act or the Exchange Act, as the case may be, and (ii) did not, at the time it was filed (or if subsequently amended or superseded by an amendment or other SEC Report, then, on the date of such subsequent filing), contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements made therein, in light of the circumstances under which they were made, not misleading.

 

The Company’s consolidated financial statements (including, in each case, any notes thereto) contained in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2020 (the “Company Consolidated Financial Statements”) were prepared in accordance with generally accepted accounting principles as in effect in the United States of America (“GAAP”), applied on a consistent basis throughout the periods indicated (except as may be indicated in the notes thereto or as may have been required by regulatory accounting principles applicable to the Company or, in the case of interim consolidated financial statements, where information and footnotes contained in such financial statements are not required to be in compliance with GAAP), and in each case such Company Consolidated Financial Statements fairly presented, in all material respects, the consolidated financial position, results of operations, cash flows and shareholders’ equity of the Company and its consolidated subsidiaries as of the respective dates thereof and for the respective periods covered thereby (subject, in the case of unaudited financial statements, to normal year-end adjustments which were not and which are not expected to be, individually or in the aggregate, material to the Company and its consolidated subsidiaries taken as a whole).

 

5

 

 

Except as set forth in the SEC Reports, including without limitation, the risk factors contained therein, and except as and to the extent set forth on the consolidated balance sheet of the Company as of March 31, 2020 (the “Company 2020 Balance Sheet”), between March 31, 2020 and the date hereof neither the Company nor any of its consolidated subsidiaries has incurred any debts, liabilities or obligations (whether accrued, absolute, contingent, liquidated or otherwise, whether due or to become due) of a nature that would be required to be reflected on a balance sheet or in notes thereto prepared in accordance with GAAP consistently applied, except for liabilities or obligations (i) that, in the aggregate, are adequately provided for in the Company 2020 Balance Sheet, or (ii) incurred in the ordinary course of business between March 31, 2020 and the date hereof that would not, individually or in the aggregate, have any material adverse effect on (x) the business, financial condition, results of operations or assets of the Company and its subsidiaries taken as a whole, or (y) the ability of the Company to consummate the transactions contemplated by this Agreement.

 

3.7 Exchange Act Registration, Trading Market.

 

The Common Stock is registered pursuant to Section 12(b) of the Exchange Act and is listed on the Trading Market, and other than as disclosed in the SEC Reports, the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Trading Market, nor has the Company received any notification that the Commission or the Trading Market is contemplating terminating such registration or listing.

 

3.8 Proceedings. The Company knows of no proceedings relating to the Second Lien Notes that are pending or threatened before any court, arbitrator or administrative or governmental body that would adversely affect the completion of the Exchange.

 

3.9 Absence of Broker’s Fees. Neither the Company nor any of its officers or directors has retained or authorized any investment banker, broker, finder or other intermediary to act on behalf of the Company or incurred any liability for any banker’s, broker’s or finder’s fees or commissions in connection with the Exchange.

 

3.10 Offer to Other Parties. Occurring on or about the date of this Agreement, the Company has extended an offer to the other lenders party to the Second Lien Loan Agreement on substantially the same terms as those set forth in this Agreement.

 

6

 

 

ARTICLE IV

REPRESENTATIONS AND WARRANTIES OF the holder

 

As a material inducement to the Company to enter into this Agreement and consummate the Exchange, the Holder represents, warrants and covenants with and to the Company as follows:

 

4.1 Authorization and Binding Obligation. The Holder has the requisite legal capacity, power and authority to enter into, and perform is obligations under, this Agreement. Each of the execution, delivery and performance of this Agreement by the Holder, and the consummation by the Holder of the Exchange, have been duly authorized by all requisite corporate action on the part of the Holder, as applicable, and no further consent or authorization is required. This Agreement has been duly authorized, executed and delivered by such Holder, and constitutes the legal, valid and binding obligations of such Holder, enforceable against such Holder in accordance with its terms, except as such enforceability may be limited by general principles of equity or applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or similar laws relating to, or affecting generally, the enforcement of applicable creditors’ rights and remedies and except as rights to indemnification and to contribution may be limited by federal or state securities laws.

 

4.2 Beneficial Owner.

 

(a) The Holder owns, beneficially and of record, good and marketable title to Notes being exchanged pursuant to this Agreement, free and clear of any taxes or encumbrances; and at the Closing, the Holder will surrender to the Agent, on behalf of the Company, good and marketable title to such Notes in their entirety, free and clear of any security interests, liens, adverse claims, taxes or encumbrances.

 

(b) The Holder is not, and has not been for the preceding three months, an Affiliate of the Company. The Holder has beneficially owned the Notes being exchanged pursuant to this Agreement, fully paid, for at least one year as of the date hereof.

 

4.3 Experience of Investor. The Holder, either alone or together with its representatives, has such knowledge, sophistication and experience in business and financial matters so as to be capable of evaluating the merits and risks of the Exchange, and has evaluated the merits and risks thereof. Such Holder is able to bear the economic risk of an investment in the Shares and, at the present time, is able to afford a complete loss of such investment. The Holder qualifies as an accredited investor as defined in Rule 501 of the Securities Act and/or a qualified institutional buyer as defined in Rule 144A of the Securities Act.

 

4.4 Disclosure of Information. The Holder has access to and has reviewed the Company’s SEC Reports, including the “Risk Factors” contained therein. The Holder has had the opportunity to ask questions of and receive answers from the Company regarding the Company, its business and the terms and conditions of the offering of the Shares.

 

7

 

 

4.5 Restricted Securities. The Holder understands that the Shares are characterized as “restricted securities” as that term is defined under Rule 144 of the Securities Act and have not been registered under the Securities Act or any applicable state securities law, and may not be resold without registration under the Securities Act or the existence of an exemption therefrom. The Holder represents that it is familiar with Rule 144, as presently in effect, and understands the resale limitations imposed thereby and by the Securities Act. The Holder agrees and acknowledges that, in connection with the transfer of any portion of, or all of, the Shares, the Company may require the Holder to provide the Company an opinion of counsel selected by the Holder and reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably satisfactory to the Company, to the effect that such transfer does not require registration of such transferred Shares under the Securities Act.

 

4.6 Legends. Except as set forth in Section 5.3 hereof, the Holder agrees to the imprinting of a legend on the Shares, or certificates evidencing such securities, in substantially the following form:

 

THIS SECURITY HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY.

 

4.7 Proceedings. The Holder knows of no proceedings relating to the Second Lien Notes that are pending or threatened before any court, arbitrator or administrative or governmental body that would adversely affect the completion of the Exchange.

 

4.8 Tax Consequences. The Holder acknowledges that the Exchange may involve tax consequences to such Holder, and that the contents of this Agreement do not contain tax advice. The Holder acknowledges that it has not relied and will not rely upon the Company or any other Holder with respect to any tax consequences related to the Exchange. The Holder assumes full responsibility for all such consequences and for the preparation and filing of any tax returns and elections which may or must be filed in connection with its beneficial ownership of the Notes or the Shares, or the Exchange.

 

8

 

 

4.9 Absence of Broker’s Fees. Neither the Holder nor any of its officers, directors, partners, managers, trustees or similar Persons has retained or authorized any investment banker, broker, finder or other intermediary to act on behalf of the Holder or incurred any liability for any banker’s, broker’s or finder’s fees or commissions in connection with the Exchange.

 

4.10 Reliance on Exemptions. The Holder understands that the Shares are being offered and exchanged in reliance on specific exemptions from the registration requirements of United States federal and state securities laws, and that the Company is relying in part upon the truth and accuracy of, and the Holder’s representations, and compliance with, the representations, warranties, agreements, acknowledgments and understandings of the Holder set forth herein in order to determine the availability of such exemptions and the eligibility of the Holder to acquire the Shares.

 

ARTICLE V

COVENANTS AND OTHER AGREEMENTS

 

5.1 Holding Period. For the purposes of Rule 144, the Company acknowledges that the Holder’s holding period of the Notes may be tacked onto the holding period of the Shares, and the Company agrees not to take a position contrary to this Section 5.1.

 

5.2 Acceptance of Holder’s Counsel’s Rule 144 Opinion. The Company covenants that it shall give specific authorization to the Transfer Agent and its legal counsel that the Transfer Agent may accept a Holder’s legal counsel’s Rule 144 opinion with regard to sale of the Shares, in accordance with and subject to the review process in the last sentence of this Section 5.2, as long as such Holder holds any of the Shares; provided that the Transfer Agent shall be instructed to contact the Company for approval of all opinions before giving effect to the removal of any restrictive legends therefrom. The Company shall be allowed two (2) Business Days to review an opinion and if no objection is affirmatively raised then the Company’s approval shall be deemed given.

 

5.3 Removal of Restrictive Legends. Notwithstanding Section 4.6 hereof, Shares may be issued or reissued, as applicable, without a restrictive legend as follows:

 

(a) the Shares shall be issued at Closing, without any restrictive legend, based on the available tacking of the holding period under Section 5.1 of the Notes, in reliance on representations made by the Holder in Section 4 hereof; and

 

(b) the Holder represents that with respect to Shares, if the Holder subsequently becomes an Affiliate of the Company, the Holder will submit any Shares then held by such Holder that are not at such time marked with a restrictive legend relating to transfers under the Securities Act, to the Company for legending.

 

9

 

 

ARTICLE VI

MISCELLANEOUS

 

6.1 Governing Law; Jurisdiction; Jury Trial. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed by the internal laws of the State of New York, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of New York or any other jurisdictions) that would cause the application of the laws of any jurisdictions other than the State of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City and County of New York, for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding is improper. Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof to such party at the address for such notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY.

 

6.2 Counterparts; Signatures. This Agreement may be executed simultaneously in two or more counterparts, including both counterparts that are executed on paper and counterparts that are in the form of electronic records and are executed electronically, any one of which need not contain the signatures of more than one party, but all such counterparts taken together will constitute one and the same Agreement. This Agreement, to the extent delivered by means of a facsimile machine or electronic mail (any such delivery, an “Electronic Delivery”), shall be treated in all manner and respects as an original agreement or instrument and shall be considered to have the same binding legal effect as if it were the original signed version thereof delivered in person. No party hereto shall raise the use of Electronic Delivery to deliver a signature or the fact that any signature or agreement or instrument was transmitted or communicated through the use of Electronic Delivery as a defense to the formation of a contract, and each such party forever waives any such defense, except to the extent such defense related to lack of authenticity. An electronic signature means any electronic sound, symbol or process attached to or logically associated with a record and executed and adopted by a party with the intent to sign such record, including facsimile or e-mail electronic signatures. The parties acknowledge and agree that electronic records and electronic signatures, as well as facsimile signatures, may be used in connection with the execution of this Agreement and any future agreement in connection with this Agreement and electronic signatures, facsimile signatures or signatures transmitted by electronic mail in so-called pdf format shall be legal and binding and shall have the same full force and effect as if a paper original of this Agreement or any future agreement in connection with this Agreement had been delivered and had been signed using a handwritten signature. The parties (a) agree that an electronic signature, whether digital or encrypted, of a party to this Agreement or to any future agreements in connection with this Agreement is intended to authenticate this writing and to have the same force and effect as a manual signature, (b) intend to be bound by the signatures (whether original, facsimiled or electronic) on any document sent or delivered by facsimile, electronic mail or other electronic means, (c) are aware that the other party(ies) will rely on such signatures, and (d) waive any defenses to the enforcement of the terms of this Agreement and any future agreement in connection with this Agreement based on the foregoing forms of signature. If this Agreement or any future agreement in connection with this Agreement have been executed by electronic signature, all parties executing this Agreement are expressly consenting under the Electronic Signatures in Global and National Commerce Act (“E-SIGN”), and Uniform Electronic Transactions Act (“UETA”), that a signature by facsimile, email or other electronic means shall constitute an electronic signature to an electronic record under both E-SIGN and UETA with respect to this specific transaction.

 

10

 

 

6.3 Headings. The headings of this Agreement are for convenience of reference and shall not form part of, or affect the interpretation of, this Agreement.

 

6.4 Severability. If any provision of this Agreement is prohibited by law or otherwise determined to be invalid or unenforceable by a court of competent jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed amended to apply to the broadest extent that it would be valid and enforceable, and the invalidity or unenforceability of such provision shall not affect the validity of the remaining provisions of this Agreement so long as this Agreement as so modified continues to express, without material change, the original intentions of the parties as to the subject matter hereof and the prohibited nature, invalidity or unenforceability of the provision(s) in question does not substantially impair the respective expectations or reciprocal obligations of the parties or the practical realization of the benefits that would otherwise be conferred upon the parties. The parties will endeavor in good faith negotiations to replace the prohibited, invalid or unenforceable provision(s) with a valid provision(s), the effect of which comes as close as possible to that of the prohibited, invalid or unenforceable provision(s).

 

6.5 Entire Agreement; Amendments. This Agreement supersedes all other prior oral or written agreements between the Holder, the Company, their affiliates and persons acting on their behalf with respect to the matters discussed herein, and this Agreement contains the entire understanding of the parties with respect to the matters covered herein and, except as specifically set forth herein, neither the Company nor any Holder makes any representation, warranty, covenant or undertaking with respect to such matters. No provision of this Agreement may be amended other than by an instrument in writing signed by the Parties, and any amendment to this Agreement made in conformity with the provisions of this Section shall be binding upon the parties. No provision hereof may be waived other than by an instrument in writing signed by the party against whom enforcement is sought.

 

6.6 Survival. The representations and warranties contained herein shall survive the Closing and the delivery of the Shares.

 

6.7 Notices. Any notices, consents, waivers or other communications required or permitted to be given under the terms of this Agreement must be in writing and will be deemed to have been delivered: (i) upon receipt, when delivered personally; (ii) upon receipt, when sent by facsimile or email (provided confirmation of transmission is mechanically or electronically generated and kept on file by the sending party); or (iii) one (1) Business Day after deposit with an overnight courier service, in each case properly addressed to the party to receive the same. The addresses for such communications shall be:

 

If to the Company:

 

Cinedigm Corp.

237 West 35th Street, Suite 605

New York, NY 10001

Telephone: (212) 206-8600

Facsimile: (212) 598-4895

Attention: General Counsel

Email: gloffredo@cinedigm.com

 

11

 

 

With a copy to:

 

Kelley Drye & Warren LLP

101 Park Avenue

New York, New York 10178

Telephone: (212) 808-7800

Facsimile: (212) 808-7897

Attention: Jonathan K. Cooperman, Esq.

Email:jcooperman@kelleydrye.com

 

If to a Holder, to the address set forth for such Holder on such Holder’s signature page.

 

6.8 Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their respective successors and assigns. The Company shall not assign this Agreement or any rights or obligations hereunder without the prior written consent of a majority of the Holder. No Holder may assign this Agreement or any rights or obligations hereunder without the consent of the Company.

 

6.9 Construction.

 

The language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent, and no rules of strict construction will be applied against any party. No specific representation or warranty shall limit the generality or applicability of a more general representation or warranty.

 

For purposes of this Agreement, whenever the context requires: the singular number shall include the plural, and vice versa; the masculine gender shall include the feminine and neutral genders; the feminine gender shall include the masculine and neutral genders; and the neutral gender shall include the masculine and feminine genders.

 

Each and every reference to share prices and shares of Common Stock in this Agreement shall be subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date of this Agreement.

 

[signature pages follow]

 

12

 

 

IN WITNESS WHEREOF, the Holder and the Company have caused their respective signature pages to this Agreement to be duly executed as of the date first written above.

 

  COMPANY:
     
  CINEDIGM CORP.
   
  By: /s/ Gary S. Loffredo
    Name:   Gary S. Loffredo 
    Title: President, Chief Operating Officer, General Counsel and Secretary

 

[Signature Page to Exchange Agreement]

 

 

 

 

  HOLDER:
     
  Wolverine Flagship Fund Trading Limited
       
       
  By: /s/ Kenneth L. Nadel
    Name:   Kenneth L. Nadel
    Title: Authorized Signatory
       
       
    Address:
    c/o Wolverine Asset Management, LLC  
    175 W. Jackson Blvd, Suite 40  
    Chicago, IL 60604

 

For Issuance of Shares:

 

Registered Name: Wolverine Flagship Fund Trading Limited

 

Address:

175 W. Jackson Blvd

Suite 340

Chicago, IL 60604

 

Federal Tax ID/SSN: 98-0383545

 

[Signature Page to Exchange Agreement]

 

 

 

 

SCHEDULE A

 

 

Holder

  Principal Amount of Second Lien Notes to be surrendered     Accrued and unpaid Interest Due     Total Number of Shares to be Issued  
Wolverine Flagship Fund Trading Limited   $ 1,289,650.37     $ 4,137.63       1,247,626  

 

 

 

 

Exhibit 31.1

 

CINEDIGM CORP.

CERTIFICATION

 

I, Christopher J. McGurk, certify that:

 

1. I have reviewed this Form 10-Q of Cinedigm Corp.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

 

5. The registrant's other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

Date: February 22, 2020   By:  /s/ Christopher J. McGurk
    Christopher J. McGurk
Chief Executive Officer and
Chairman of the Board of Directors
(Principal Executive Officer)

 

Exhibit 31.2

 

CINEDIGM CORP.

CERTIFICATION

 

I, Gary Loffredo, certify that:

 

1. I have reviewed this Form 10-Q of Cinedigm Corp.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

 

5. The registrant's other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

Date: February 22, 2020   By:  /s/ Gary Loffredo  
    Gary Loffredo
Chief Operating Officer, President Digital Cinema,
General Counsel and Secretary
(Principal Financial Officer and
Principal Accounting Officer)  

 

Exhibit 32.1

 

CINEDIGM CORP.

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with Form 10-Q of Cinedigm Corp. (the “Company”) for the period ended December 31, 2020 as filed with the SEC (the “Report”), the undersigned, in the capacity and on the date indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

 

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

 

Date: February 22, 2020   By: /s/ Christopher J. McGurk
    Christopher J. McGurk
Chief Executive Officer and
Chairman of the Board of Directors
(Principal Executive Officer)

Exhibit 32.2

 

CINEDIGM CORP.

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with Form 10-Q of Cinedigm Corp. (the “Company”) for the period ended December 31, 2020 as filed with the SEC (the “Report”), the undersigned, in the capacity and on the date indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

 

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

 

Date: February 22, 2020   By: /s/ Gary Loffredo
    Gary Loffredo
Chief Operating Officer, President Digital Cinema,
General Counsel and Secretary
(Principal Financial Officer and
Principal Accounting Officer)